BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 327284 CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:4.3,wD:7.7,(6,-5.78,;7.34,-5,;8.67,-5.78,;7.34,-3.47,;6,-2.69,;4.67,-3.47,;3.33,-2.69,;3.33,-1.15,;2,-.38,;2,1.15,;.67,1.93,;-.67,1.15,;-2,1.93,;-2,3.47,;-.67,4.24,;.67,3.47,;-3.33,4.23,;-3.33,5.78,;-6,5.78,;-6,4.23,;-7.34,3.47,;-7.34,1.93,;-8.67,1.15,;-6,1.15,;-4.67,1.93,;-4.67,3.47,;4.67,-.38,;6,-1.15,)| InChI=1S/C22H30FN3O2/c1-15(27)24-19-5-2-16(3-6-19)8-11-26-12-9-17(10-13-26)22-20-7-4-18(23)14-21(20)28-25-22/h4,7,14,16-17,19H,2-3,5-6,8-13H2,1H3,(H,24,27) ZTPVZJYMOVCRTF-UHFFFAOYSA-N 180697 US8829029, 1 5-hydroxytryptamine receptor 2A Homo sapiens 2.224 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180697&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205906 313362859 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327285 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-6,-5.78,;-6,-4.24,;-4.67,-3.47,;-4.67,-1.93,;-6,-1.16,;-6,.38,;-7.34,1.15,;-8.67,-1.16,;-7.34,-1.93,;-7.34,-3.47,;-4.67,1.15,;-3.33,.38,;-2,1.15,;-2,2.69,;-.67,3.46,;.67,2.69,;2,3.46,;3.33,2.69,;4.67,3.46,;4.67,5,;3.33,5.78,;2,5,;6,5.77,;7.34,5,;8.67,5.77,;7.34,3.46,;6,2.69,;6,1.15,;7.34,.38,;8.67,1.15,;8.67,2.69,;-3.33,3.46,;-4.67,2.69,)| InChI=1S/C26H36FN3O3/c27-21-3-6-23-24(17-21)33-29-25(23)19-8-13-30(14-9-19)12-7-18-1-4-22(5-2-18)28-26(31)20-10-15-32-16-11-20/h3,6,17-20,22H,1-2,4-5,7-16H2,(H,28,31) FEQXRZMYCWCJKY-UHFFFAOYSA-N 180698 US8829029, 2 5-hydroxytryptamine receptor 2A Homo sapiens 1.739 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180698 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180698&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205907 313362860 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327286 COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:7.6,wD:10.10,(9.34,.38,;8,1.15,;8,2.69,;6.67,3.46,;6.67,5,;8,5.77,;5.33,5.77,;4,5,;4,3.46,;2.67,2.69,;1.33,3.46,;,2.69,;-1.33,3.46,;-2.67,2.69,;-2.67,1.15,;-4,.38,;-5.33,1.15,;-5.33,2.69,;-4,3.46,;-6.67,.38,;-8,1.15,;-9.34,-1.16,;-8,-1.93,;-8,-3.47,;-6.67,-4.24,;-6.67,-5.78,;-5.33,-3.47,;-5.33,-1.93,;-6.67,-1.16,;1.33,5,;2.67,5.78,)| InChI=1S/C24H34FN3O3/c1-30-15-11-23(29)26-20-5-2-17(3-6-20)8-12-28-13-9-18(10-14-28)24-21-7-4-19(25)16-22(21)31-27-24/h4,7,16-18,20H,2-3,5-6,8-15H2,1H3,(H,26,29) OWCFHTULJYSSNJ-UHFFFAOYSA-N 180699 US8829029, 3 5-hydroxytryptamine receptor 2A Homo sapiens 1.809 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180699 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180699&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205908 313362861 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327287 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(cc2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-6,-5.78,;-6,-4.24,;-4.67,-3.47,;-4.67,-1.93,;-6,-1.16,;-6,.38,;-7.34,1.15,;-8.67,-1.16,;-7.34,-1.93,;-7.34,-3.47,;-4.67,1.15,;-3.33,.38,;-2,1.15,;-2,2.69,;-.67,3.46,;.67,2.69,;2,3.46,;3.33,2.69,;4.67,3.46,;4.67,5,;3.33,5.78,;2,5,;6,5.77,;7.34,5,;8.67,5.77,;7.34,3.46,;8.67,2.69,;8.67,1.15,;7.34,.38,;6,1.15,;6,2.69,;7.34,-1.15,;6,-1.92,;6,-3.46,;7.34,-4.23,;8.67,-3.46,;8.67,-1.92,;-3.33,3.46,;-4.67,2.69,)| InChI=1S/C31H39FN4O3/c32-25-5-10-28-29(21-25)39-34-30(28)23-12-15-35(16-13-23)14-11-22-1-6-26(7-2-22)33-31(37)24-3-8-27(9-4-24)36-17-19-38-20-18-36/h3-5,8-10,21-23,26H,1-2,6-7,11-20H2,(H,33,37) DMESLZJUXZVTNG-UHFFFAOYSA-N 180700 US8829029, 4 5-hydroxytryptamine receptor 2A Homo sapiens 9.519 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180700 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180700&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206053 313362862 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327288 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(nc2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-8.67,3.47,;-7.34,4.23,;-6,3.47,;-4.67,4.23,;-4.67,5.78,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.78,;-2,5.78,;-2,4.23,;-.67,3.47,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.15,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.15,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.47,;6,-3.47,;4.67,-2.69,;3.33,-3.47,;3.33,-5,;4.67,-5.78,;6,-5,;2,-5.77,;.67,-5,;-.67,-5.77,;-.67,-7.31,;.67,-8.08,;2,-7.31,;.67,5.78,;-.67,6.55,)| InChI=1S/C30H38FN5O3/c31-24-4-7-26-27(19-24)39-34-29(26)22-10-13-35(14-11-22)12-9-21-1-5-25(6-2-21)33-30(37)23-3-8-28(32-20-23)36-15-17-38-18-16-36/h3-4,7-8,19-22,25H,1-2,5-6,9-18H2,(H,33,37) ZFNISNPBEQEQHE-UHFFFAOYSA-N 180701 US8829029, 4A 5-hydroxytryptamine receptor 2A Homo sapiens 2.701 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180701 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180701&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206054 313362863 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327289 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2cnc(cn2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-8.67,3.47,;-7.34,4.23,;-6,3.47,;-4.67,4.23,;-4.67,5.78,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.78,;-2,5.78,;-2,4.23,;-.67,3.47,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.15,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.15,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.47,;6,-3.47,;6,-5,;4.67,-5.78,;3.33,-5,;3.33,-3.47,;4.67,-2.69,;2,-5.77,;.67,-5,;-.67,-5.77,;-.67,-7.31,;.67,-8.08,;2,-7.31,;.67,5.78,;-.67,6.55,)| InChI=1S/C29H37FN6O3/c30-22-3-6-24-26(17-22)39-34-28(24)21-8-11-35(12-9-21)10-7-20-1-4-23(5-2-20)33-29(37)25-18-32-27(19-31-25)36-13-15-38-16-14-36/h3,6,17-21,23H,1-2,4-5,7-16H2,(H,33,37) LSHSMBQZYASNDB-UHFFFAOYSA-N 180702 US8829029, 4B 5-hydroxytryptamine receptor 2A Homo sapiens 3.81 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180702 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180702&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206055 313362864 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327290 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(nn2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-8.67,3.47,;-7.34,4.23,;-6,3.47,;-4.67,4.23,;-4.67,5.78,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.78,;-2,5.78,;-2,4.23,;-.67,3.47,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.15,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.15,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.47,;6,-3.47,;6,-5,;4.67,-5.78,;3.33,-5,;3.33,-3.47,;4.67,-2.69,;2,-5.77,;.67,-5,;-.67,-5.77,;-.67,-7.31,;.67,-8.08,;2,-7.31,;.67,5.78,;-.67,6.55,)| InChI=1S/C29H37FN6O3/c30-22-3-6-24-26(19-22)39-34-28(24)21-10-13-35(14-11-21)12-9-20-1-4-23(5-2-20)31-29(37)25-7-8-27(33-32-25)36-15-17-38-18-16-36/h3,6-8,19-21,23H,1-2,4-5,9-18H2,(H,31,37) RJFINFRRQCTSTE-UHFFFAOYSA-N 180703 US8829029, 4C 5-hydroxytryptamine receptor 2A Homo sapiens 3.181 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180703 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180703&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206056 313362865 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327291 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2cnc(nc2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-8.67,3.46,;-7.34,4.23,;-6,3.46,;-4.67,4.23,;-4.67,5.77,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.77,;-2,5.77,;-2,4.23,;-.67,3.46,;.67,4.23,;2,3.46,;2,1.92,;3.33,1.15,;3.33,-.39,;4.67,-1.16,;6,-.39,;6,1.15,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.46,;6,-3.46,;4.67,-2.69,;3.33,-3.46,;3.33,-5,;4.67,-5.77,;6,-5,;2,-5.77,;.67,-5,;-.67,-5.77,;-.67,-7.31,;.67,-8.08,;2,-7.31,;.67,5.77,;-.67,6.54,)| InChI=1S/C29H37FN6O3/c30-23-3-6-25-26(17-23)39-34-27(25)21-8-11-35(12-9-21)10-7-20-1-4-24(5-2-20)33-28(37)22-18-31-29(32-19-22)36-13-15-38-16-14-36/h3,6,17-21,24H,1-2,4-5,7-16H2,(H,33,37) XVKCBMHQXDTJBS-UHFFFAOYSA-N 180704 US8829029, 4D 5-hydroxytryptamine receptor 2A Homo sapiens 2.453 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180704 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180704&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206376 313362866 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327292 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(N3CCOCC3)c(F)c2)CC1 |r,wU:19.24,wD:16.17,(-5.05,-7.48,;-5.44,-5.99,;-4.36,-4.9,;-4.75,-3.41,;-6.24,-3.01,;-6.64,-1.53,;-8.13,-1.13,;-8.82,-3.7,;-7.33,-4.1,;-6.93,-5.59,;-5.55,-.44,;-4.06,-.84,;-2.98,.25,;-3.37,1.74,;-2.28,2.83,;-.8,2.43,;.29,3.52,;1.78,3.12,;2.87,4.21,;2.47,5.7,;.98,6.1,;-.11,5.01,;3.56,6.79,;5.05,6.39,;6.14,7.48,;5.44,4.9,;4.36,3.81,;4.75,2.32,;6.24,1.93,;6.64,.44,;5.55,-.65,;5.95,-2.14,;7.44,-2.54,;8.53,-1.45,;8.13,.04,;7.33,3.01,;8.82,2.62,;6.93,4.5,;-4.86,2.14,;-5.95,1.05,)| InChI=1S/C31H38F2N4O3/c32-24-4-7-26-29(20-24)40-35-30(26)22-10-13-36(14-11-22)12-9-21-1-5-25(6-2-21)34-31(38)23-3-8-28(27(33)19-23)37-15-17-39-18-16-37/h3-4,7-8,19-22,25H,1-2,5-6,9-18H2,(H,34,38) LUYOYJRCUNHAKE-UHFFFAOYSA-N 180705 US8829029, 5 5-hydroxytryptamine receptor 2A Homo sapiens 17.46 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180705 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180705&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206208 313362867 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327293 CN(C)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:12.12,wD:15.16,(5.9,-.65,;6.99,.44,;8.47,.04,;6.59,1.93,;5.1,2.32,;4.7,3.81,;5.79,4.9,;7.28,4.5,;7.68,3.01,;5.39,6.39,;6.48,7.48,;3.9,6.79,;2.81,5.7,;3.21,4.21,;2.12,3.12,;.64,3.52,;-.45,2.43,;-1.94,2.83,;-3.03,1.74,;-2.63,.25,;-3.72,-.84,;-5.21,-.44,;-5.6,1.05,;-4.52,2.14,;-6.3,-1.53,;-7.78,-1.13,;-8.47,-3.7,;-6.99,-4.1,;-6.59,-5.59,;-5.1,-5.99,;-4.7,-7.48,;-4.01,-4.9,;-4.41,-3.41,;-5.9,-3.01,;.24,5.01,;1.33,6.1,)| InChI=1S/C29H37FN4O2/c1-33(2)25-10-5-22(6-11-25)29(35)31-24-8-3-20(4-9-24)13-16-34-17-14-21(15-18-34)28-26-12-7-23(30)19-27(26)36-32-28/h5-7,10-12,19-21,24H,3-4,8-9,13-18H2,1-2H3,(H,31,35) ZXEXODRNGHENCD-UHFFFAOYSA-N 180706 US8829029, 6 5-hydroxytryptamine receptor 2A Homo sapiens 11.383 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180706 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180706&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 57555503 313362868 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327294 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)Cc2ccc3OCOc3c2)CC1 |r,wU:19.24,wD:16.17,(-6.64,-7.48,;-7.03,-5.99,;-5.95,-4.9,;-6.34,-3.41,;-7.83,-3.01,;-8.23,-1.53,;-9.72,-1.13,;-10.41,-3.7,;-8.92,-4.1,;-8.52,-5.59,;-7.14,-.44,;-5.65,-.84,;-4.56,.25,;-4.96,1.74,;-3.87,2.83,;-2.39,2.43,;-1.3,3.52,;.19,3.12,;1.28,4.21,;.88,5.7,;-.61,6.1,;-1.7,5.01,;1.97,6.79,;3.46,6.39,;4.55,7.48,;3.86,4.9,;5.34,4.5,;5.74,3.01,;7.23,2.62,;8.32,3.7,;9.86,3.62,;10.41,5.06,;9.21,6.03,;7.92,5.19,;6.43,5.59,;-6.45,2.14,;-7.54,1.05,)| InChI=1S/C29H34FN3O4/c30-22-4-7-24-26(17-22)37-32-29(24)21-10-13-33(14-11-21)12-9-19-1-5-23(6-2-19)31-28(34)16-20-3-8-25-27(15-20)36-18-35-25/h3-4,7-8,15,17,19,21,23H,1-2,5-6,9-14,16,18H2,(H,31,34) QSYSGNJXSQQELK-UHFFFAOYSA-N 180707 US8829029, 7 5-hydroxytryptamine receptor 2A Homo sapiens 2.087 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180707 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180707&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 57555505 313362869 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327295 COc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:11.11,wD:14.15,(6.3,-.65,;7.38,.44,;6.99,1.93,;5.5,2.32,;5.1,3.81,;6.19,4.9,;7.68,4.5,;8.07,3.01,;5.79,6.39,;6.88,7.48,;4.3,6.79,;3.21,5.7,;3.61,4.21,;2.52,3.12,;1.04,3.52,;-.05,2.43,;-1.54,2.83,;-2.63,1.74,;-2.23,.25,;-3.32,-.84,;-4.81,-.44,;-5.21,1.05,;-4.12,2.14,;-5.9,-1.53,;-7.38,-1.13,;-8.07,-3.7,;-6.59,-4.1,;-6.19,-5.59,;-4.7,-5.99,;-4.3,-7.48,;-3.61,-4.9,;-4.01,-3.41,;-5.5,-3.01,;.64,5.01,;1.73,6.1,)| InChI=1S/C28H34FN3O3/c1-34-24-9-4-21(5-10-24)28(33)30-23-7-2-19(3-8-23)12-15-32-16-13-20(14-17-32)27-25-11-6-22(29)18-26(25)35-31-27/h4-6,9-11,18-20,23H,2-3,7-8,12-17H2,1H3,(H,30,33) YZBUHABEHVWWRM-UHFFFAOYSA-N 180708 US8829029, 8 5-hydroxytryptamine receptor 2A Homo sapiens 3.654 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180708 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180708&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206210 313362870 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327296 CC(C)(C)Oc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:14.14,wD:17.18,(5.64,-1.05,;7.18,-1.05,;6.1,-2.14,;8.67,-1.45,;6.79,.44,;6.39,1.93,;4.9,2.32,;4.5,3.81,;5.59,4.9,;7.08,4.5,;7.48,3.01,;5.19,6.39,;6.28,7.48,;3.7,6.79,;2.62,5.7,;3.01,4.21,;1.93,3.12,;.44,3.52,;-.65,2.43,;-2.14,2.83,;-3.23,1.74,;-2.83,.25,;-3.92,-.84,;-5.41,-.44,;-5.8,1.05,;-4.72,2.14,;-6.49,-1.53,;-7.98,-1.13,;-8.67,-3.7,;-7.18,-4.1,;-6.79,-5.59,;-5.3,-5.99,;-4.9,-7.48,;-4.21,-4.9,;-4.61,-3.41,;-6.1,-3.01,;.04,5.01,;1.13,6.1,)| InChI=1S/C31H40FN3O3/c1-31(2,3)37-26-11-6-23(7-12-26)30(36)33-25-9-4-21(5-10-25)14-17-35-18-15-22(16-19-35)29-27-13-8-24(32)20-28(27)38-34-29/h6-8,11-13,20-22,25H,4-5,9-10,14-19H2,1-3H3,(H,33,36) YGFINQFSLIMLPP-UHFFFAOYSA-N 180709 US8829029, 9 5-hydroxytryptamine receptor 2A Homo sapiens 1.724 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180709 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180709&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206211 313362871 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327297 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(Cl)cc2)CC1 |r,wU:19.24,wD:16.17,(-4.3,-7.48,;-4.7,-5.99,;-3.61,-4.9,;-4.01,-3.41,;-5.5,-3.01,;-5.9,-1.53,;-7.38,-1.13,;-8.07,-3.7,;-6.59,-4.1,;-6.19,-5.59,;-4.81,-.44,;-3.32,-.84,;-2.23,.25,;-2.63,1.74,;-1.54,2.83,;-.05,2.43,;1.04,3.52,;2.52,3.12,;3.61,4.21,;3.21,5.7,;1.73,6.1,;.64,5.01,;4.3,6.79,;5.79,6.39,;6.88,7.48,;6.19,4.9,;5.1,3.81,;5.5,2.32,;6.99,1.93,;7.38,.44,;8.07,3.01,;7.68,4.5,;-4.12,2.14,;-5.21,1.05,)| InChI=1S/C27H31ClFN3O2/c28-21-5-3-20(4-6-21)27(33)30-23-8-1-18(2-9-23)11-14-32-15-12-19(13-16-32)26-24-10-7-22(29)17-25(24)34-31-26/h3-7,10,17-19,23H,1-2,8-9,11-16H2,(H,30,33) RYUCLQAAFLZLPD-UHFFFAOYSA-N 180710 US8829029, 10 5-hydroxytryptamine receptor 2A Homo sapiens 2.666 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180710 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180710&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206212 313362872 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327298 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(cc2)N2CCS(=O)(=O)CC2)CC1 |r,wU:19.24,wD:16.17,(-4.9,-7.48,;-5.3,-5.99,;-4.21,-4.9,;-4.61,-3.41,;-6.1,-3.01,;-6.49,-1.53,;-7.98,-1.13,;-8.67,-3.7,;-7.18,-4.1,;-6.79,-5.59,;-5.41,-.44,;-3.92,-.84,;-2.83,.25,;-3.23,1.74,;-2.14,2.83,;-.65,2.43,;.44,3.52,;1.93,3.12,;3.01,4.21,;2.62,5.7,;1.13,6.1,;.04,5.01,;3.7,6.79,;5.19,6.39,;6.28,7.48,;5.59,4.9,;4.5,3.81,;4.9,2.32,;6.39,1.93,;7.48,3.01,;7.08,4.5,;6.79,.44,;5.7,-.65,;6.1,-2.14,;7.58,-2.54,;7.18,-4.02,;8.67,-3.63,;8.67,-1.45,;8.27,.04,;-4.72,2.14,;-5.8,1.05,)| InChI=1S/C31H39FN4O4S/c32-25-5-10-28-29(21-25)40-34-30(28)23-12-15-35(16-13-23)14-11-22-1-6-26(7-2-22)33-31(37)24-3-8-27(9-4-24)36-17-19-41(38,39)20-18-36/h3-5,8-10,21-23,26H,1-2,6-7,11-20H2,(H,33,37) SQXPURWSUNRRIZ-UHFFFAOYSA-N 180711 US8829029, 11 5-hydroxytryptamine receptor 2A Homo sapiens 2.483 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180711 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180711&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205754 313362873 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327299 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccnc(c2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-6.53,-7.48,;-6.93,-5.99,;-5.84,-4.9,;-6.24,-3.41,;-7.73,-3.01,;-8.13,-1.53,;-9.62,-1.13,;-10.31,-3.7,;-8.82,-4.1,;-8.42,-5.59,;-7.04,-.44,;-5.55,-.84,;-4.46,.25,;-4.86,1.74,;-3.77,2.83,;-2.28,2.43,;-1.2,3.52,;.29,3.12,;1.38,4.21,;.98,5.7,;-.51,6.1,;-1.59,5.01,;2.07,6.79,;3.56,6.39,;4.65,7.48,;3.96,4.9,;2.87,3.81,;3.27,2.32,;4.75,1.93,;5.84,3.01,;5.44,4.5,;7.33,2.62,;7.73,1.13,;9.22,.73,;10.31,1.82,;9.91,3.31,;8.42,3.7,;-6.35,2.14,;-7.44,1.05,)| InChI=1S/C30H38FN5O3/c31-24-3-6-26-27(20-24)39-34-29(26)22-9-13-35(14-10-22)12-8-21-1-4-25(5-2-21)33-30(37)23-7-11-32-28(19-23)36-15-17-38-18-16-36/h3,6-7,11,19-22,25H,1-2,4-5,8-10,12-18H2,(H,33,37) VWGPRFQVSJZKGC-UHFFFAOYSA-N 180712 US8829029, 12 5-hydroxytryptamine receptor 2A Homo sapiens 2.459 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180712 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180712&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206377 313362874 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327300 COc1cc(ccn1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:11.11,wD:14.15,(9.02,1.13,;8.62,2.62,;7.13,3.01,;6.73,4.5,;5.25,4.9,;4.16,3.81,;4.56,2.32,;6.04,1.93,;4.85,6.39,;5.94,7.48,;3.36,6.79,;2.27,5.7,;2.67,4.21,;1.58,3.12,;.09,3.52,;-1,2.43,;-2.48,2.83,;-3.57,1.74,;-3.17,.25,;-4.26,-.84,;-5.75,-.44,;-6.15,1.05,;-5.06,2.14,;-6.84,-1.53,;-8.33,-1.13,;-9.02,-3.7,;-7.53,-4.1,;-7.13,-5.59,;-5.64,-5.99,;-5.25,-7.48,;-4.56,-4.9,;-4.95,-3.41,;-6.44,-3.01,;-.31,5.01,;.78,6.1,)| InChI=1S/C27H33FN4O3/c1-34-25-16-20(8-12-29-25)27(33)30-22-5-2-18(3-6-22)9-13-32-14-10-19(11-15-32)26-23-7-4-21(28)17-24(23)35-31-26/h4,7-8,12,16-19,22H,2-3,5-6,9-11,13-15H2,1H3,(H,30,33) WNNTXSLBSCNVQL-UHFFFAOYSA-N 180713 US8829029, 13 5-hydroxytryptamine receptor 2A Homo sapiens 1.623 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180713 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180713&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206378 313362875 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327301 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(cc2)N2CCCCC2)CC1 |r,wU:19.24,wD:16.17,(-4.9,-7.48,;-5.3,-5.99,;-4.21,-4.9,;-4.61,-3.41,;-6.1,-3.01,;-6.49,-1.53,;-7.98,-1.13,;-8.67,-3.7,;-7.18,-4.1,;-6.79,-5.59,;-5.41,-.44,;-3.92,-.84,;-2.83,.25,;-3.23,1.74,;-2.14,2.83,;-.65,2.43,;.44,3.52,;1.93,3.12,;3.01,4.21,;2.62,5.7,;1.13,6.1,;.04,5.01,;3.7,6.79,;5.19,6.39,;6.28,7.48,;5.59,4.9,;4.5,3.81,;4.9,2.32,;6.39,1.93,;7.48,3.01,;7.08,4.5,;6.79,.44,;5.7,-.65,;6.1,-2.14,;7.58,-2.54,;8.67,-1.45,;8.27,.04,;-4.72,2.14,;-5.8,1.05,)| InChI=1S/C32H41FN4O2/c33-26-8-13-29-30(22-26)39-35-31(29)24-15-20-36(21-16-24)19-14-23-4-9-27(10-5-23)34-32(38)25-6-11-28(12-7-25)37-17-2-1-3-18-37/h6-8,11-13,22-24,27H,1-5,9-10,14-21H2,(H,34,38) BACBDGDLWOOPAD-UHFFFAOYSA-N 180714 US8829029, 14 5-hydroxytryptamine receptor 2A Homo sapiens 2.598 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180714 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180714&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206379 313362876 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327302 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2COc3ccccc3O2)CC1 |r,wU:19.24,wD:16.17,(-5.25,-7.48,;-5.64,-5.99,;-4.56,-4.9,;-4.95,-3.41,;-6.44,-3.01,;-6.84,-1.53,;-8.33,-1.13,;-9.02,-3.7,;-7.53,-4.1,;-7.13,-5.59,;-5.75,-.44,;-4.26,-.84,;-3.17,.25,;-3.57,1.74,;-2.48,2.83,;-1,2.43,;.09,3.52,;1.58,3.12,;2.67,4.21,;2.27,5.7,;.78,6.1,;-.31,5.01,;3.36,6.79,;4.85,6.39,;5.94,7.48,;5.25,4.9,;4.16,3.81,;4.56,2.32,;6.04,1.93,;6.44,.44,;7.93,.04,;9.02,1.13,;8.62,2.62,;7.13,3.01,;6.73,4.5,;-5.06,2.14,;-6.15,1.05,)| InChI=1S/C29H34FN3O4/c30-21-7-10-23-26(17-21)37-32-28(23)20-12-15-33(16-13-20)14-11-19-5-8-22(9-6-19)31-29(34)27-18-35-24-3-1-2-4-25(24)36-27/h1-4,7,10,17,19-20,22,27H,5-6,8-9,11-16,18H2,(H,31,34) MDBJINZABFWALU-UHFFFAOYSA-N 180715 US8829029, 15 5-hydroxytryptamine receptor 2A Homo sapiens 2.57 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180715 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180715&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206380 313362877 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327303 Cc1ccn(CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)ccc34)CC2)n1 |r,wU:9.8,wD:12.12,(9.79,5.27,;8.45,4.5,;7.98,3.04,;6.44,3.04,;5.96,4.5,;4.47,4.9,;4.08,6.39,;5.17,7.48,;2.59,6.79,;1.5,5.7,;1.9,4.21,;.81,3.12,;-.68,3.52,;-1.77,2.43,;-3.25,2.83,;-4.34,1.74,;-3.94,.25,;-5.03,-.84,;-6.52,-.44,;-6.92,1.05,;-5.83,2.14,;-7.61,-1.53,;-9.1,-1.13,;-9.79,-3.7,;-8.3,-4.1,;-7.9,-5.59,;-6.41,-5.99,;-6.02,-7.48,;-5.33,-4.9,;-5.72,-3.41,;-7.21,-3.01,;-1.08,5.01,;.01,6.1,;7.21,5.41,)| InChI=1S/C26H34FN5O2/c1-18-8-15-32(29-18)17-25(33)28-22-5-2-19(3-6-22)9-12-31-13-10-20(11-14-31)26-23-7-4-21(27)16-24(23)34-30-26/h4,7-8,15-16,19-20,22H,2-3,5-6,9-14,17H2,1H3,(H,28,33) RLVPJHQAQHSEHQ-UHFFFAOYSA-N 180716 US8829029, 16 5-hydroxytryptamine receptor 2A Homo sapiens 2.795 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180716 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180716&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206706 313362878 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327304 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(cc2)-n2cccc2)CC1 |r,wU:19.24,wD:16.17,(-4.69,-7.48,;-5.09,-5.99,;-4,-4.9,;-4.4,-3.41,;-5.89,-3.01,;-6.28,-1.53,;-7.77,-1.13,;-8.46,-3.7,;-6.97,-4.1,;-6.58,-5.59,;-5.19,-.44,;-3.71,-.84,;-2.62,.25,;-3.02,1.74,;-1.93,2.83,;-.44,2.43,;.65,3.52,;2.14,3.12,;3.22,4.21,;2.83,5.7,;1.34,6.1,;.25,5.01,;3.92,6.79,;5.4,6.39,;6.49,7.48,;5.8,4.9,;4.71,3.81,;5.11,2.32,;6.6,1.93,;7.69,3.01,;7.29,4.5,;7,.44,;8.46,-.04,;8.46,-1.58,;7,-2.05,;6.09,-.81,;-4.5,2.14,;-5.59,1.05,)| InChI=1S/C31H35FN4O2/c32-25-7-12-28-29(21-25)38-34-30(28)23-14-19-35(20-15-23)18-13-22-3-8-26(9-4-22)33-31(37)24-5-10-27(11-6-24)36-16-1-2-17-36/h1-2,5-7,10-12,16-17,21-23,26H,3-4,8-9,13-15,18-20H2,(H,33,37) SIOXKMDYIGNNPU-UHFFFAOYSA-N 180717 US8829029, 17 5-hydroxytryptamine receptor 2A Homo sapiens 2.45 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180717 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180717&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206538 313362879 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327305 OC1(CC1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:7.7,wD:10.11,(7.88,5.3,;6.39,4.9,;5.99,3.41,;7.48,3.81,;5.99,6.39,;7.08,7.48,;4.5,6.79,;3.41,5.7,;3.81,4.21,;2.72,3.12,;1.23,3.52,;.15,2.43,;-1.34,2.83,;-2.43,1.74,;-2.03,.25,;-3.12,-.84,;-4.61,-.44,;-5.01,1.05,;-3.92,2.14,;-5.7,-1.53,;-7.18,-1.13,;-7.88,-3.7,;-6.39,-4.1,;-5.99,-5.59,;-4.5,-5.99,;-4.1,-7.48,;-3.41,-4.9,;-3.81,-3.41,;-5.3,-3.01,;.84,5.01,;1.93,6.1,)| InChI=1S/C24H32FN3O3/c25-18-3-6-20-21(15-18)31-27-22(20)17-8-13-28(14-9-17)12-7-16-1-4-19(5-2-16)26-23(29)24(30)10-11-24/h3,6,15-17,19,30H,1-2,4-5,7-14H2,(H,26,29) TYMYSUSJLROMAC-UHFFFAOYSA-N 180718 US8829029, 18 5-hydroxytryptamine receptor 2A Homo sapiens 1.444 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180718 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180718&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25141111 313362880 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327306 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2(CCC2)C(F)(F)F)CC1 |r,wU:19.24,wD:16.17,(-4.85,-7.48,;-5.25,-5.99,;-4.16,-4.9,;-4.56,-3.41,;-6.04,-3.01,;-6.44,-1.53,;-7.93,-1.13,;-8.62,-3.7,;-7.13,-4.1,;-6.73,-5.59,;-5.35,-.44,;-3.86,-.84,;-2.78,.25,;-3.17,1.74,;-2.09,2.83,;-.6,2.43,;.49,3.52,;1.98,3.12,;3.07,4.21,;2.67,5.7,;1.18,6.1,;.09,5.01,;3.76,6.79,;5.25,6.39,;6.33,7.48,;5.64,4.9,;4.87,3.57,;6.21,2.8,;6.98,4.13,;7.13,5.3,;8.62,5.7,;6.73,6.79,;7.53,3.81,;-4.66,2.14,;-5.75,1.05,)| InChI=1S/C26H33F4N3O2/c27-19-4-7-21-22(16-19)35-32-23(21)18-9-14-33(15-10-18)13-8-17-2-5-20(6-3-17)31-24(34)25(11-1-12-25)26(28,29)30/h4,7,16-18,20H,1-3,5-6,8-15H2,(H,31,34) SKJYMWUUJASLOP-UHFFFAOYSA-N 180719 US8829029, 19 5-hydroxytryptamine receptor 2A Homo sapiens 2.257 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180719 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180719&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206539 313362881 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327307 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC(F)(F)F)CC1 |r,wU:19.24,wD:16.17,(-3.7,-7.48,;-4.1,-5.99,;-3.01,-4.9,;-3.41,-3.41,;-4.9,-3.01,;-5.3,-1.53,;-6.79,-1.13,;-7.48,-3.7,;-5.99,-4.1,;-5.59,-5.59,;-4.21,-.44,;-2.72,-.84,;-1.63,.25,;-2.03,1.74,;-.94,2.83,;.54,2.43,;1.63,3.52,;3.12,3.12,;4.21,4.21,;3.81,5.7,;2.32,6.1,;1.23,5.01,;4.9,6.79,;6.39,6.39,;7.48,7.48,;6.79,4.9,;5.7,3.81,;4.61,2.72,;4.61,4.9,;6.79,2.72,;-3.52,2.14,;-4.61,1.05,)| InChI=1S/C23H29F4N3O2/c24-17-3-6-19-20(13-17)32-29-22(19)16-8-11-30(12-9-16)10-7-15-1-4-18(5-2-15)28-21(31)14-23(25,26)27/h3,6,13,15-16,18H,1-2,4-5,7-12,14H2,(H,28,31) PAZGGYGNWVGTBZ-UHFFFAOYSA-N 180720 US8829029, 20 5-hydroxytryptamine receptor 2A Homo sapiens 2.782 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180720 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180720&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206540 313362882 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327308 COc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)ccc34)CC2)cc(OC)c1 |r,wU:9.8,wD:12.12,(10.45,5.88,;8.96,6.28,;7.88,5.19,;6.39,5.59,;5.3,4.5,;3.81,4.9,;3.41,6.39,;4.5,7.48,;1.93,6.79,;.84,5.7,;1.23,4.21,;.15,3.12,;-1.34,3.52,;-2.43,2.43,;-3.92,2.83,;-5.01,1.74,;-4.61,.25,;-5.7,-.84,;-7.18,-.44,;-7.58,1.05,;-6.49,2.14,;-8.27,-1.53,;-9.76,-1.13,;-10.45,-3.7,;-8.96,-4.1,;-8.57,-5.59,;-7.08,-5.99,;-6.68,-7.48,;-5.99,-4.9,;-6.39,-3.41,;-7.88,-3.01,;-1.74,5.01,;-.65,6.1,;5.7,3.01,;7.18,2.62,;7.58,1.13,;9.07,.73,;8.27,3.7,)| InChI=1S/C30H38FN3O4/c1-36-25-15-21(16-26(19-25)37-2)17-29(35)32-24-6-3-20(4-7-24)9-12-34-13-10-22(11-14-34)30-27-8-5-23(31)18-28(27)38-33-30/h5,8,15-16,18-20,22,24H,3-4,6-7,9-14,17H2,1-2H3,(H,32,35) FDGBPEVIZWNWEX-UHFFFAOYSA-N 180721 US8829029, 21 5-hydroxytryptamine receptor 2A Homo sapiens 2.953 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180721 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180721&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206541 313362883 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327309 CC1CN(CC(C)O1)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:17.18,wD:20.22,(4.26,-3.23,;5.35,-2.14,;4.95,-.65,;6.04,.44,;7.53,.04,;7.93,-1.45,;9.42,-1.85,;6.84,-2.54,;5.64,1.93,;4.16,2.32,;3.76,3.81,;4.85,4.9,;6.33,4.5,;6.73,3.01,;4.45,6.39,;5.54,7.48,;2.96,6.79,;1.87,5.7,;2.27,4.21,;1.18,3.12,;-.31,3.52,;-1.39,2.43,;-2.88,2.83,;-3.97,1.74,;-3.57,.25,;-4.66,-.84,;-6.15,-.44,;-6.55,1.05,;-5.46,2.14,;-7.24,-1.53,;-8.73,-1.13,;-9.42,-3.7,;-7.93,-4.1,;-7.53,-5.59,;-6.04,-5.99,;-5.64,-7.48,;-4.95,-4.9,;-5.35,-3.41,;-6.84,-3.01,;-.7,5.01,;.38,6.1,)| InChI=1S/C33H43FN4O3/c1-22-20-38(21-23(2)40-22)29-10-5-26(6-11-29)33(39)35-28-8-3-24(4-9-28)13-16-37-17-14-25(15-18-37)32-30-12-7-27(34)19-31(30)41-36-32/h5-7,10-12,19,22-25,28H,3-4,8-9,13-18,20-21H2,1-2H3,(H,35,39) GCNYBTOKPNSCEU-UHFFFAOYSA-N 180722 US8829029, 22 5-hydroxytryptamine receptor 2A Homo sapiens 21.224 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180722 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180722&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206542 313362884 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327310 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc3OCOc3c2)CC1 |r,wU:19.24,wD:16.17,(-4.99,-7.48,;-5.39,-5.99,;-4.3,-4.9,;-4.7,-3.41,;-6.18,-3.01,;-6.58,-1.53,;-8.07,-1.13,;-8.76,-3.7,;-7.27,-4.1,;-6.87,-5.59,;-5.49,-.44,;-4.01,-.84,;-2.92,.25,;-3.32,1.74,;-2.23,2.83,;-.74,2.43,;.35,3.52,;1.84,3.12,;2.93,4.21,;2.53,5.7,;1.04,6.1,;-.05,5.01,;3.62,6.79,;5.1,6.39,;6.19,7.48,;5.5,4.9,;4.41,3.81,;4.81,2.32,;6.3,1.93,;7,.55,;8.52,.79,;8.76,2.32,;7.39,3.01,;6.99,4.5,;-4.8,2.14,;-5.89,1.05,)| InChI=1S/C28H32FN3O4/c29-21-4-7-23-25(16-21)36-31-27(23)19-10-13-32(14-11-19)12-9-18-1-5-22(6-2-18)30-28(33)20-3-8-24-26(15-20)35-17-34-24/h3-4,7-8,15-16,18-19,22H,1-2,5-6,9-14,17H2,(H,30,33) NHPZGAKHYOUQRR-UHFFFAOYSA-N 180723 US8829029, 23 5-hydroxytryptamine receptor 2A Homo sapiens 1.714 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180723 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180723&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206707 313362885 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327311 CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3ccc(F)cc23)CC1 |r,wU:4.3,wD:7.7,(8,-5.77,;6.67,-5,;5.33,-5.77,;6.67,-3.46,;5.33,-2.7,;4,-3.47,;2.67,-2.7,;2.67,-1.16,;1.33,-.39,;1.33,1.15,;,1.92,;-1.33,1.15,;-2.67,1.92,;-2.67,3.46,;-1.33,4.23,;,3.46,;-4,4.23,;-4,5.77,;-6.67,5.77,;-6.67,4.23,;-8,3.46,;-8,1.92,;-6.67,1.15,;-6.67,-.39,;-5.33,1.92,;-5.33,3.46,;4,-.38,;5.33,-1.16,)| InChI=1S/C22H30FN3O2/c1-15(27)24-19-5-2-16(3-6-19)8-11-26-12-9-17(10-13-26)22-20-14-18(23)4-7-21(20)28-25-22/h4,7,14,16-17,19H,2-3,5-6,8-13H2,1H3,(H,24,27) VPIBUDXDYGVIBY-UHFFFAOYSA-N 180724 US8829029, 24 5-hydroxytryptamine receptor 2A Homo sapiens 46.865 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180724 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180724&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206708 313362886 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327312 Fc1ccc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)c4ccc(cc4)N4CCOCC4)CC3)c2c1 |r,wU:17.20,wD:14.13,(-6.67,1.92,;-6.67,3.46,;-8,4.23,;-8,5.77,;-6.67,6.54,;-6.67,8.08,;-4,8.08,;-4,6.54,;-2.67,5.77,;-2.67,4.23,;-1.33,3.46,;,4.23,;1.33,3.46,;1.33,1.92,;2.67,1.15,;2.67,-.39,;4,-1.16,;5.33,-.39,;5.33,1.15,;4,1.93,;6.67,-1.15,;6.67,-2.69,;8,-3.46,;5.33,-3.46,;4,-2.69,;2.67,-3.46,;2.67,-5,;4,-5.77,;5.33,-5,;1.33,-5.77,;,-5,;-1.33,-5.77,;-1.33,-7.31,;,-8.08,;1.33,-7.31,;,5.77,;-1.33,6.54,;-5.33,5.77,;-5.33,4.23,)| InChI=1S/C31H39FN4O3/c32-25-5-10-29-28(21-25)30(34-39-29)23-12-15-35(16-13-23)14-11-22-1-6-26(7-2-22)33-31(37)24-3-8-27(9-4-24)36-17-19-38-20-18-36/h3-5,8-10,21-23,26H,1-2,6-7,11-20H2,(H,33,37) CIQACWAFDSMBMG-UHFFFAOYSA-N 180725 US8829029, 25 5-hydroxytryptamine receptor 2A Homo sapiens 22.32 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180725 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180725&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206709 313362887 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327313 COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3ccc(F)cc23)CC1 |r,wU:7.6,wD:10.10,(5.82,1.49,;6.91,.4,;6.52,-1.09,;7.6,-2.18,;7.21,-3.67,;8.29,-4.75,;5.72,-4.06,;4.63,-2.98,;3.14,-3.37,;2.05,-2.29,;2.45,-.8,;1.36,.29,;-.13,-.11,;-1.21,.98,;-2.7,.58,;-3.79,1.67,;-3.39,3.16,;-1.9,3.56,;-.82,2.47,;-4.88,3.56,;-5.85,4.75,;-7.29,4.2,;-7.21,2.67,;-8.29,1.58,;-7.9,.09,;-6.41,-.31,;-6.01,-1.8,;-5.32,.78,;-5.72,2.27,;3.94,-.4,;5.03,-1.49,)| InChI=1S/C24H34FN3O3/c1-30-15-11-23(29)26-20-5-2-17(3-6-20)8-12-28-13-9-18(10-14-28)24-21-16-19(25)4-7-22(21)31-27-24/h4,7,16-18,20H,2-3,5-6,8-15H2,1H3,(H,26,29) HZDFSRLOPVRUAU-UHFFFAOYSA-N 180726 US8829029, 26 5-hydroxytryptamine receptor 2A Homo sapiens 36.954 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180726 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180726&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206710 313362888 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327314 Fc1ccc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)c4ccc(cc4)N4CCCCC4)CC3)c2c1 |r,wU:17.20,wD:14.13,(-2.72,-6.04,;-4.21,-5.64,;-5.3,-6.73,;-6.79,-6.33,;-7.18,-4.85,;-8.67,-4.45,;-7.98,-1.87,;-6.49,-2.27,;-5.41,-1.18,;-3.92,-1.58,;-2.83,-.49,;-3.23,1,;-2.14,2.09,;-.65,1.69,;.44,2.78,;1.93,2.38,;3.01,3.47,;2.62,4.95,;1.13,5.35,;.04,4.26,;3.7,6.04,;5.19,5.64,;6.28,6.73,;5.59,4.16,;4.5,3.07,;4.9,1.58,;6.39,1.18,;7.48,2.27,;7.08,3.76,;6.79,-.31,;5.7,-1.39,;6.1,-2.88,;7.58,-3.28,;8.67,-2.19,;8.27,-.7,;-4.72,1.39,;-5.8,.31,;-6.1,-3.76,;-4.61,-4.16,)| InChI=1S/C32H41FN4O2/c33-26-8-13-30-29(22-26)31(35-39-30)24-15-20-36(21-16-24)19-14-23-4-9-27(10-5-23)34-32(38)25-6-11-28(12-7-25)37-17-2-1-3-18-37/h6-8,11-13,22-24,27H,1-5,9-10,14-21H2,(H,34,38) IWQHFZLOBAGAOK-UHFFFAOYSA-N 180727 US8829029, 27 5-hydroxytryptamine receptor 2A Homo sapiens 7.004 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180727 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180727&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207028 313362889 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327315 CC1CN(CC(C)O1)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3ccc(F)cc23)CC1 |r,wU:17.18,wD:20.22,(4.26,-3.97,;5.35,-2.88,;4.95,-1.39,;6.04,-.31,;7.53,-.7,;7.93,-2.19,;9.42,-2.59,;6.84,-3.28,;5.64,1.18,;4.16,1.58,;3.76,3.07,;4.85,4.16,;6.33,3.76,;6.73,2.27,;4.45,5.64,;5.54,6.73,;2.96,6.04,;1.87,4.95,;2.27,3.47,;1.18,2.38,;-.31,2.78,;-1.39,1.69,;-2.88,2.09,;-3.97,1,;-3.57,-.49,;-4.66,-1.58,;-6.15,-1.18,;-6.55,.31,;-5.46,1.39,;-7.24,-2.27,;-8.73,-1.87,;-9.42,-4.45,;-7.93,-4.85,;-7.53,-6.33,;-6.04,-6.73,;-4.95,-5.64,;-3.47,-6.04,;-5.35,-4.16,;-6.84,-3.76,;-.7,4.26,;.38,5.35,)| InChI=1S/C33H43FN4O3/c1-22-20-38(21-23(2)40-22)29-10-5-26(6-11-29)33(39)35-28-8-3-24(4-9-28)13-16-37-17-14-25(15-18-37)32-30-19-27(34)7-12-31(30)41-36-32/h5-7,10-12,19,22-25,28H,3-4,8-9,13-18,20-21H2,1-2H3,(H,35,39) RNAKUHHBSZEVQT-UHFFFAOYSA-N 180728 US8829029, 28 5-hydroxytryptamine receptor 2A Homo sapiens 99.138 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180728 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180728&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206870 313362890 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327316 Fc1ccc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)c4ccc(cc4)N4CCS(=O)(=O)CC4)CC3)c2c1 |r,wU:17.20,wD:14.13,(-2.72,-6.04,;-4.21,-5.64,;-5.3,-6.73,;-6.79,-6.33,;-7.18,-4.85,;-8.67,-4.45,;-7.98,-1.87,;-6.49,-2.27,;-5.41,-1.18,;-3.92,-1.58,;-2.83,-.49,;-3.23,1,;-2.14,2.09,;-.65,1.69,;.44,2.78,;1.93,2.38,;3.01,3.47,;2.62,4.95,;1.13,5.35,;.04,4.26,;3.7,6.04,;5.19,5.64,;6.28,6.73,;5.59,4.16,;4.5,3.07,;4.9,1.58,;6.39,1.18,;7.48,2.27,;7.08,3.76,;6.79,-.31,;5.7,-1.39,;6.1,-2.88,;7.58,-3.28,;7.18,-4.77,;8.67,-4.37,;8.67,-2.19,;8.27,-.7,;-4.72,1.39,;-5.8,.31,;-6.1,-3.76,;-4.61,-4.16,)| InChI=1S/C31H39FN4O4S/c32-25-5-10-29-28(21-25)30(34-40-29)23-12-15-35(16-13-23)14-11-22-1-6-26(7-2-22)33-31(37)24-3-8-27(9-4-24)36-17-19-41(38,39)20-18-36/h3-5,8-10,21-23,26H,1-2,6-7,11-20H2,(H,33,37) KHTOBAZDVUSQIH-UHFFFAOYSA-N 180729 US8829029, 29 5-hydroxytryptamine receptor 2A Homo sapiens 12.352 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180729 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180729&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205755 313362891 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327317 Fc1ccc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)c4ccc5OCOc5c4)CC3)c2c1 |r,wU:17.20,wD:14.13,(-2.81,-6.04,;-4.3,-5.64,;-5.39,-6.73,;-6.87,-6.33,;-7.27,-4.85,;-8.76,-4.45,;-8.07,-1.87,;-6.58,-2.27,;-5.49,-1.18,;-4.01,-1.58,;-2.92,-.49,;-3.32,1,;-2.23,2.09,;-.74,1.69,;.35,2.78,;1.84,2.38,;2.93,3.47,;2.53,4.95,;1.04,5.35,;-.05,4.26,;3.62,6.04,;5.1,5.64,;6.19,6.73,;5.5,4.16,;4.41,3.07,;4.81,1.58,;6.3,1.18,;7,-.19,;8.52,.05,;8.76,1.57,;7.39,2.27,;6.99,3.76,;-4.8,1.39,;-5.89,.31,;-6.18,-3.76,;-4.7,-4.16,)| InChI=1S/C28H32FN3O4/c29-21-4-8-24-23(16-21)27(31-36-24)19-10-13-32(14-11-19)12-9-18-1-5-22(6-2-18)30-28(33)20-3-7-25-26(15-20)35-17-34-25/h3-4,7-8,15-16,18-19,22H,1-2,5-6,9-14,17H2,(H,30,33) PGQVBLPLAKZWKQ-UHFFFAOYSA-N 180730 US8829029, 30 5-hydroxytryptamine receptor 2A Homo sapiens 11.217 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180730 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180730&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206871 313362892 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327318 COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:7.6,wD:10.10,(12.24,-1.15,;10.9,-1.92,;9.57,-1.15,;8.24,-1.92,;6.9,-1.15,;6.9,.39,;5.57,-1.92,;4.03,-1.92,;3.26,-3.26,;1.72,-3.26,;.95,-1.92,;-.59,-1.92,;-1.36,-.59,;-2.9,-.59,;-2.9,.95,;-4.23,1.72,;-5.57,.95,;-5.57,-.59,;-4.23,-1.36,;-6.9,1.72,;-6.9,3.26,;-9.57,3.26,;-9.57,1.72,;-10.9,.95,;-10.9,-.59,;-12.24,-1.36,;-9.57,-1.36,;-8.24,-.59,;-8.24,.95,;1.72,-.59,;3.26,-.59,)| InChI=1S/C24H34ClN3O3/c1-30-15-11-23(29)26-20-5-2-17(3-6-20)8-12-28-13-9-18(10-14-28)24-21-7-4-19(25)16-22(21)31-27-24/h4,7,16-18,20H,2-3,5-6,8-15H2,1H3,(H,26,29) IZWSUUXSTWDMST-UHFFFAOYSA-N 180731 US8829029, 32 5-hydroxytryptamine receptor 2A Homo sapiens 16.55 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180731 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180731&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206872 313362893 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327319 OC(C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1)C(F)(F)F |r,wU:5.4,wD:8.8,(4.67,-3.46,;6,-4.23,;7.34,-3.46,;8.67,-4.23,;7.34,-1.92,;6,-1.15,;4.67,-1.92,;3.33,-1.15,;3.33,.39,;2,1.16,;2,2.7,;.67,3.46,;.67,5,;-.67,5.77,;-2,5,;-2,3.46,;-.67,2.69,;-3.33,5.77,;-3.33,7.31,;-6,7.31,;-6,5.77,;-7.34,5,;-7.34,3.46,;-8.67,2.69,;-6,2.69,;-4.67,3.46,;-4.67,5,;4.67,1.16,;6,.39,;6,-5.77,;6,-7.31,;7.54,-5.77,;4.46,-5.77,)| InChI=1S/C23H29ClF3N3O3/c24-16-3-6-18-19(13-16)33-29-20(18)15-8-11-30(12-9-15)10-7-14-1-4-17(5-2-14)28-22(32)21(31)23(25,26)27/h3,6,13-15,17,21,31H,1-2,4-5,7-12H2,(H,28,32) XXFBAYGHJVLPQT-UHFFFAOYSA-N 180732 US8829029, 33 5-hydroxytryptamine receptor 2A Homo sapiens 21.866 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180732 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180732&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206873 313362894 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327320 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCCCO2)CC1 |r,wU:19.24,wD:16.17,(-8.67,3.46,;-7.34,4.23,;-6,3.46,;-4.67,4.23,;-4.67,5.77,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.77,;-2,5.77,;-.67,6.54,;.67,5.77,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.16,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.16,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.46,;6,-3.46,;6,-5,;7.34,-5.77,;7.34,-7.31,;6,-8.08,;4.67,-7.31,;4.67,-5.77,;-.67,3.46,;-2,4.23,)| InChI=1S/C27H38ClN3O3/c28-21-6-9-24-25(17-21)34-30-27(24)20-11-14-31(15-12-20)13-10-19-4-7-22(8-5-19)29-26(32)18-23-3-1-2-16-33-23/h6,9,17,19-20,22-23H,1-5,7-8,10-16,18H2,(H,29,32) GAKGHYKFFZHEBW-UHFFFAOYSA-N 180733 US8829029, 34 5-hydroxytryptamine receptor 2A Homo sapiens 5.829 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180733 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180733&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25206874 313362895 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327321 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C[C@@H]2CCCCO2)CC1 |r,wU:19.24,wD:16.17,26.28,(-8.67,3.46,;-7.34,4.23,;-6,3.46,;-4.67,4.23,;-4.67,5.77,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.77,;-2,5.77,;-.67,6.54,;.67,5.77,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.16,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.16,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.46,;6,-3.46,;6,-5,;7.34,-5.77,;7.34,-7.31,;6,-8.08,;4.67,-7.31,;4.67,-5.77,;-.67,3.46,;-2,4.23,)| InChI=1S/C27H38ClN3O3/c28-21-6-9-24-25(17-21)34-30-27(24)20-11-14-31(15-12-20)13-10-19-4-7-22(8-5-19)29-26(32)18-23-3-1-2-16-33-23/h6,9,17,19-20,22-23H,1-5,7-8,10-16,18H2,(H,29,32) GAKGHYKFFZHEBW-UHFFFAOYSA-N 180734 US8829029, 34A 5-hydroxytryptamine receptor 2A Homo sapiens 13.68 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180734 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180734&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207030 313362896 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327322 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C[C@H]2CCCCO2)CC1 |r,wU:19.24,26.28,wD:16.17,(-8.67,3.46,;-7.34,4.23,;-6,3.46,;-4.67,4.23,;-4.67,5.77,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.77,;-2,5.77,;-.67,6.54,;.67,5.77,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.16,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.16,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.46,;6,-3.46,;6,-5,;7.34,-5.77,;7.34,-7.31,;6,-8.08,;4.67,-7.31,;4.67,-5.77,;-.67,3.46,;-2,4.23,)| InChI=1S/C27H38ClN3O3/c28-21-6-9-24-25(17-21)34-30-27(24)20-11-14-31(15-12-20)13-10-19-4-7-22(8-5-19)29-26(32)18-23-3-1-2-16-33-23/h6,9,17,19-20,22-23H,1-5,7-8,10-16,18H2,(H,29,32) GAKGHYKFFZHEBW-UHFFFAOYSA-N 180735 US8829029, 34B 5-hydroxytryptamine receptor 2A Homo sapiens 15.304 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180735 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180735&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207029 313362897 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327323 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)OC1 |r,wU:10.9,2.1,wD:13.13,5.5,(7.34,-9.24,;6,-8.47,;6,-6.93,;7.34,-6.16,;7.34,-4.62,;6,-3.85,;6,-2.31,;7.34,-1.54,;8.67,-2.31,;7.34,,;6,.77,;4.67,,;3.33,.77,;3.33,2.31,;2,3.08,;2,4.62,;.67,5.39,;.67,6.93,;-.67,7.7,;-2,6.93,;-2,5.39,;-.67,4.62,;-3.33,7.7,;-3.33,9.24,;-6,9.24,;-6,7.7,;-7.34,6.93,;-7.34,5.39,;-8.67,4.62,;-6,4.62,;-4.67,5.39,;-4.67,6.93,;4.67,3.08,;6,2.31,;4.67,-4.62,;4.67,-6.16,)| InChI=1S/C28H40ClN3O4/c1-34-24-8-7-23(35-18-24)17-27(33)30-22-5-2-19(3-6-22)10-13-32-14-11-20(12-15-32)28-25-9-4-21(29)16-26(25)36-31-28/h4,9,16,19-20,22-24H,2-3,5-8,10-15,17-18H2,1H3,(H,30,33) RDWXEESICWYGFN-UHFFFAOYSA-N 180736 US8829029, 35 5-hydroxytryptamine receptor 2A Homo sapiens 9.637 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180736 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180736&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 89664252 313362898 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327324 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCC3(CC2)OCCO3)CC1 |r,wU:19.24,wD:16.17,(-13.67,-1.36,;-12.34,-.59,;-11.01,-1.36,;-9.67,-.59,;-9.67,.95,;-8.34,1.72,;-8.34,3.26,;-11.01,3.26,;-11.01,1.72,;-12.34,.95,;-7.01,.95,;-5.67,1.72,;-4.34,.95,;-4.34,-.59,;-2.8,-.59,;-2.03,-1.92,;-.49,-1.92,;.28,-3.26,;1.82,-3.26,;2.59,-1.92,;1.82,-.59,;.28,-.59,;4.13,-1.92,;5.47,-1.16,;5.47,.39,;6.8,-1.92,;8.13,-1.16,;9.47,-1.92,;10.8,-1.16,;10.8,.39,;9.47,1.16,;8.13,.39,;11.57,1.72,;12.9,2.49,;13.67,1.16,;12.34,.39,;-5.67,-1.36,;-7.01,-.59,)| InChI=1S/C30H42ClN3O4/c31-24-3-6-26-27(20-24)38-33-29(26)23-10-15-34(16-11-23)14-9-21-1-4-25(5-2-21)32-28(35)19-22-7-12-30(13-8-22)36-17-18-37-30/h3,6,20-23,25H,1-2,4-5,7-19H2,(H,32,35) YDGKDHWBZFSXFF-UHFFFAOYSA-N 180737 US8829029, 36 5-hydroxytryptamine receptor 2A Homo sapiens 8.31 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180737 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180737&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207032 313362899 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327325 COC(CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1)OC |r,wU:7.6,wD:10.10,(12.24,-1.15,;10.9,-1.92,;9.57,-1.15,;8.24,-1.92,;6.9,-1.15,;6.9,.39,;5.57,-1.92,;4.03,-1.92,;3.26,-3.26,;1.72,-3.26,;.95,-1.92,;-.59,-1.92,;-1.36,-.59,;-2.9,-.59,;-2.9,.95,;-4.23,1.72,;-5.57,.95,;-5.57,-.59,;-4.23,-1.36,;-6.9,1.72,;-6.9,3.26,;-9.57,3.26,;-9.57,1.72,;-10.9,.95,;-10.9,-.59,;-12.24,-1.36,;-9.57,-1.36,;-8.24,-.59,;-8.24,.95,;1.72,-.59,;3.26,-.59,;9.57,.39,;10.9,1.15,)| InChI=1S/C25H36ClN3O4/c1-31-24(32-2)16-23(30)27-20-6-3-17(4-7-20)9-12-29-13-10-18(11-14-29)25-21-8-5-19(26)15-22(21)33-28-25/h5,8,15,17-18,20,24H,3-4,6-7,9-14,16H2,1-2H3,(H,27,30) AOWKBRDSGSHTGO-UHFFFAOYSA-N 180738 US8829029, 37 5-hydroxytryptamine receptor 2A Homo sapiens 13.65 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180738 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180738&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207339 313362900 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327326 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCCO2)CC1 |r,wU:19.24,wD:16.17,(-11.91,-2.69,;-10.57,-1.92,;-9.24,-2.69,;-7.91,-1.92,;-7.91,-.39,;-6.76,.65,;-7.39,2.05,;-8.92,1.89,;-9.24,.39,;-10.57,-.39,;-5.27,.25,;-4.88,-1.24,;-3.39,-1.64,;-2.3,-.55,;-.81,-.95,;.28,.14,;1.76,-.26,;2.16,-1.75,;3.65,-2.14,;4.74,-1.06,;4.34,.43,;2.85,.83,;6.23,-1.45,;7.32,-.37,;6.92,1.12,;8.8,-.76,;9.89,.32,;11.43,.32,;11.91,1.79,;10.66,2.69,;9.42,1.79,;-2.7,.94,;-4.19,1.34,)| InChI=1S/C26H36ClN3O3/c27-20-5-8-23-24(16-20)33-29-26(23)19-10-13-30(14-11-19)12-9-18-3-6-21(7-4-18)28-25(31)17-22-2-1-15-32-22/h5,8,16,18-19,21-22H,1-4,6-7,9-15,17H2,(H,28,31) XLEPAPXUDZKLLX-UHFFFAOYSA-N 180739 US8829029, 38 5-hydroxytryptamine receptor 2A Homo sapiens 13 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180739 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180739&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207180 313362901 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327327 C[C@@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:7.6,1.1,wD:10.10,(11.57,-1.44,;10.24,-2.21,;10.24,-3.75,;8.9,-1.44,;7.57,-2.21,;7.57,-3.75,;6.24,-1.44,;4.7,-1.44,;3.93,-2.77,;2.39,-2.77,;1.62,-1.44,;.08,-1.44,;-.69,-.1,;-2.23,-.1,;-2.23,1.44,;-3.57,2.21,;-4.9,1.44,;-4.9,-.1,;-3.57,-.87,;-6.24,2.21,;-6.24,3.75,;-8.9,3.75,;-8.9,2.21,;-10.24,1.44,;-10.24,-.1,;-11.57,-.87,;-8.9,-.87,;-7.57,-.1,;-7.57,1.44,;2.39,-.1,;3.93,-.1,)| InChI=1S/C24H34ClN3O3/c1-16(29)14-23(30)26-20-5-2-17(3-6-20)8-11-28-12-9-18(10-13-28)24-21-7-4-19(25)15-22(21)31-27-24/h4,7,15-18,20,29H,2-3,5-6,8-14H2,1H3,(H,26,30) NSDNFDRCTHNFLQ-UHFFFAOYSA-N 180740 US8829029, 39 5-hydroxytryptamine receptor 2A Homo sapiens 13 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180740 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180740&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207181 313362902 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327328 CC1(C)OC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)O1 |r,wU:10.9,wD:13.13,5.5,(10.69,2.35,;11.09,.86,;12.18,1.95,;12,-.39,;11.09,-1.63,;9.63,-1.16,;8.29,-1.92,;6.96,-1.16,;6.96,.39,;5.63,-1.92,;4.09,-1.92,;3.32,-3.26,;1.78,-3.26,;1.01,-1.92,;-.53,-1.92,;-1.3,-.59,;-2.84,-.59,;-2.84,.95,;-4.18,1.72,;-5.51,.95,;-5.51,-.59,;-4.18,-1.36,;-6.85,1.72,;-6.85,3.26,;-9.51,3.26,;-9.51,1.72,;-10.85,.95,;-10.85,-.59,;-12.18,-1.36,;-9.51,-1.36,;-8.18,-.59,;-8.18,.95,;1.78,-.59,;3.32,-.59,;9.63,.39,)| InChI=1S/C27H38ClN3O4/c1-27(2)33-17-22(34-27)16-25(32)29-21-6-3-18(4-7-21)9-12-31-13-10-19(11-14-31)26-23-8-5-20(28)15-24(23)35-30-26/h5,8,15,18-19,21-22H,3-4,6-7,9-14,16-17H2,1-2H3,(H,29,32) KQMNZZIIXVDTBN-UHFFFAOYSA-N 180741 US8829029, 40 5-hydroxytryptamine receptor 2A Homo sapiens 25 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180741 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180741&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207182 313362903 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327329 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)C1 |r,wU:10.9,5.5,wD:13.13,2.1,(13.24,-1.72,;12.47,-.39,;10.93,-.39,;10.03,.86,;8.56,.39,;8.56,-1.16,;7.23,-1.92,;5.9,-1.16,;5.9,.39,;4.56,-1.92,;3.02,-1.92,;2.25,-3.26,;.71,-3.26,;-.06,-1.92,;-1.6,-1.92,;-2.37,-.59,;-3.91,-.59,;-3.91,.95,;-5.24,1.72,;-6.57,.95,;-6.57,-.59,;-5.24,-1.36,;-7.91,1.72,;-7.91,3.26,;-10.58,3.26,;-10.58,1.72,;-11.91,.95,;-11.91,-.59,;-13.24,-1.36,;-10.58,-1.36,;-9.24,-.59,;-9.24,.95,;.71,-.59,;2.25,-.59,;10.03,-1.63,)| InChI=1S/C28H40ClN3O3/c1-34-24-8-4-20(16-24)17-27(33)30-23-6-2-19(3-7-23)10-13-32-14-11-21(12-15-32)28-25-9-5-22(29)18-26(25)35-31-28/h5,9,18-21,23-24H,2-4,6-8,10-17H2,1H3,(H,30,33) FMGBBVCKDCTAKW-UHFFFAOYSA-N 180742 US8829029, 41 5-hydroxytryptamine receptor 2A Homo sapiens 14 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180742&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207183 313362904 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327330 COC1(C)CCC(CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)CC1 |r,wU:11.10,wD:14.14,(12.93,-.03,;12.53,1.46,;11.05,1.86,;10.65,3.34,;11.44,.37,;10.36,-.72,;8.87,-.32,;7.78,-1.41,;6.29,-1.01,;5.89,.47,;5.2,-2.1,;3.72,-1.7,;2.63,-2.79,;1.14,-2.39,;.74,-.91,;-.75,-.51,;-1.84,-1.6,;-3.32,-1.2,;-4.41,-2.29,;-5.9,-1.89,;-6.3,-.4,;-5.21,.69,;-3.72,.29,;-7.79,-0,;-8.41,1.4,;-9.94,1.24,;-10.26,-.26,;-11.6,-1.03,;-11.6,-2.57,;-12.93,-3.34,;-10.26,-3.34,;-8.93,-2.57,;-8.93,-1.03,;1.83,.18,;3.32,-.22,;8.47,1.16,;9.56,2.25,)| InChI=1S/C30H44ClN3O3/c1-30(36-2)14-9-22(10-15-30)19-28(35)32-25-6-3-21(4-7-25)11-16-34-17-12-23(13-18-34)29-26-8-5-24(31)20-27(26)37-33-29/h5,8,20-23,25H,3-4,6-7,9-19H2,1-2H3,(H,32,35) YUMQWMQAMSUQRF-UHFFFAOYSA-N 180743 US8829029, 42 5-hydroxytryptamine receptor 2A Homo sapiens 19 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180743&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207184 313362905 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327331 CO[C@@]1(C)CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)CC1 |r,wU:11.10,6.6,2.2,wD:14.14,2.1,(10.2,-8.06,;9.8,-6.57,;8.47,-5.8,;7.14,-6.57,;9.8,-5.03,;9.8,-3.49,;8.47,-2.72,;8.47,-1.18,;7.14,-.41,;7.14,1.13,;5.8,-1.18,;4.47,-.41,;3.13,-1.18,;1.8,-.41,;1.8,1.13,;.47,1.9,;.47,3.44,;-.87,4.21,;-.87,5.75,;-2.2,6.52,;-3.53,5.75,;-3.53,4.21,;-2.2,3.44,;-4.87,6.52,;-4.87,8.06,;-7.53,8.06,;-7.53,6.52,;-8.87,5.75,;-8.87,4.21,;-10.2,3.44,;-7.53,3.44,;-6.2,4.21,;-6.2,5.75,;3.13,1.9,;4.47,1.13,;7.14,-3.49,;7.14,-5.03,)| InChI=1S/C30H44ClN3O3/c1-30(36-2)14-9-22(10-15-30)19-28(35)32-25-6-3-21(4-7-25)11-16-34-17-12-23(13-18-34)29-26-8-5-24(31)20-27(26)37-33-29/h5,8,20-23,25H,3-4,6-7,9-19H2,1-2H3,(H,32,35) YUMQWMQAMSUQRF-UHFFFAOYSA-N 180744 US8829029, 42A 5-hydroxytryptamine receptor 2A Homo sapiens 16 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180744&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207184 313362906 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327332 CO[C@]1(C)CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)CC1 |r,wU:11.10,6.6,2.1,wD:14.14,2.2,(10.2,-8.06,;9.8,-6.57,;8.47,-5.8,;7.14,-6.57,;9.8,-5.03,;9.8,-3.49,;8.47,-2.72,;8.47,-1.18,;7.14,-.41,;7.14,1.13,;5.8,-1.18,;4.47,-.41,;3.13,-1.18,;1.8,-.41,;1.8,1.13,;.47,1.9,;.47,3.44,;-.87,4.21,;-.87,5.75,;-2.2,6.52,;-3.53,5.75,;-3.53,4.21,;-2.2,3.44,;-4.87,6.52,;-4.87,8.06,;-7.53,8.06,;-7.53,6.52,;-8.87,5.75,;-8.87,4.21,;-10.2,3.44,;-7.53,3.44,;-6.2,4.21,;-6.2,5.75,;3.13,1.9,;4.47,1.13,;7.14,-3.49,;7.14,-5.03,)| InChI=1S/C30H44ClN3O3/c1-30(36-2)14-9-22(10-15-30)19-28(35)32-25-6-3-21(4-7-25)11-16-34-17-12-23(13-18-34)29-26-8-5-24(31)20-27(26)37-33-29/h5,8,20-23,25H,3-4,6-7,9-19H2,1-2H3,(H,32,35) YUMQWMQAMSUQRF-UHFFFAOYSA-N 180745 US8829029, 42B 5-hydroxytryptamine receptor 2A Homo sapiens 14 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180745 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180745&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207184 313362907 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327333 COC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:8.7,wD:11.11,(11.57,1.16,;10.24,.39,;10.24,-1.15,;11.57,-1.92,;8.9,-1.92,;7.57,-1.15,;7.57,.39,;6.24,-1.92,;4.7,-1.92,;3.93,-3.26,;2.39,-3.26,;1.62,-1.92,;.08,-1.92,;-.69,-.59,;-2.23,-.59,;-2.23,.95,;-3.57,1.72,;-4.9,.95,;-4.9,-.59,;-3.57,-1.36,;-6.24,1.72,;-6.24,3.26,;-8.9,3.26,;-8.9,1.72,;-10.24,.95,;-10.24,-.59,;-11.57,-1.36,;-8.9,-1.36,;-7.57,-.59,;-7.57,.95,;2.39,-.59,;3.93,-.59,)| InChI=1S/C25H36ClN3O3/c1-17(31-2)15-24(30)27-21-6-3-18(4-7-21)9-12-29-13-10-19(11-14-29)25-22-8-5-20(26)16-23(22)32-28-25/h5,8,16-19,21H,3-4,6-7,9-15H2,1-2H3,(H,27,30) JIZQRMQHJXHWIA-UHFFFAOYSA-N 180746 US8829029, 43 5-hydroxytryptamine receptor 2A Homo sapiens 13 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180746&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207340 313362908 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327334 CO[C@H](C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:8.7,wD:11.11,2.2,(10.61,2.78,;9.52,1.69,;9.92,.2,;11.4,-.2,;8.83,-.89,;7.34,-.49,;6.94,1,;6.25,-1.58,;4.71,-1.58,;3.94,-2.91,;2.4,-2.91,;1.63,-1.58,;.09,-1.58,;-.31,-.09,;-1.8,.31,;-2.88,-.78,;-4.37,-.38,;-4.77,1.11,;-3.68,2.19,;-2.19,1.8,;-6.26,1.5,;-6.88,2.91,;-8.42,2.75,;-8.74,1.24,;-10.07,.47,;-10.07,-1.07,;-11.4,-1.84,;-8.74,-1.84,;-7.4,-1.07,;-7.4,.47,;2.4,-.24,;3.94,-.24,)| InChI=1S/C25H36ClN3O3/c1-17(31-2)15-24(30)27-21-6-3-18(4-7-21)9-12-29-13-10-19(11-14-29)25-22-8-5-20(26)16-23(22)32-28-25/h5,8,16-19,21H,3-4,6-7,9-15H2,1-2H3,(H,27,30) JIZQRMQHJXHWIA-UHFFFAOYSA-N 180747 US8829029, 43A 5-hydroxytryptamine receptor 2A Homo sapiens 16 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180747&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207341 313362909 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327335 CO[C@@H](C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:8.7,2.2,wD:11.11,(11.57,1.16,;10.24,.39,;10.24,-1.15,;11.57,-1.92,;8.9,-1.92,;7.57,-1.15,;7.57,.39,;6.24,-1.92,;4.7,-1.92,;3.93,-3.26,;2.39,-3.26,;1.62,-1.92,;.08,-1.92,;-.69,-.59,;-2.23,-.59,;-2.23,.95,;-3.57,1.72,;-4.9,.95,;-4.9,-.59,;-3.57,-1.36,;-6.24,1.72,;-6.24,3.26,;-8.9,3.26,;-8.9,1.72,;-10.24,.95,;-10.24,-.59,;-11.57,-1.36,;-8.9,-1.36,;-7.57,-.59,;-7.57,.95,;2.39,-.59,;3.93,-.59,)| InChI=1S/C25H36ClN3O3/c1-17(31-2)15-24(30)27-21-6-3-18(4-7-21)9-12-29-13-10-19(11-14-29)25-22-8-5-20(26)16-23(22)32-28-25/h5,8,16-19,21H,3-4,6-7,9-15H2,1-2H3,(H,27,30) JIZQRMQHJXHWIA-UHFFFAOYSA-N 180748 US8829029, 43B 5-hydroxytryptamine receptor 2A Homo sapiens 16 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180748&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207342 313362910 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327336 COC[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)CC1 |r,wU:11.10,6.6,wD:14.14,3.2,(7.34,-8.85,;7.34,-7.31,;8.67,-6.54,;8.67,-5,;10,-4.23,;10,-2.69,;8.67,-1.92,;8.67,-.38,;7.34,.39,;7.34,1.93,;6,-.38,;4.67,.39,;3.33,-.38,;2,.39,;2,1.93,;.67,2.7,;.67,4.24,;-.67,5,;-.67,6.54,;-2,7.31,;-3.33,6.54,;-3.33,5,;-2,4.23,;-4.67,7.31,;-4.67,8.85,;-7.34,8.85,;-7.34,7.31,;-8.67,6.54,;-8.67,5,;-10,4.23,;-7.34,4.23,;-6,5,;-6,6.54,;3.33,2.7,;4.67,1.93,;7.34,-2.69,;7.34,-4.23,)| InChI=1S/C30H44ClN3O3/c1-36-20-23-4-2-22(3-5-23)18-29(35)32-26-9-6-21(7-10-26)12-15-34-16-13-24(14-17-34)30-27-11-8-25(31)19-28(27)37-33-30/h8,11,19,21-24,26H,2-7,9-10,12-18,20H2,1H3,(H,32,35) JACOQOMTWSSQPK-UHFFFAOYSA-N 180749 US8829029, 44 5-hydroxytryptamine receptor 2A Homo sapiens 19 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180749&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205074 313362911 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327337 CC1(O)CCC(CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)CC1 |r,wU:10.9,wD:13.13,(7.34,-7.31,;8.67,-6.54,;10,-7.31,;7.34,-5.77,;7.34,-4.23,;8.67,-3.46,;8.67,-1.92,;7.34,-1.15,;7.34,.39,;6,-1.92,;4.67,-1.15,;3.33,-1.92,;2,-1.15,;2,.39,;.67,1.16,;.67,2.7,;-.67,3.46,;-.67,5,;-2,5.77,;-3.33,5,;-3.33,3.46,;-2,2.69,;-4.67,5.77,;-4.67,7.31,;-7.34,7.31,;-7.34,5.77,;-8.67,5,;-8.67,3.46,;-10,2.69,;-7.34,2.69,;-6,3.46,;-6,5,;3.33,1.16,;4.67,.39,;10,-4.23,;10,-5.77,)| InChI=1S/C29H42ClN3O3/c1-29(35)13-8-21(9-14-29)18-27(34)31-24-5-2-20(3-6-24)10-15-33-16-11-22(12-17-33)28-25-7-4-23(30)19-26(25)36-32-28/h4,7,19-22,24,35H,2-3,5-6,8-18H2,1H3,(H,31,34) QSQXTUUDWHMEIT-UHFFFAOYSA-N 180750 US8829029, 45 5-hydroxytryptamine receptor 2A Homo sapiens 15 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180750&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207506 313362912 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327338 CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:4.3,wD:7.7,(10.36,-.44,;8.87,-.04,;8.47,1.44,;7.78,-1.13,;6.29,-.73,;5.2,-1.82,;3.72,-1.42,;3.32,.06,;1.83,.46,;.74,-.63,;-.75,-.23,;-1.84,-1.32,;-3.32,-.92,;-3.72,.57,;-2.63,1.66,;-1.15,1.26,;-5.21,.97,;-5.84,2.37,;-7.37,2.21,;-7.69,.71,;-9.02,-.06,;-9.02,-1.6,;-10.36,-2.37,;-7.69,-2.37,;-6.35,-1.6,;-6.35,-.06,;4.41,1.15,;5.89,.75,)| InChI=1S/C22H30ClN3O2/c1-15(27)24-19-5-2-16(3-6-19)8-11-26-12-9-17(10-13-26)22-20-7-4-18(23)14-21(20)28-25-22/h4,7,14,16-17,19H,2-3,5-6,8-13H2,1H3,(H,24,27) BKICZVHEIHZFNF-UHFFFAOYSA-N 180751 US8829029, 46 5-hydroxytryptamine receptor 2A Homo sapiens 23.745 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180751&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207507 313362913 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327339 CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:6.5,wD:9.9,(8.67,2.41,;8.67,3.95,;7.34,4.72,;8.11,6.06,;6.57,3.39,;6,5.49,;4.67,4.72,;4.67,3.18,;3.33,2.41,;2,3.18,;.67,2.41,;-.67,3.18,;-2,2.41,;-2,.87,;-3.33,.1,;-4.67,.87,;-4.67,2.41,;-3.33,3.18,;-6,.1,;-7.34,.87,;-8.67,-1.44,;-7.34,-2.21,;-7.34,-3.75,;-6,-4.52,;-6,-6.06,;-4.67,-3.75,;-4.67,-2.21,;-6,-1.44,;2,4.72,;3.33,5.49,)| InChI=1S/C22H32FN3O3S/c1-2-30(27,28)25-19-6-3-16(4-7-19)9-12-26-13-10-17(11-14-26)22-20-8-5-18(23)15-21(20)29-24-22/h5,8,15-17,19,25H,2-4,6-7,9-14H2,1H3 OZTXHPJAKOCEFC-UHFFFAOYSA-N 180752 US8829029, 47 5-hydroxytryptamine receptor 2A Homo sapiens 1.664 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180752&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207508 313362914 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327340 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NS(=O)(=O)c2ccc(Cl)cc2)CC1 |r,wU:19.24,wD:16.17,(-8,-6.06,;-8,-4.52,;-6.67,-3.75,;-6.67,-2.21,;-8,-1.44,;-8,.1,;-9.34,.87,;-10.67,-1.44,;-9.34,-2.21,;-9.34,-3.75,;-6.67,.87,;-5.33,.1,;-4,.87,;-4,2.41,;-2.67,3.18,;-1.33,2.41,;,3.18,;1.33,2.41,;2.67,3.18,;2.67,4.72,;1.33,5.49,;,4.72,;4,5.49,;5.33,4.72,;6.1,6.06,;4.56,3.39,;6.67,3.95,;6.67,2.41,;8,1.64,;9.34,2.41,;10.67,1.64,;9.34,3.95,;8,4.72,;-5.33,3.18,;-6.67,2.41,)| InChI=1S/C26H31ClFN3O3S/c27-20-3-8-23(9-4-20)35(32,33)30-22-6-1-18(2-7-22)11-14-31-15-12-19(13-16-31)26-24-10-5-21(28)17-25(24)34-29-26/h3-5,8-10,17-19,22,30H,1-2,6-7,11-16H2 AAUYCVIXPYMWAL-UHFFFAOYSA-N 180753 US8829029, 48 5-hydroxytryptamine receptor 2A Homo sapiens 5.132 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180753&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207509 313362915 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327341 COc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:12.12,wD:15.16,(10.67,.1,;10.67,1.64,;9.34,2.41,;8,1.64,;6.67,2.41,;6.67,3.95,;8,4.72,;9.34,3.95,;5.33,4.72,;6.1,6.06,;4.56,3.39,;4,5.49,;2.67,4.72,;2.67,3.18,;1.33,2.41,;,3.18,;-1.33,2.41,;-2.67,3.18,;-4,2.41,;-4,.87,;-5.33,.1,;-6.67,.87,;-6.67,2.41,;-5.33,3.18,;-8,.1,;-9.34,.87,;-10.67,-1.44,;-9.34,-2.21,;-9.34,-3.75,;-8,-4.52,;-8,-6.06,;-6.67,-3.75,;-6.67,-2.21,;-8,-1.44,;,4.72,;1.33,5.49,)| InChI=1S/C27H34FN3O4S/c1-34-23-7-9-24(10-8-23)36(32,33)30-22-5-2-19(3-6-22)12-15-31-16-13-20(14-17-31)27-25-11-4-21(28)18-26(25)35-29-27/h4,7-11,18-20,22,30H,2-3,5-6,12-17H2,1H3 LICMDQXLIJBJOR-UHFFFAOYSA-N 180754 US8829029, 49 5-hydroxytryptamine receptor 2A Homo sapiens 4.394 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180754&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25207510 313362916 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327342 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NS(=O)(=O)c2cccnc2)CC1 |r,wU:19.24,wD:16.17,(-7.34,-6.06,;-7.34,-4.52,;-6,-3.75,;-6,-2.21,;-7.34,-1.44,;-7.34,.1,;-8.67,.87,;-10,-1.44,;-8.67,-2.21,;-8.67,-3.75,;-6,.87,;-4.67,.1,;-3.33,.87,;-3.33,2.41,;-2,3.18,;-.67,2.41,;.67,3.18,;2,2.41,;3.33,3.18,;3.33,4.72,;2,5.49,;.67,4.72,;4.67,5.49,;6,4.72,;6.77,6.06,;5.23,3.39,;7.34,3.95,;7.34,2.41,;8.67,1.64,;10,2.41,;10,3.95,;8.67,4.72,;-4.67,3.18,;-6,2.41,)| InChI=1S/C25H31FN4O3S/c26-20-5-8-23-24(16-20)33-28-25(23)19-10-14-30(15-11-19)13-9-18-3-6-21(7-4-18)29-34(31,32)22-2-1-12-27-17-22/h1-2,5,8,12,16-19,21,29H,3-4,6-7,9-11,13-15H2 OWNNKPRXFVCNAN-UHFFFAOYSA-N 180755 US8829029, 50 5-hydroxytryptamine receptor 2A Homo sapiens 2.476 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180755&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205075 313362917 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327343 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CCC#N)CC1 |r,wU:19.24,wD:16.17,(-11.91,-.96,;-10.57,-.19,;-9.24,-.96,;-7.91,-.19,;-7.91,1.35,;-6.76,2.38,;-7.39,3.78,;-8.92,3.62,;-9.24,2.12,;-10.57,1.35,;-5.43,1.61,;-5.43,.07,;-4.1,-.7,;-2.76,.07,;-1.43,-.7,;-.09,.07,;1.24,-.7,;1.24,-2.24,;2.57,-3.01,;3.91,-2.24,;3.91,-.7,;2.57,.07,;5.24,-3.01,;6.57,-2.24,;6.57,-.7,;7.91,-3.01,;9.24,-2.24,;10.57,-3.01,;11.91,-3.78,;-2.76,1.61,;-4.1,2.38,)| InChI=1S/C24H31ClN4O2/c25-19-5-8-21-22(16-19)31-28-24(21)18-10-14-29(15-11-18)13-9-17-3-6-20(7-4-17)27-23(30)2-1-12-26/h5,8,16-18,20H,1-4,6-7,9-11,13-15H2,(H,27,30) QSMRRBPLPRZVCE-UHFFFAOYSA-N 180756 US8829029, 51 5-hydroxytryptamine receptor 2A Homo sapiens 23.745 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180756&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205076 313362918 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327344 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC#N)CC1 |r,wU:19.24,wD:16.17,(-11.34,-1.15,;-10,-.38,;-8.67,-1.15,;-7.34,-.38,;-7.34,1.16,;-6,1.92,;-6,3.46,;-8.67,3.47,;-8.67,1.93,;-10,1.16,;-4.67,1.15,;-4.67,-.39,;-3.33,-1.16,;-2,-.39,;-.67,-1.16,;.67,-.39,;2,-1.16,;2,-2.7,;3.33,-3.47,;4.67,-2.7,;4.67,-1.16,;3.33,-.39,;6,-3.47,;7.34,-2.7,;7.34,-1.16,;8.67,-3.47,;10,-2.7,;11.34,-1.93,;-2,1.15,;-3.33,1.92,)| InChI=1S/C23H29ClN4O2/c24-18-3-6-20-21(15-18)30-27-23(20)17-9-13-28(14-10-17)12-8-16-1-4-19(5-2-16)26-22(29)7-11-25/h3,6,15-17,19H,1-2,4-5,7-10,12-14H2,(H,26,29) MDIVYFVFTFEFJF-UHFFFAOYSA-N 180757 US8829029, 52 5-hydroxytryptamine receptor 2A Homo sapiens 15.582 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180757&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205077 313362919 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327345 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C[C@H]2CCCO2)CC1 |r,wU:19.24,wD:16.17,26.28,(-11.91,-2.69,;-10.57,-1.92,;-9.24,-2.69,;-7.91,-1.92,;-7.91,-.38,;-6.76,.65,;-7.39,2.05,;-8.92,1.89,;-9.24,.39,;-10.57,-.38,;-5.27,.25,;-4.88,-1.24,;-3.39,-1.64,;-2.3,-.55,;-.81,-.95,;.28,.14,;1.76,-.26,;2.16,-1.75,;3.65,-2.14,;4.74,-1.06,;4.34,.43,;2.85,.83,;6.23,-1.45,;7.32,-.37,;6.92,1.12,;8.8,-.76,;9.89,.33,;11.43,.33,;11.91,1.79,;10.66,2.69,;9.42,1.79,;-2.7,.94,;-4.19,1.34,)| InChI=1S/C26H36ClN3O3/c27-20-5-8-23-24(16-20)33-29-26(23)19-10-13-30(14-11-19)12-9-18-3-6-21(7-4-18)28-25(31)17-22-2-1-15-32-22/h5,8,16,18-19,21-22H,1-4,6-7,9-15,17H2,(H,28,31) XLEPAPXUDZKLLX-UHFFFAOYSA-N 180758 US8829029, 53 5-hydroxytryptamine receptor 2A Homo sapiens 6.193 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180758&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 66741766 313362920 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327346 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CC2)CC1 |r,wU:19.24,wD:16.17,(-10.11,1.15,;-8.77,1.93,;-7.44,1.15,;-6.1,1.93,;-6.1,3.47,;-4.77,4.23,;-4.77,5.78,;-7.44,5.78,;-7.44,4.23,;-8.77,3.47,;-3.44,3.47,;-3.44,1.93,;-2.1,1.15,;-.77,1.93,;.56,1.16,;.56,-.38,;1.9,-1.15,;1.9,-2.69,;3.23,-3.47,;4.56,-2.69,;4.56,-1.15,;3.23,-.38,;5.9,-3.46,;5.9,-5,;4.56,-5.78,;7.23,-5.78,;8.57,-5,;10.11,-5,;9.34,-3.67,;-.77,3.47,;-2.1,4.24,)| InChI=1S/C25H34ClN3O2/c26-20-5-8-22-23(16-20)31-28-25(22)19-10-13-29(14-11-19)12-9-17-3-6-21(7-4-17)27-24(30)15-18-1-2-18/h5,8,16-19,21H,1-4,6-7,9-15H2,(H,27,30) APRSYGAYLCLFDY-UHFFFAOYSA-N 180759 US8829029, 54 5-hydroxytryptamine receptor 2A Homo sapiens 13.092 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180759&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205244 313362921 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327347 OCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:5.4,wD:8.8,(10.92,-2.81,;9.59,-3.58,;8.25,-2.81,;8.25,-1.27,;6.92,-3.58,;5.58,-2.81,;4.25,-3.58,;2.92,-2.81,;2.92,-1.27,;1.58,-.5,;.25,-1.27,;-1.08,-.5,;-2.42,-1.27,;-3.75,-.5,;-3.75,1.04,;-2.42,1.81,;-1.08,1.04,;-5.08,1.81,;-5.33,3.33,;-6.85,3.58,;-7.55,2.2,;-9.03,1.81,;-9.43,.32,;-10.92,-.08,;-8.34,-.77,;-6.86,-.37,;-6.46,1.11,;4.25,-.5,;5.58,-1.27,)| InChI=1S/C22H30ClN3O3/c23-17-3-6-19-20(13-17)29-25-22(19)16-8-11-26(12-9-16)10-7-15-1-4-18(5-2-15)24-21(28)14-27/h3,6,13,15-16,18,27H,1-2,4-5,7-12,14H2,(H,24,28) RICCGUYAQMEDQJ-UHFFFAOYSA-N 180760 US8829029, 55 5-hydroxytryptamine receptor 2A Homo sapiens 14.991 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180760 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180760&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205245 313362922 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327348 CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:8.7,wD:11.11,(11.59,-3.58,;10.25,-2.81,;9.48,-1.47,;11.02,-1.47,;8.92,-3.58,;7.59,-2.81,;7.59,-1.27,;6.25,-3.58,;4.92,-2.81,;3.58,-3.58,;2.25,-2.81,;2.25,-1.27,;.92,-.5,;-.42,-1.27,;-1.75,-.5,;-3.08,-1.27,;-4.42,-.5,;-4.42,1.04,;-3.08,1.81,;-1.75,1.04,;-5.75,1.81,;-5.99,3.33,;-7.51,3.58,;-8.21,2.2,;-9.7,1.81,;-10.1,.32,;-11.59,-.08,;-9.01,-.77,;-7.52,-.37,;-7.12,1.11,;3.58,-.5,;4.92,-1.27,)| InChI=1S/C23H32ClN3O4S/c1-32(29,30)15-22(28)25-19-5-2-16(3-6-19)8-11-27-12-9-17(10-13-27)23-20-7-4-18(24)14-21(20)31-26-23/h4,7,14,16-17,19H,2-3,5-6,8-13,15H2,1H3,(H,25,28) XASDIOYQYXRDEM-UHFFFAOYSA-N 180761 US8829029, 56 5-hydroxytryptamine receptor 2A Homo sapiens 15.216 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180761&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205246 313362923 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327349 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2OCCCO2)CC1 |r,wU:19.24,wD:16.17,(-12.06,-1.36,;-10.72,-.59,;-9.39,-1.36,;-8.06,-.59,;-8.06,.95,;-6.91,1.98,;-7.54,3.39,;-9.07,3.23,;-9.39,1.72,;-10.72,.95,;-5.42,1.58,;-5.02,.09,;-3.54,-.3,;-2.45,.78,;-.96,.39,;-.56,-1.1,;.93,-1.5,;1.32,-2.99,;2.81,-3.39,;3.9,-2.3,;3.5,-.81,;2.01,-.41,;5.39,-2.7,;6.72,-1.93,;6.72,-.39,;8.06,-2.7,;9.39,-1.93,;10.72,-2.7,;12.06,-1.93,;12.06,-.39,;10.72,.38,;9.39,-.39,;-2.85,2.27,;-4.33,2.67,)| InChI=1S/C26H36ClN3O4/c27-20-4-7-22-23(16-20)34-29-26(22)19-9-12-30(13-10-19)11-8-18-2-5-21(6-3-18)28-24(31)17-25-32-14-1-15-33-25/h4,7,16,18-19,21,25H,1-3,5-6,8-15,17H2,(H,28,31) QXBMPTZQYXHXCG-UHFFFAOYSA-N 180762 US8829029, 57 5-hydroxytryptamine receptor 2A Homo sapiens 17.625 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180762 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180762&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205247 313362924 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327350 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4ccc(Cl)cc34)CC2)CC1 |r,wU:10.9,2.1,wD:13.13,5.5,(12.84,-1.27,;11.51,-.5,;10.18,-1.27,;10.18,-2.81,;8.84,-3.58,;7.51,-2.81,;6.17,-3.58,;4.84,-2.81,;4.84,-1.27,;3.51,-3.58,;2.17,-2.81,;.84,-3.58,;-.49,-2.81,;-.49,-1.27,;-1.83,-.5,;-3.16,-1.27,;-4.49,-.5,;-5.83,-1.27,;-7.16,-.5,;-7.16,1.04,;-5.83,1.81,;-4.49,1.04,;-8.5,1.81,;-8.74,3.33,;-10.26,3.58,;-10.96,2.2,;-12.44,1.81,;-12.84,.32,;-11.75,-.77,;-12.15,-2.26,;-10.27,-.37,;-9.87,1.11,;.84,-.5,;2.17,-1.27,;7.51,-1.27,;8.84,-.5,)| InChI=1S/C29H42ClN3O3/c1-35-25-9-4-21(5-10-25)18-28(34)31-24-7-2-20(3-8-24)12-15-33-16-13-22(14-17-33)29-26-19-23(30)6-11-27(26)36-32-29/h6,11,19-22,24-25H,2-5,7-10,12-18H2,1H3,(H,31,34) CMOUHGOJSYWQFR-UHFFFAOYSA-N 180763 US8829029, 58 5-hydroxytryptamine receptor 2A Homo sapiens 24.67 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180763 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180763&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205248 313362925 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327351 CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3ccc(F)cc23)CC1 |r,wU:5.4,wD:8.8,(9.91,.76,;8.43,.36,;8.43,1.9,;8.43,-1.18,;6.89,.36,;5.4,-.04,;5,-1.52,;3.51,-1.92,;2.42,-.83,;.94,-1.23,;-.15,-.14,;-1.64,-.54,;-2.04,-2.03,;-3.53,-2.43,;-4.61,-1.34,;-4.22,.15,;-2.73,.55,;-6.1,-1.74,;-6.73,-3.14,;-8.26,-2.98,;-8.58,-1.48,;-9.91,-.71,;-9.91,.83,;-8.58,1.6,;-8.58,3.14,;-7.25,.83,;-7.25,-.71,;2.82,.65,;4.31,1.05,)| InChI=1S/C21H30FN3O3S/c1-29(26,27)24-18-5-2-15(3-6-18)8-11-25-12-9-16(10-13-25)21-19-14-17(22)4-7-20(19)28-23-21/h4,7,14-16,18,24H,2-3,5-6,8-13H2,1H3 MPTVODVQFOZFHF-UHFFFAOYSA-N 180764 US8829029, 59 5-hydroxytryptamine receptor 2A Homo sapiens 27.483 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180764 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180764&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205249 313362926 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327352 COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)c(F)cc23)CC1 |r,wU:7.6,wD:10.10,(12.06,-1.93,;10.72,-2.7,;9.39,-1.93,;8.06,-2.7,;6.72,-1.93,;6.72,-.39,;5.39,-2.7,;3.9,-2.3,;2.81,-3.39,;1.32,-2.99,;.93,-1.5,;-.56,-1.1,;-.96,.39,;-2.45,.78,;-3.54,-.3,;-5.02,.09,;-5.42,1.58,;-4.33,2.67,;-2.85,2.27,;-6.91,1.98,;-7.54,3.39,;-9.07,3.23,;-9.39,1.72,;-10.72,.95,;-10.72,-.59,;-12.06,-1.36,;-9.39,-1.36,;-9.39,-2.9,;-8.06,-.59,;-8.06,.95,;2.01,-.41,;3.5,-.81,)| InChI=1S/C24H33ClFN3O3/c1-31-13-9-23(30)27-18-4-2-16(3-5-18)6-10-29-11-7-17(8-12-29)24-19-14-21(26)20(25)15-22(19)32-28-24/h14-18H,2-13H2,1H3,(H,27,30) HGFFXOQKGSYWIH-UHFFFAOYSA-N 180765 US8829029, 60 5-hydroxytryptamine receptor 2A Homo sapiens 43.968 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180765 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180765&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205417 313362927 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327353 Fc1cc2c(noc2cc1Cl)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCCO2)CC1 |r,wU:20.25,wD:17.18,(-9.3,-2.9,;-9.3,-1.36,;-7.97,-.59,;-7.97,.95,;-6.82,1.98,;-7.45,3.39,;-8.98,3.23,;-9.3,1.72,;-10.63,.95,;-10.63,-.59,;-11.97,-1.36,;-5.34,1.58,;-4.94,.09,;-3.45,-.3,;-2.36,.78,;-.87,.39,;-.47,-1.1,;1.01,-1.5,;1.41,-2.99,;2.9,-3.39,;3.99,-2.3,;3.59,-.81,;2.1,-.41,;5.48,-2.7,;6.81,-1.93,;6.81,-.39,;8.14,-2.7,;9.48,-1.93,;10.72,-2.83,;11.97,-1.93,;11.49,-.46,;9.95,-.46,;-2.76,2.27,;-4.25,2.67,)| InChI=1S/C26H35ClFN3O3/c27-22-16-24-21(15-23(22)28)26(30-34-24)18-8-11-31(12-9-18)10-7-17-3-5-19(6-4-17)29-25(32)14-20-2-1-13-33-20/h15-20H,1-14H2,(H,29,32) QKGGUYOGIVKJFF-UHFFFAOYSA-N 180766 US8829029, 61 5-hydroxytryptamine receptor 2A Homo sapiens 31.001 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180766 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180766&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205418 313362928 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327354 COCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)c(F)cc23)CC1 |r,wU:6.5,wD:9.9,(11.39,-2.7,;10.06,-1.93,;8.72,-2.7,;7.39,-1.93,;7.39,-.39,;6.05,-2.7,;4.57,-2.3,;3.48,-3.39,;1.99,-2.99,;1.59,-1.5,;.1,-1.1,;-.29,.39,;-1.78,.78,;-2.87,-.3,;-4.36,.09,;-4.76,1.58,;-3.67,2.67,;-2.18,2.27,;-6.24,1.98,;-6.87,3.39,;-8.4,3.23,;-8.72,1.72,;-10.06,.95,;-10.06,-.59,;-11.39,-1.36,;-8.72,-1.36,;-8.72,-2.9,;-7.39,-.59,;-7.39,.95,;2.68,-.41,;4.17,-.81,)| InChI=1S/C23H31F2N3O3/c1-30-14-22(29)26-17-4-2-15(3-5-17)6-9-28-10-7-16(8-11-28)23-18-12-19(24)20(25)13-21(18)31-27-23/h12-13,15-17H,2-11,14H2,1H3,(H,26,29) OCLIEDSOSAGNEM-UHFFFAOYSA-N 180767 US8829029, 62 5-hydroxytryptamine receptor 2A Homo sapiens 10.52 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180767 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180767&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205419 313362929 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327355 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)c(F)cc34)CC2)C1 |r,wU:10.9,2.1,wD:13.13,5.5,(13.26,-1.24,;12.17,-2.32,;10.68,-1.93,;10.2,-.46,;8.66,-.46,;8.19,-1.93,;6.85,-2.7,;5.52,-1.93,;5.52,-.39,;4.19,-2.7,;2.7,-2.3,;1.61,-3.39,;.12,-2.99,;-.27,-1.5,;-1.76,-1.1,;-2.16,.39,;-3.65,.78,;-4.74,-.3,;-6.22,.09,;-6.62,1.58,;-5.53,2.67,;-4.05,2.27,;-8.11,1.98,;-8.74,3.39,;-10.27,3.23,;-10.59,1.72,;-11.92,.95,;-11.92,-.59,;-13.26,-1.36,;-10.59,-1.36,;-10.59,-2.9,;-9.26,-.59,;-9.26,.95,;.81,-.41,;2.3,-.81,;9.43,-2.83,)| InChI=1S/C28H39F2N3O3/c1-35-22-7-4-19(14-22)15-27(34)31-21-5-2-18(3-6-21)8-11-33-12-9-20(10-13-33)28-23-16-24(29)25(30)17-26(23)36-32-28/h16-22H,2-15H2,1H3,(H,31,34) HJUAHZKICLIRDT-UHFFFAOYSA-N 180768 US8829029, 63 5-hydroxytryptamine receptor 2A Homo sapiens 13.209 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180768 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180768&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205420 313362930 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327356 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)c(F)cc34)CC2)CC1 |r,wU:10.9,2.1,wD:13.13,5.5,(13.39,-.39,;12.06,.38,;10.72,-.39,;10.72,-1.93,;9.39,-2.7,;8.06,-1.93,;6.72,-2.7,;5.39,-1.93,;5.39,-.39,;4.05,-2.7,;2.57,-2.3,;1.48,-3.39,;-.01,-2.99,;-.41,-1.5,;-1.9,-1.1,;-2.29,.39,;-3.78,.78,;-4.87,-.3,;-6.36,.09,;-6.76,1.58,;-5.67,2.67,;-4.18,2.27,;-8.24,1.98,;-8.87,3.39,;-10.4,3.23,;-10.72,1.72,;-12.06,.95,;-12.06,-.59,;-13.39,-1.36,;-10.72,-1.36,;-10.72,-2.9,;-9.39,-.59,;-9.39,.95,;.68,-.41,;2.17,-.81,;8.06,-.39,;9.39,.38,)| InChI=1S/C29H41F2N3O3/c1-36-23-8-4-20(5-9-23)16-28(35)32-22-6-2-19(3-7-22)10-13-34-14-11-21(12-15-34)29-24-17-25(30)26(31)18-27(24)37-33-29/h17-23H,2-16H2,1H3,(H,32,35) ORNXSTGAFURZLS-UHFFFAOYSA-N 180769 US8829029, 64 5-hydroxytryptamine receptor 2A Homo sapiens 7.67 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180769&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205421 313362931 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327357 COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)c(F)cc23)CC1 |r,wU:7.6,wD:10.10,(12.06,-1.93,;10.72,-2.7,;9.39,-1.93,;8.06,-2.7,;6.72,-1.93,;6.72,-.39,;5.39,-2.7,;3.9,-2.3,;2.81,-3.39,;1.32,-2.99,;.93,-1.5,;-.56,-1.1,;-.96,.39,;-2.45,.78,;-3.54,-.3,;-5.02,.09,;-5.42,1.58,;-4.33,2.67,;-2.85,2.27,;-6.91,1.98,;-7.54,3.39,;-9.07,3.23,;-9.39,1.72,;-10.72,.95,;-10.72,-.59,;-12.06,-1.36,;-9.39,-1.36,;-9.39,-2.9,;-8.06,-.59,;-8.06,.95,;2.01,-.41,;3.5,-.81,)| InChI=1S/C24H33F2N3O3/c1-31-13-9-23(30)27-18-4-2-16(3-5-18)6-10-29-11-7-17(8-12-29)24-19-14-20(25)21(26)15-22(19)32-28-24/h14-18H,2-13H2,1H3,(H,27,30) OUHCXMUUIFHTFO-UHFFFAOYSA-N 180770 US8829029, 65 5-hydroxytryptamine receptor 2A Homo sapiens 12.918 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180770 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180770&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205584 313362932 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327358 CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)c(F)cc23)CC1 |r,wU:4.3,wD:7.7,(10.06,-2.7,;8.72,-1.93,;8.72,-.39,;7.39,-2.7,;5.9,-2.3,;4.81,-3.39,;3.32,-2.99,;2.93,-1.5,;1.44,-1.1,;1.04,.39,;-.45,.78,;-1.54,-.3,;-3.02,.09,;-3.42,1.58,;-2.33,2.67,;-.85,2.27,;-4.91,1.98,;-5.54,3.39,;-7.07,3.23,;-7.39,1.72,;-8.72,.95,;-8.72,-.59,;-10.06,-1.36,;-7.39,-1.36,;-7.39,-2.9,;-6.05,-.59,;-6.05,.95,;4.01,-.41,;5.5,-.81,)| InChI=1S/C22H29F2N3O2/c1-14(28)25-17-4-2-15(3-5-17)6-9-27-10-7-16(8-11-27)22-18-12-19(23)20(24)13-21(18)29-26-22/h12-13,15-17H,2-11H2,1H3,(H,25,28) WTUNYPKNGBFPKZ-UHFFFAOYSA-N 180771 US8829029, 66 5-hydroxytryptamine receptor 2A Homo sapiens 17.739 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180771 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180771&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205585 313362933 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327359 OCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)c(F)cc23)CC1 |r,wU:5.4,wD:8.8,(10.72,-1.93,;9.39,-2.7,;8.06,-1.93,;8.06,-.39,;6.72,-2.7,;5.23,-2.3,;4.15,-3.39,;2.66,-2.99,;2.26,-1.5,;.77,-1.1,;.37,.39,;-1.11,.78,;-2.2,-.3,;-3.69,.09,;-4.09,1.58,;-3,2.67,;-1.51,2.27,;-5.58,1.98,;-6.2,3.39,;-7.74,3.23,;-8.06,1.72,;-9.39,.95,;-9.39,-.59,;-10.72,-1.36,;-8.06,-1.36,;-8.06,-2.9,;-6.72,-.59,;-6.72,.95,;3.35,-.41,;4.84,-.81,)| InChI=1S/C22H29F2N3O3/c23-18-11-17-20(12-19(18)24)30-26-22(17)15-6-9-27(10-7-15)8-5-14-1-3-16(4-2-14)25-21(29)13-28/h11-12,14-16,28H,1-10,13H2,(H,25,29) MQHVJCAEBAKURM-UHFFFAOYSA-N 180772 US8829029, 67 5-hydroxytryptamine receptor 2A Homo sapiens 11.782 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180772 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180772&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205586 313362934 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327360 OCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)c(F)cc23)CC1 |r,wU:6.5,wD:9.9,(11.59,-3.58,;10.25,-2.81,;8.92,-3.58,;7.59,-2.81,;7.59,-1.27,;6.25,-3.58,;4.92,-2.81,;3.58,-3.58,;2.25,-2.81,;2.25,-1.27,;.92,-.5,;-.42,-1.27,;-1.75,-.5,;-3.08,-1.27,;-4.42,-.5,;-4.42,1.04,;-3.08,1.81,;-1.75,1.04,;-5.75,1.81,;-5.99,3.33,;-7.51,3.58,;-8.21,2.2,;-9.7,1.81,;-10.1,.32,;-11.59,-.08,;-9.01,-.77,;-9.41,-2.26,;-7.52,-.37,;-7.12,1.11,;3.58,-.5,;4.92,-1.27,)| InChI=1S/C23H31F2N3O3/c24-19-13-18-21(14-20(19)25)31-27-23(18)16-6-10-28(11-7-16)9-5-15-1-3-17(4-2-15)26-22(30)8-12-29/h13-17,29H,1-12H2,(H,26,30) ZCRJZGXULSARDJ-UHFFFAOYSA-N 180773 US8829029, 68 5-hydroxytryptamine receptor 2A Homo sapiens 24.792 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180773&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205587 313362935 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327361 O[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)c(F)cc34)CC2)CC1 |r,wU:9.8,1.0,wD:12.12,4.4,(12.92,-.5,;11.59,-1.27,;11.59,-2.81,;10.25,-3.58,;8.92,-2.81,;7.59,-3.58,;6.25,-2.81,;6.25,-1.27,;4.92,-3.58,;3.58,-2.81,;2.25,-3.58,;.92,-2.81,;.92,-1.27,;-.42,-.5,;-1.75,-1.27,;-3.08,-.5,;-4.42,-1.27,;-5.75,-.5,;-5.75,1.04,;-4.42,1.81,;-3.08,1.04,;-7.09,1.81,;-7.33,3.34,;-8.85,3.58,;-9.55,2.2,;-11.03,1.81,;-11.43,.32,;-12.92,-.08,;-10.34,-.77,;-10.74,-2.26,;-8.86,-.37,;-8.46,1.11,;2.25,-.5,;3.58,-1.27,;8.92,-1.27,;10.25,-.5,)| InChI=1S/C28H39F2N3O3/c29-24-16-23-26(17-25(24)30)36-32-28(23)20-10-13-33(14-11-20)12-9-18-1-5-21(6-2-18)31-27(35)15-19-3-7-22(34)8-4-19/h16-22,34H,1-15H2,(H,31,35) BIIZSYSIBVAOCG-UHFFFAOYSA-N 180774 US8829029, 69 5-hydroxytryptamine receptor 2A Homo sapiens 7.848 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180774 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180774&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205588 313362936 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327362 O[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)c(F)cc34)CC2)C1 |r,wU:9.8,1.0,wD:12.12,4.4,(12.68,-1.16,;11.14,-1.16,;10.23,.09,;8.77,-.39,;8.77,-1.93,;7.43,-2.7,;6.1,-1.93,;6.1,-.39,;4.77,-2.7,;3.28,-2.3,;2.19,-3.39,;.7,-2.99,;.3,-1.5,;-1.18,-1.1,;-1.58,.39,;-3.07,.78,;-4.16,-.3,;-5.65,.09,;-6.04,1.58,;-4.96,2.67,;-3.47,2.27,;-7.53,1.98,;-8.16,3.39,;-9.69,3.23,;-10.01,1.72,;-11.34,.95,;-11.34,-.59,;-12.68,-1.36,;-10.01,-1.36,;-10.01,-2.9,;-8.68,-.59,;-8.68,.95,;1.39,-.41,;2.88,-.81,;10.23,-2.4,)| InChI=1S/C27H37F2N3O3/c28-23-15-22-25(16-24(23)29)35-31-27(22)19-8-11-32(12-9-19)10-7-17-1-4-20(5-2-17)30-26(34)14-18-3-6-21(33)13-18/h15-21,33H,1-14H2,(H,30,34) RQSYJHOVRPMPEE-UHFFFAOYSA-N 180775 US8829029, 70 5-hydroxytryptamine receptor 2A Homo sapiens 11.439 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180775 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180775&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205589 313362937 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327363 Fc1cc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)C4CCOCC4)CC3)c2cc1F |r,wU:16.19,wD:13.12,(-11.59,1.07,;-10.1,1.47,;-9.7,2.96,;-8.21,3.36,;-7.51,4.73,;-5.99,4.49,;-5.75,2.97,;-4.42,2.2,;-4.42,.66,;-3.08,-.11,;-1.75,.66,;-.42,-.11,;.92,.66,;2.25,-.11,;2.25,-1.65,;3.58,-2.42,;4.92,-1.65,;4.92,-.11,;3.58,.66,;6.25,-2.42,;7.59,-1.65,;7.59,-.11,;8.92,-2.42,;8.92,-3.96,;10.25,-4.73,;11.59,-3.96,;11.59,-2.42,;10.25,-1.65,;-1.75,2.2,;-3.08,2.97,;-7.12,2.27,;-7.52,.78,;-9.01,.38,;-9.41,-1.1,)| InChI=1S/C26H35F2N3O3/c27-22-15-21-24(16-23(22)28)34-30-25(21)18-6-11-31(12-7-18)10-5-17-1-3-20(4-2-17)29-26(32)19-8-13-33-14-9-19/h15-20H,1-14H2,(H,29,32) XJIBUBWKKHZDSR-UHFFFAOYSA-N 180776 US8829029, 71 5-hydroxytryptamine receptor 2A Homo sapiens 7.86 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180776&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205751 313362938 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327364 Fc1cc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)CC4OCCCO4)CC3)c2cc1F |r,wU:16.19,wD:13.12,(-12.25,-.08,;-10.77,.32,;-10.37,1.81,;-8.88,2.2,;-8.18,3.58,;-6.66,3.33,;-6.42,1.81,;-5.08,1.04,;-5.08,-.5,;-3.75,-1.27,;-2.42,-.5,;-1.08,-1.27,;.25,-.5,;1.58,-1.27,;1.58,-2.81,;2.92,-3.58,;4.25,-2.81,;4.25,-1.27,;2.92,-.5,;5.58,-3.58,;6.92,-2.81,;6.92,-1.27,;8.25,-3.58,;9.59,-2.81,;10.92,-3.58,;12.25,-2.81,;12.25,-1.27,;10.92,-.5,;9.59,-1.27,;-2.42,1.04,;-3.75,1.81,;-7.79,1.11,;-8.19,-.37,;-9.68,-.77,;-10.08,-2.26,)| InChI=1S/C26H35F2N3O4/c27-21-14-20-23(15-22(21)28)35-30-26(20)18-7-10-31(11-8-18)9-6-17-2-4-19(5-3-17)29-24(32)16-25-33-12-1-13-34-25/h14-15,17-19,25H,1-13,16H2,(H,29,32) CWGVRZIECOGVLA-UHFFFAOYSA-N 180777 US8829029, 72 5-hydroxytryptamine receptor 2A Homo sapiens 9.394 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180777&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205752 313362939 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327365 CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(C)ccc23)CC1 |r,wU:4.3,wD:7.7,(10.25,-3.58,;8.92,-2.81,;8.92,-1.27,;7.59,-3.58,;6.25,-2.81,;4.92,-3.58,;3.58,-2.81,;3.58,-1.27,;2.25,-.5,;.92,-1.27,;-.42,-.5,;-1.75,-1.27,;-3.08,-.5,;-3.08,1.04,;-1.75,1.81,;-.42,1.04,;-4.42,1.81,;-4.66,3.33,;-6.18,3.58,;-6.88,2.2,;-8.37,1.81,;-8.77,.32,;-10.25,-.08,;-7.68,-.77,;-6.19,-.37,;-5.79,1.11,;4.92,-.5,;6.25,-1.27,)| InChI=1S/C23H33N3O2/c1-16-3-8-21-22(15-16)28-25-23(21)19-10-13-26(14-11-19)12-9-18-4-6-20(7-5-18)24-17(2)27/h3,8,15,18-20H,4-7,9-14H2,1-2H3,(H,24,27) FJCLYLWFKWDKEV-UHFFFAOYSA-N 180778 US8829029, 73 5-hydroxytryptamine receptor 2A Homo sapiens 16.758 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180778&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 25205753 313362940 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 327366 CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:4.3,wD:7.7,(6,-5.78,;7.34,-5,;8.67,-5.78,;7.34,-3.47,;6,-2.69,;4.67,-3.47,;3.33,-2.69,;3.33,-1.15,;2,-.38,;2,1.15,;.67,1.93,;-.67,1.15,;-2,1.93,;-2,3.47,;-.67,4.24,;.67,3.47,;-3.33,4.23,;-3.33,5.78,;-6,5.78,;-6,4.23,;-7.34,3.47,;-7.34,1.93,;-8.67,1.15,;-6,1.15,;-4.67,1.93,;-4.67,3.47,;4.67,-.38,;6,-1.15,)| InChI=1S/C22H30FN3O2/c1-15(27)24-19-5-2-16(3-6-19)8-11-26-12-9-17(10-13-26)22-20-7-4-18(23)14-21(20)28-25-22/h4,7,14,16-17,19H,2-3,5-6,8-13H2,1H3,(H,24,27) ZTPVZJYMOVCRTF-UHFFFAOYSA-N 180697 US8829029, 1 D(3) dopamine receptor Homo sapiens 4.964 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180697&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205906 313362859 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327367 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-6,-5.78,;-6,-4.24,;-4.67,-3.47,;-4.67,-1.93,;-6,-1.16,;-6,.38,;-7.34,1.15,;-8.67,-1.16,;-7.34,-1.93,;-7.34,-3.47,;-4.67,1.15,;-3.33,.38,;-2,1.15,;-2,2.69,;-.67,3.46,;.67,2.69,;2,3.46,;3.33,2.69,;4.67,3.46,;4.67,5,;3.33,5.78,;2,5,;6,5.77,;7.34,5,;8.67,5.77,;7.34,3.46,;6,2.69,;6,1.15,;7.34,.38,;8.67,1.15,;8.67,2.69,;-3.33,3.46,;-4.67,2.69,)| InChI=1S/C26H36FN3O3/c27-21-3-6-23-24(17-21)33-29-25(23)19-8-13-30(14-9-19)12-7-18-1-4-22(5-2-18)28-26(31)20-10-15-32-16-11-20/h3,6,17-20,22H,1-2,4-5,7-16H2,(H,28,31) FEQXRZMYCWCJKY-UHFFFAOYSA-N 180698 US8829029, 2 D(3) dopamine receptor Homo sapiens 9.744 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180698 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180698&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205907 313362860 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327368 COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:7.6,wD:10.10,(9.34,.38,;8,1.15,;8,2.69,;6.67,3.46,;6.67,5,;8,5.77,;5.33,5.77,;4,5,;4,3.46,;2.67,2.69,;1.33,3.46,;,2.69,;-1.33,3.46,;-2.67,2.69,;-2.67,1.15,;-4,.38,;-5.33,1.15,;-5.33,2.69,;-4,3.46,;-6.67,.38,;-8,1.15,;-9.34,-1.16,;-8,-1.93,;-8,-3.47,;-6.67,-4.24,;-6.67,-5.78,;-5.33,-3.47,;-5.33,-1.93,;-6.67,-1.16,;1.33,5,;2.67,5.78,)| InChI=1S/C24H34FN3O3/c1-30-15-11-23(29)26-20-5-2-17(3-6-20)8-12-28-13-9-18(10-14-28)24-21-7-4-19(25)16-22(21)31-27-24/h4,7,16-18,20H,2-3,5-6,8-15H2,1H3,(H,26,29) OWCFHTULJYSSNJ-UHFFFAOYSA-N 180699 US8829029, 3 D(3) dopamine receptor Homo sapiens 4.749 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180699 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180699&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205908 313362861 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327369 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(cc2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-6,-5.78,;-6,-4.24,;-4.67,-3.47,;-4.67,-1.93,;-6,-1.16,;-6,.38,;-7.34,1.15,;-8.67,-1.16,;-7.34,-1.93,;-7.34,-3.47,;-4.67,1.15,;-3.33,.38,;-2,1.15,;-2,2.69,;-.67,3.46,;.67,2.69,;2,3.46,;3.33,2.69,;4.67,3.46,;4.67,5,;3.33,5.78,;2,5,;6,5.77,;7.34,5,;8.67,5.77,;7.34,3.46,;8.67,2.69,;8.67,1.15,;7.34,.38,;6,1.15,;6,2.69,;7.34,-1.15,;6,-1.92,;6,-3.46,;7.34,-4.23,;8.67,-3.46,;8.67,-1.92,;-3.33,3.46,;-4.67,2.69,)| InChI=1S/C31H39FN4O3/c32-25-5-10-28-29(21-25)39-34-30(28)23-12-15-35(16-13-23)14-11-22-1-6-26(7-2-22)33-31(37)24-3-8-27(9-4-24)36-17-19-38-20-18-36/h3-5,8-10,21-23,26H,1-2,6-7,11-20H2,(H,33,37) DMESLZJUXZVTNG-UHFFFAOYSA-N 180700 US8829029, 4 D(3) dopamine receptor Homo sapiens 28.161 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180700 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180700&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206053 313362862 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327370 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(nc2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-8.67,3.47,;-7.34,4.23,;-6,3.47,;-4.67,4.23,;-4.67,5.78,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.78,;-2,5.78,;-2,4.23,;-.67,3.47,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.15,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.15,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.47,;6,-3.47,;4.67,-2.69,;3.33,-3.47,;3.33,-5,;4.67,-5.78,;6,-5,;2,-5.77,;.67,-5,;-.67,-5.77,;-.67,-7.31,;.67,-8.08,;2,-7.31,;.67,5.78,;-.67,6.55,)| InChI=1S/C30H38FN5O3/c31-24-4-7-26-27(19-24)39-34-29(26)22-10-13-35(14-11-22)12-9-21-1-5-25(6-2-21)33-30(37)23-3-8-28(32-20-23)36-15-17-38-18-16-36/h3-4,7-8,19-22,25H,1-2,5-6,9-18H2,(H,33,37) ZFNISNPBEQEQHE-UHFFFAOYSA-N 180701 US8829029, 4A D(3) dopamine receptor Homo sapiens 7.948 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180701 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180701&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206054 313362863 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327371 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2cnc(cn2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-8.67,3.47,;-7.34,4.23,;-6,3.47,;-4.67,4.23,;-4.67,5.78,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.78,;-2,5.78,;-2,4.23,;-.67,3.47,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.15,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.15,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.47,;6,-3.47,;6,-5,;4.67,-5.78,;3.33,-5,;3.33,-3.47,;4.67,-2.69,;2,-5.77,;.67,-5,;-.67,-5.77,;-.67,-7.31,;.67,-8.08,;2,-7.31,;.67,5.78,;-.67,6.55,)| InChI=1S/C29H37FN6O3/c30-22-3-6-24-26(17-22)39-34-28(24)21-8-11-35(12-9-21)10-7-20-1-4-23(5-2-20)33-29(37)25-18-32-27(19-31-25)36-13-15-38-16-14-36/h3,6,17-21,23H,1-2,4-5,7-16H2,(H,33,37) LSHSMBQZYASNDB-UHFFFAOYSA-N 180702 US8829029, 4B D(3) dopamine receptor Homo sapiens 19.443 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180702 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180702&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206055 313362864 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327372 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(nn2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-8.67,3.47,;-7.34,4.23,;-6,3.47,;-4.67,4.23,;-4.67,5.78,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.78,;-2,5.78,;-2,4.23,;-.67,3.47,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.15,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.15,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.47,;6,-3.47,;6,-5,;4.67,-5.78,;3.33,-5,;3.33,-3.47,;4.67,-2.69,;2,-5.77,;.67,-5,;-.67,-5.77,;-.67,-7.31,;.67,-8.08,;2,-7.31,;.67,5.78,;-.67,6.55,)| InChI=1S/C29H37FN6O3/c30-22-3-6-24-26(19-22)39-34-28(24)21-10-13-35(14-11-21)12-9-20-1-4-23(5-2-20)31-29(37)25-7-8-27(33-32-25)36-15-17-38-18-16-36/h3,6-8,19-21,23H,1-2,4-5,9-18H2,(H,31,37) RJFINFRRQCTSTE-UHFFFAOYSA-N 180703 US8829029, 4C D(3) dopamine receptor Homo sapiens 25.326 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180703 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180703&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206056 313362865 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327373 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2cnc(nc2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-8.67,3.46,;-7.34,4.23,;-6,3.46,;-4.67,4.23,;-4.67,5.77,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.77,;-2,5.77,;-2,4.23,;-.67,3.46,;.67,4.23,;2,3.46,;2,1.92,;3.33,1.15,;3.33,-.39,;4.67,-1.16,;6,-.39,;6,1.15,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.46,;6,-3.46,;4.67,-2.69,;3.33,-3.46,;3.33,-5,;4.67,-5.77,;6,-5,;2,-5.77,;.67,-5,;-.67,-5.77,;-.67,-7.31,;.67,-8.08,;2,-7.31,;.67,5.77,;-.67,6.54,)| InChI=1S/C29H37FN6O3/c30-23-3-6-25-26(17-23)39-34-27(25)21-8-11-35(12-9-21)10-7-20-1-4-24(5-2-20)33-28(37)22-18-31-29(32-19-22)36-13-15-38-16-14-36/h3,6,17-21,24H,1-2,4-5,7-16H2,(H,33,37) XVKCBMHQXDTJBS-UHFFFAOYSA-N 180704 US8829029, 4D D(3) dopamine receptor Homo sapiens 15.34 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180704 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180704&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206376 313362866 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327374 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(N3CCOCC3)c(F)c2)CC1 |r,wU:19.24,wD:16.17,(-5.05,-7.48,;-5.44,-5.99,;-4.36,-4.9,;-4.75,-3.41,;-6.24,-3.01,;-6.64,-1.53,;-8.13,-1.13,;-8.82,-3.7,;-7.33,-4.1,;-6.93,-5.59,;-5.55,-.44,;-4.06,-.84,;-2.98,.25,;-3.37,1.74,;-2.28,2.83,;-.8,2.43,;.29,3.52,;1.78,3.12,;2.87,4.21,;2.47,5.7,;.98,6.1,;-.11,5.01,;3.56,6.79,;5.05,6.39,;6.14,7.48,;5.44,4.9,;4.36,3.81,;4.75,2.32,;6.24,1.93,;6.64,.44,;5.55,-.65,;5.95,-2.14,;7.44,-2.54,;8.53,-1.45,;8.13,.04,;7.33,3.01,;8.82,2.62,;6.93,4.5,;-4.86,2.14,;-5.95,1.05,)| InChI=1S/C31H38F2N4O3/c32-24-4-7-26-29(20-24)40-35-30(26)22-10-13-36(14-11-22)12-9-21-1-5-25(6-2-21)34-31(38)23-3-8-28(27(33)19-23)37-15-17-39-18-16-37/h3-4,7-8,19-22,25H,1-2,5-6,9-18H2,(H,34,38) LUYOYJRCUNHAKE-UHFFFAOYSA-N 180705 US8829029, 5 D(3) dopamine receptor Homo sapiens 45.277 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180705 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180705&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206208 313362867 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327375 CN(C)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:12.12,wD:15.16,(5.9,-.65,;6.99,.44,;8.47,.04,;6.59,1.93,;5.1,2.32,;4.7,3.81,;5.79,4.9,;7.28,4.5,;7.68,3.01,;5.39,6.39,;6.48,7.48,;3.9,6.79,;2.81,5.7,;3.21,4.21,;2.12,3.12,;.64,3.52,;-.45,2.43,;-1.94,2.83,;-3.03,1.74,;-2.63,.25,;-3.72,-.84,;-5.21,-.44,;-5.6,1.05,;-4.52,2.14,;-6.3,-1.53,;-7.78,-1.13,;-8.47,-3.7,;-6.99,-4.1,;-6.59,-5.59,;-5.1,-5.99,;-4.7,-7.48,;-4.01,-4.9,;-4.41,-3.41,;-5.9,-3.01,;.24,5.01,;1.33,6.1,)| InChI=1S/C29H37FN4O2/c1-33(2)25-10-5-22(6-11-25)29(35)31-24-8-3-20(4-9-24)13-16-34-17-14-21(15-18-34)28-26-12-7-23(30)19-27(26)36-32-28/h5-7,10-12,19-21,24H,3-4,8-9,13-18H2,1-2H3,(H,31,35) ZXEXODRNGHENCD-UHFFFAOYSA-N 180706 US8829029, 6 D(3) dopamine receptor Homo sapiens 11.52 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180706 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180706&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 57555503 313362868 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327376 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)Cc2ccc3OCOc3c2)CC1 |r,wU:19.24,wD:16.17,(-6.64,-7.48,;-7.03,-5.99,;-5.95,-4.9,;-6.34,-3.41,;-7.83,-3.01,;-8.23,-1.53,;-9.72,-1.13,;-10.41,-3.7,;-8.92,-4.1,;-8.52,-5.59,;-7.14,-.44,;-5.65,-.84,;-4.56,.25,;-4.96,1.74,;-3.87,2.83,;-2.39,2.43,;-1.3,3.52,;.19,3.12,;1.28,4.21,;.88,5.7,;-.61,6.1,;-1.7,5.01,;1.97,6.79,;3.46,6.39,;4.55,7.48,;3.86,4.9,;5.34,4.5,;5.74,3.01,;7.23,2.62,;8.32,3.7,;9.86,3.62,;10.41,5.06,;9.21,6.03,;7.92,5.19,;6.43,5.59,;-6.45,2.14,;-7.54,1.05,)| InChI=1S/C29H34FN3O4/c30-22-4-7-24-26(17-22)37-32-29(24)21-10-13-33(14-11-21)12-9-19-1-5-23(6-2-19)31-28(34)16-20-3-8-25-27(15-20)36-18-35-25/h3-4,7-8,15,17,19,21,23H,1-2,5-6,9-14,16,18H2,(H,31,34) QSYSGNJXSQQELK-UHFFFAOYSA-N 180707 US8829029, 7 D(3) dopamine receptor Homo sapiens 4.015 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180707 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180707&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 57555505 313362869 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327377 COc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:11.11,wD:14.15,(6.3,-.65,;7.38,.44,;6.99,1.93,;5.5,2.32,;5.1,3.81,;6.19,4.9,;7.68,4.5,;8.07,3.01,;5.79,6.39,;6.88,7.48,;4.3,6.79,;3.21,5.7,;3.61,4.21,;2.52,3.12,;1.04,3.52,;-.05,2.43,;-1.54,2.83,;-2.63,1.74,;-2.23,.25,;-3.32,-.84,;-4.81,-.44,;-5.21,1.05,;-4.12,2.14,;-5.9,-1.53,;-7.38,-1.13,;-8.07,-3.7,;-6.59,-4.1,;-6.19,-5.59,;-4.7,-5.99,;-4.3,-7.48,;-3.61,-4.9,;-4.01,-3.41,;-5.5,-3.01,;.64,5.01,;1.73,6.1,)| InChI=1S/C28H34FN3O3/c1-34-24-9-4-21(5-10-24)28(33)30-23-7-2-19(3-8-23)12-15-32-16-13-20(14-17-32)27-25-11-6-22(29)18-26(25)35-31-27/h4-6,9-11,18-20,23H,2-3,7-8,12-17H2,1H3,(H,30,33) YZBUHABEHVWWRM-UHFFFAOYSA-N 180708 US8829029, 8 D(3) dopamine receptor Homo sapiens 4.525 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180708 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180708&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206210 313362870 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327378 CC(C)(C)Oc1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:14.14,wD:17.18,(5.64,-1.05,;7.18,-1.05,;6.1,-2.14,;8.67,-1.45,;6.79,.44,;6.39,1.93,;4.9,2.32,;4.5,3.81,;5.59,4.9,;7.08,4.5,;7.48,3.01,;5.19,6.39,;6.28,7.48,;3.7,6.79,;2.62,5.7,;3.01,4.21,;1.93,3.12,;.44,3.52,;-.65,2.43,;-2.14,2.83,;-3.23,1.74,;-2.83,.25,;-3.92,-.84,;-5.41,-.44,;-5.8,1.05,;-4.72,2.14,;-6.49,-1.53,;-7.98,-1.13,;-8.67,-3.7,;-7.18,-4.1,;-6.79,-5.59,;-5.3,-5.99,;-4.9,-7.48,;-4.21,-4.9,;-4.61,-3.41,;-6.1,-3.01,;.04,5.01,;1.13,6.1,)| InChI=1S/C31H40FN3O3/c1-31(2,3)37-26-11-6-23(7-12-26)30(36)33-25-9-4-21(5-10-25)14-17-35-18-15-22(16-19-35)29-27-13-8-24(32)20-28(27)38-34-29/h6-8,11-13,20-22,25H,4-5,9-10,14-19H2,1-3H3,(H,33,36) YGFINQFSLIMLPP-UHFFFAOYSA-N 180709 US8829029, 9 D(3) dopamine receptor Homo sapiens 3.417 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180709 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180709&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206211 313362871 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327379 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(Cl)cc2)CC1 |r,wU:19.24,wD:16.17,(-4.3,-7.48,;-4.7,-5.99,;-3.61,-4.9,;-4.01,-3.41,;-5.5,-3.01,;-5.9,-1.53,;-7.38,-1.13,;-8.07,-3.7,;-6.59,-4.1,;-6.19,-5.59,;-4.81,-.44,;-3.32,-.84,;-2.23,.25,;-2.63,1.74,;-1.54,2.83,;-.05,2.43,;1.04,3.52,;2.52,3.12,;3.61,4.21,;3.21,5.7,;1.73,6.1,;.64,5.01,;4.3,6.79,;5.79,6.39,;6.88,7.48,;6.19,4.9,;5.1,3.81,;5.5,2.32,;6.99,1.93,;7.38,.44,;8.07,3.01,;7.68,4.5,;-4.12,2.14,;-5.21,1.05,)| InChI=1S/C27H31ClFN3O2/c28-21-5-3-20(4-6-21)27(33)30-23-8-1-18(2-9-23)11-14-32-15-12-19(13-16-32)26-24-10-7-22(29)17-25(24)34-31-26/h3-7,10,17-19,23H,1-2,8-9,11-16H2,(H,30,33) RYUCLQAAFLZLPD-UHFFFAOYSA-N 180710 US8829029, 10 D(3) dopamine receptor Homo sapiens 3.498 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180710 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180710&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206212 313362872 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327380 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(cc2)N2CCS(=O)(=O)CC2)CC1 |r,wU:19.24,wD:16.17,(-4.9,-7.48,;-5.3,-5.99,;-4.21,-4.9,;-4.61,-3.41,;-6.1,-3.01,;-6.49,-1.53,;-7.98,-1.13,;-8.67,-3.7,;-7.18,-4.1,;-6.79,-5.59,;-5.41,-.44,;-3.92,-.84,;-2.83,.25,;-3.23,1.74,;-2.14,2.83,;-.65,2.43,;.44,3.52,;1.93,3.12,;3.01,4.21,;2.62,5.7,;1.13,6.1,;.04,5.01,;3.7,6.79,;5.19,6.39,;6.28,7.48,;5.59,4.9,;4.5,3.81,;4.9,2.32,;6.39,1.93,;7.48,3.01,;7.08,4.5,;6.79,.44,;5.7,-.65,;6.1,-2.14,;7.58,-2.54,;7.18,-4.02,;8.67,-3.63,;8.67,-1.45,;8.27,.04,;-4.72,2.14,;-5.8,1.05,)| InChI=1S/C31H39FN4O4S/c32-25-5-10-28-29(21-25)40-34-30(28)23-12-15-35(16-13-23)14-11-22-1-6-26(7-2-22)33-31(37)24-3-8-27(9-4-24)36-17-19-41(38,39)20-18-36/h3-5,8-10,21-23,26H,1-2,6-7,11-20H2,(H,33,37) SQXPURWSUNRRIZ-UHFFFAOYSA-N 180711 US8829029, 11 D(3) dopamine receptor Homo sapiens 4.674 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180711 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180711&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205754 313362873 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327381 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccnc(c2)N2CCOCC2)CC1 |r,wU:19.24,wD:16.17,(-6.53,-7.48,;-6.93,-5.99,;-5.84,-4.9,;-6.24,-3.41,;-7.73,-3.01,;-8.13,-1.53,;-9.62,-1.13,;-10.31,-3.7,;-8.82,-4.1,;-8.42,-5.59,;-7.04,-.44,;-5.55,-.84,;-4.46,.25,;-4.86,1.74,;-3.77,2.83,;-2.28,2.43,;-1.2,3.52,;.29,3.12,;1.38,4.21,;.98,5.7,;-.51,6.1,;-1.59,5.01,;2.07,6.79,;3.56,6.39,;4.65,7.48,;3.96,4.9,;2.87,3.81,;3.27,2.32,;4.75,1.93,;5.84,3.01,;5.44,4.5,;7.33,2.62,;7.73,1.13,;9.22,.73,;10.31,1.82,;9.91,3.31,;8.42,3.7,;-6.35,2.14,;-7.44,1.05,)| InChI=1S/C30H38FN5O3/c31-24-3-6-26-27(20-24)39-34-29(26)22-9-13-35(14-10-22)12-8-21-1-4-25(5-2-21)33-30(37)23-7-11-32-28(19-23)36-15-17-38-18-16-36/h3,6-7,11,19-22,25H,1-2,4-5,8-10,12-18H2,(H,33,37) VWGPRFQVSJZKGC-UHFFFAOYSA-N 180712 US8829029, 12 D(3) dopamine receptor Homo sapiens 5.747 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180712 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180712&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206377 313362874 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327382 COc1cc(ccn1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:11.11,wD:14.15,(9.02,1.13,;8.62,2.62,;7.13,3.01,;6.73,4.5,;5.25,4.9,;4.16,3.81,;4.56,2.32,;6.04,1.93,;4.85,6.39,;5.94,7.48,;3.36,6.79,;2.27,5.7,;2.67,4.21,;1.58,3.12,;.09,3.52,;-1,2.43,;-2.48,2.83,;-3.57,1.74,;-3.17,.25,;-4.26,-.84,;-5.75,-.44,;-6.15,1.05,;-5.06,2.14,;-6.84,-1.53,;-8.33,-1.13,;-9.02,-3.7,;-7.53,-4.1,;-7.13,-5.59,;-5.64,-5.99,;-5.25,-7.48,;-4.56,-4.9,;-4.95,-3.41,;-6.44,-3.01,;-.31,5.01,;.78,6.1,)| InChI=1S/C27H33FN4O3/c1-34-25-16-20(8-12-29-25)27(33)30-22-5-2-18(3-6-22)9-13-32-14-10-19(11-15-32)26-23-7-4-21(28)17-24(23)35-31-26/h4,7-8,12,16-19,22H,2-3,5-6,9-11,13-15H2,1H3,(H,30,33) WNNTXSLBSCNVQL-UHFFFAOYSA-N 180713 US8829029, 13 D(3) dopamine receptor Homo sapiens 3.738 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180713 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180713&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206378 313362875 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327383 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(cc2)N2CCCCC2)CC1 |r,wU:19.24,wD:16.17,(-4.9,-7.48,;-5.3,-5.99,;-4.21,-4.9,;-4.61,-3.41,;-6.1,-3.01,;-6.49,-1.53,;-7.98,-1.13,;-8.67,-3.7,;-7.18,-4.1,;-6.79,-5.59,;-5.41,-.44,;-3.92,-.84,;-2.83,.25,;-3.23,1.74,;-2.14,2.83,;-.65,2.43,;.44,3.52,;1.93,3.12,;3.01,4.21,;2.62,5.7,;1.13,6.1,;.04,5.01,;3.7,6.79,;5.19,6.39,;6.28,7.48,;5.59,4.9,;4.5,3.81,;4.9,2.32,;6.39,1.93,;7.48,3.01,;7.08,4.5,;6.79,.44,;5.7,-.65,;6.1,-2.14,;7.58,-2.54,;8.67,-1.45,;8.27,.04,;-4.72,2.14,;-5.8,1.05,)| InChI=1S/C32H41FN4O2/c33-26-8-13-29-30(22-26)39-35-31(29)24-15-20-36(21-16-24)19-14-23-4-9-27(10-5-23)34-32(38)25-6-11-28(12-7-25)37-17-2-1-3-18-37/h6-8,11-13,22-24,27H,1-5,9-10,14-21H2,(H,34,38) BACBDGDLWOOPAD-UHFFFAOYSA-N 180714 US8829029, 14 D(3) dopamine receptor Homo sapiens 8.685 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180714 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180714&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206379 313362876 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327384 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2COc3ccccc3O2)CC1 |r,wU:19.24,wD:16.17,(-5.25,-7.48,;-5.64,-5.99,;-4.56,-4.9,;-4.95,-3.41,;-6.44,-3.01,;-6.84,-1.53,;-8.33,-1.13,;-9.02,-3.7,;-7.53,-4.1,;-7.13,-5.59,;-5.75,-.44,;-4.26,-.84,;-3.17,.25,;-3.57,1.74,;-2.48,2.83,;-1,2.43,;.09,3.52,;1.58,3.12,;2.67,4.21,;2.27,5.7,;.78,6.1,;-.31,5.01,;3.36,6.79,;4.85,6.39,;5.94,7.48,;5.25,4.9,;4.16,3.81,;4.56,2.32,;6.04,1.93,;6.44,.44,;7.93,.04,;9.02,1.13,;8.62,2.62,;7.13,3.01,;6.73,4.5,;-5.06,2.14,;-6.15,1.05,)| InChI=1S/C29H34FN3O4/c30-21-7-10-23-26(17-21)37-32-28(23)20-12-15-33(16-13-20)14-11-19-5-8-22(9-6-19)31-29(34)27-18-35-24-3-1-2-4-25(24)36-27/h1-4,7,10,17,19-20,22,27H,5-6,8-9,11-16,18H2,(H,31,34) MDBJINZABFWALU-UHFFFAOYSA-N 180715 US8829029, 15 D(3) dopamine receptor Homo sapiens 12.66 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180715 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180715&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206380 313362877 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327385 Cc1ccn(CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)ccc34)CC2)n1 |r,wU:9.8,wD:12.12,(9.79,5.27,;8.45,4.5,;7.98,3.04,;6.44,3.04,;5.96,4.5,;4.47,4.9,;4.08,6.39,;5.17,7.48,;2.59,6.79,;1.5,5.7,;1.9,4.21,;.81,3.12,;-.68,3.52,;-1.77,2.43,;-3.25,2.83,;-4.34,1.74,;-3.94,.25,;-5.03,-.84,;-6.52,-.44,;-6.92,1.05,;-5.83,2.14,;-7.61,-1.53,;-9.1,-1.13,;-9.79,-3.7,;-8.3,-4.1,;-7.9,-5.59,;-6.41,-5.99,;-6.02,-7.48,;-5.33,-4.9,;-5.72,-3.41,;-7.21,-3.01,;-1.08,5.01,;.01,6.1,;7.21,5.41,)| InChI=1S/C26H34FN5O2/c1-18-8-15-32(29-18)17-25(33)28-22-5-2-19(3-6-22)9-12-31-13-10-20(11-14-31)26-23-7-4-21(27)16-24(23)34-30-26/h4,7-8,15-16,19-20,22H,2-3,5-6,9-14,17H2,1H3,(H,28,33) RLVPJHQAQHSEHQ-UHFFFAOYSA-N 180716 US8829029, 16 D(3) dopamine receptor Homo sapiens 27.618 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180716 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180716&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206706 313362878 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327386 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(cc2)-n2cccc2)CC1 |r,wU:19.24,wD:16.17,(-4.69,-7.48,;-5.09,-5.99,;-4,-4.9,;-4.4,-3.41,;-5.89,-3.01,;-6.28,-1.53,;-7.77,-1.13,;-8.46,-3.7,;-6.97,-4.1,;-6.58,-5.59,;-5.19,-.44,;-3.71,-.84,;-2.62,.25,;-3.02,1.74,;-1.93,2.83,;-.44,2.43,;.65,3.52,;2.14,3.12,;3.22,4.21,;2.83,5.7,;1.34,6.1,;.25,5.01,;3.92,6.79,;5.4,6.39,;6.49,7.48,;5.8,4.9,;4.71,3.81,;5.11,2.32,;6.6,1.93,;7.69,3.01,;7.29,4.5,;7,.44,;8.46,-.04,;8.46,-1.58,;7,-2.05,;6.09,-.81,;-4.5,2.14,;-5.59,1.05,)| InChI=1S/C31H35FN4O2/c32-25-7-12-28-29(21-25)38-34-30(28)23-14-19-35(20-15-23)18-13-22-3-8-26(9-4-22)33-31(37)24-5-10-27(11-6-24)36-16-1-2-17-36/h1-2,5-7,10-12,16-17,21-23,26H,3-4,8-9,13-15,18-20H2,(H,33,37) SIOXKMDYIGNNPU-UHFFFAOYSA-N 180717 US8829029, 17 D(3) dopamine receptor Homo sapiens 2.607 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180717 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180717&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206538 313362879 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327387 OC1(CC1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:7.7,wD:10.11,(7.88,5.3,;6.39,4.9,;5.99,3.41,;7.48,3.81,;5.99,6.39,;7.08,7.48,;4.5,6.79,;3.41,5.7,;3.81,4.21,;2.72,3.12,;1.23,3.52,;.15,2.43,;-1.34,2.83,;-2.43,1.74,;-2.03,.25,;-3.12,-.84,;-4.61,-.44,;-5.01,1.05,;-3.92,2.14,;-5.7,-1.53,;-7.18,-1.13,;-7.88,-3.7,;-6.39,-4.1,;-5.99,-5.59,;-4.5,-5.99,;-4.1,-7.48,;-3.41,-4.9,;-3.81,-3.41,;-5.3,-3.01,;.84,5.01,;1.93,6.1,)| InChI=1S/C24H32FN3O3/c25-18-3-6-20-21(15-18)31-27-22(20)17-8-13-28(14-9-17)12-7-16-1-4-19(5-2-16)26-23(29)24(30)10-11-24/h3,6,15-17,19,30H,1-2,4-5,7-14H2,(H,26,29) TYMYSUSJLROMAC-UHFFFAOYSA-N 180718 US8829029, 18 D(3) dopamine receptor Homo sapiens 5.916 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180718 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180718&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25141111 313362880 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327388 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C2(CCC2)C(F)(F)F)CC1 |r,wU:19.24,wD:16.17,(-4.85,-7.48,;-5.25,-5.99,;-4.16,-4.9,;-4.56,-3.41,;-6.04,-3.01,;-6.44,-1.53,;-7.93,-1.13,;-8.62,-3.7,;-7.13,-4.1,;-6.73,-5.59,;-5.35,-.44,;-3.86,-.84,;-2.78,.25,;-3.17,1.74,;-2.09,2.83,;-.6,2.43,;.49,3.52,;1.98,3.12,;3.07,4.21,;2.67,5.7,;1.18,6.1,;.09,5.01,;3.76,6.79,;5.25,6.39,;6.33,7.48,;5.64,4.9,;4.87,3.57,;6.21,2.8,;6.98,4.13,;7.13,5.3,;8.62,5.7,;6.73,6.79,;7.53,3.81,;-4.66,2.14,;-5.75,1.05,)| InChI=1S/C26H33F4N3O2/c27-19-4-7-21-22(16-19)35-32-23(21)18-9-14-33(15-10-18)13-8-17-2-5-20(6-3-17)31-24(34)25(11-1-12-25)26(28,29)30/h4,7,16-18,20H,1-3,5-6,8-15H2,(H,31,34) SKJYMWUUJASLOP-UHFFFAOYSA-N 180719 US8829029, 19 D(3) dopamine receptor Homo sapiens 7.74 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180719 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180719&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206539 313362881 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327389 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC(F)(F)F)CC1 |r,wU:19.24,wD:16.17,(-3.7,-7.48,;-4.1,-5.99,;-3.01,-4.9,;-3.41,-3.41,;-4.9,-3.01,;-5.3,-1.53,;-6.79,-1.13,;-7.48,-3.7,;-5.99,-4.1,;-5.59,-5.59,;-4.21,-.44,;-2.72,-.84,;-1.63,.25,;-2.03,1.74,;-.94,2.83,;.54,2.43,;1.63,3.52,;3.12,3.12,;4.21,4.21,;3.81,5.7,;2.32,6.1,;1.23,5.01,;4.9,6.79,;6.39,6.39,;7.48,7.48,;6.79,4.9,;5.7,3.81,;4.61,2.72,;4.61,4.9,;6.79,2.72,;-3.52,2.14,;-4.61,1.05,)| InChI=1S/C23H29F4N3O2/c24-17-3-6-19-20(13-17)32-29-22(19)16-8-11-30(12-9-16)10-7-15-1-4-18(5-2-15)28-21(31)14-23(25,26)27/h3,6,13,15-16,18H,1-2,4-5,7-12,14H2,(H,28,31) PAZGGYGNWVGTBZ-UHFFFAOYSA-N 180720 US8829029, 20 D(3) dopamine receptor Homo sapiens 5.189 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180720 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180720&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206540 313362882 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327390 COc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)ccc34)CC2)cc(OC)c1 |r,wU:9.8,wD:12.12,(10.45,5.88,;8.96,6.28,;7.88,5.19,;6.39,5.59,;5.3,4.5,;3.81,4.9,;3.41,6.39,;4.5,7.48,;1.93,6.79,;.84,5.7,;1.23,4.21,;.15,3.12,;-1.34,3.52,;-2.43,2.43,;-3.92,2.83,;-5.01,1.74,;-4.61,.25,;-5.7,-.84,;-7.18,-.44,;-7.58,1.05,;-6.49,2.14,;-8.27,-1.53,;-9.76,-1.13,;-10.45,-3.7,;-8.96,-4.1,;-8.57,-5.59,;-7.08,-5.99,;-6.68,-7.48,;-5.99,-4.9,;-6.39,-3.41,;-7.88,-3.01,;-1.74,5.01,;-.65,6.1,;5.7,3.01,;7.18,2.62,;7.58,1.13,;9.07,.73,;8.27,3.7,)| InChI=1S/C30H38FN3O4/c1-36-25-15-21(16-26(19-25)37-2)17-29(35)32-24-6-3-20(4-7-24)9-12-34-13-10-22(11-14-34)30-27-8-5-23(31)18-28(27)38-33-30/h5,8,15-16,18-20,22,24H,3-4,6-7,9-14,17H2,1-2H3,(H,32,35) FDGBPEVIZWNWEX-UHFFFAOYSA-N 180721 US8829029, 21 D(3) dopamine receptor Homo sapiens 8.772 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180721 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180721&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206541 313362883 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327391 CC1CN(CC(C)O1)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:17.18,wD:20.22,(4.26,-3.23,;5.35,-2.14,;4.95,-.65,;6.04,.44,;7.53,.04,;7.93,-1.45,;9.42,-1.85,;6.84,-2.54,;5.64,1.93,;4.16,2.32,;3.76,3.81,;4.85,4.9,;6.33,4.5,;6.73,3.01,;4.45,6.39,;5.54,7.48,;2.96,6.79,;1.87,5.7,;2.27,4.21,;1.18,3.12,;-.31,3.52,;-1.39,2.43,;-2.88,2.83,;-3.97,1.74,;-3.57,.25,;-4.66,-.84,;-6.15,-.44,;-6.55,1.05,;-5.46,2.14,;-7.24,-1.53,;-8.73,-1.13,;-9.42,-3.7,;-7.93,-4.1,;-7.53,-5.59,;-6.04,-5.99,;-5.64,-7.48,;-4.95,-4.9,;-5.35,-3.41,;-6.84,-3.01,;-.7,5.01,;.38,6.1,)| InChI=1S/C33H43FN4O3/c1-22-20-38(21-23(2)40-22)29-10-5-26(6-11-29)33(39)35-28-8-3-24(4-9-28)13-16-37-17-14-25(15-18-37)32-30-12-7-27(34)19-31(30)41-36-32/h5-7,10-12,19,22-25,28H,3-4,8-9,13-18,20-21H2,1-2H3,(H,35,39) GCNYBTOKPNSCEU-UHFFFAOYSA-N 180722 US8829029, 22 D(3) dopamine receptor Homo sapiens 136.625 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180722 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180722&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206542 313362884 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327392 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc3OCOc3c2)CC1 |r,wU:19.24,wD:16.17,(-4.99,-7.48,;-5.39,-5.99,;-4.3,-4.9,;-4.7,-3.41,;-6.18,-3.01,;-6.58,-1.53,;-8.07,-1.13,;-8.76,-3.7,;-7.27,-4.1,;-6.87,-5.59,;-5.49,-.44,;-4.01,-.84,;-2.92,.25,;-3.32,1.74,;-2.23,2.83,;-.74,2.43,;.35,3.52,;1.84,3.12,;2.93,4.21,;2.53,5.7,;1.04,6.1,;-.05,5.01,;3.62,6.79,;5.1,6.39,;6.19,7.48,;5.5,4.9,;4.41,3.81,;4.81,2.32,;6.3,1.93,;7,.55,;8.52,.79,;8.76,2.32,;7.39,3.01,;6.99,4.5,;-4.8,2.14,;-5.89,1.05,)| InChI=1S/C28H32FN3O4/c29-21-4-7-23-25(16-21)36-31-27(23)19-10-13-32(14-11-19)12-9-18-1-5-22(6-2-18)30-28(33)20-3-8-24-26(15-20)35-17-34-24/h3-4,7-8,15-16,18-19,22H,1-2,5-6,9-14,17H2,(H,30,33) NHPZGAKHYOUQRR-UHFFFAOYSA-N 180723 US8829029, 23 D(3) dopamine receptor Homo sapiens 2.746 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180723 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180723&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206707 313362885 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327393 CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3ccc(F)cc23)CC1 |r,wU:4.3,wD:7.7,(8,-5.77,;6.67,-5,;5.33,-5.77,;6.67,-3.46,;5.33,-2.7,;4,-3.47,;2.67,-2.7,;2.67,-1.16,;1.33,-.39,;1.33,1.15,;,1.92,;-1.33,1.15,;-2.67,1.92,;-2.67,3.46,;-1.33,4.23,;,3.46,;-4,4.23,;-4,5.77,;-6.67,5.77,;-6.67,4.23,;-8,3.46,;-8,1.92,;-6.67,1.15,;-6.67,-.39,;-5.33,1.92,;-5.33,3.46,;4,-.38,;5.33,-1.16,)| InChI=1S/C22H30FN3O2/c1-15(27)24-19-5-2-16(3-6-19)8-11-26-12-9-17(10-13-26)22-20-14-18(23)4-7-21(20)28-25-22/h4,7,14,16-17,19H,2-3,5-6,8-13H2,1H3,(H,24,27) VPIBUDXDYGVIBY-UHFFFAOYSA-N 180724 US8829029, 24 D(3) dopamine receptor Homo sapiens 2.438 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180724 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180724&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206708 313362886 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327394 Fc1ccc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)c4ccc(cc4)N4CCOCC4)CC3)c2c1 |r,wU:17.20,wD:14.13,(-6.67,1.92,;-6.67,3.46,;-8,4.23,;-8,5.77,;-6.67,6.54,;-6.67,8.08,;-4,8.08,;-4,6.54,;-2.67,5.77,;-2.67,4.23,;-1.33,3.46,;,4.23,;1.33,3.46,;1.33,1.92,;2.67,1.15,;2.67,-.39,;4,-1.16,;5.33,-.39,;5.33,1.15,;4,1.93,;6.67,-1.15,;6.67,-2.69,;8,-3.46,;5.33,-3.46,;4,-2.69,;2.67,-3.46,;2.67,-5,;4,-5.77,;5.33,-5,;1.33,-5.77,;,-5,;-1.33,-5.77,;-1.33,-7.31,;,-8.08,;1.33,-7.31,;,5.77,;-1.33,6.54,;-5.33,5.77,;-5.33,4.23,)| InChI=1S/C31H39FN4O3/c32-25-5-10-29-28(21-25)30(34-39-29)23-12-15-35(16-13-23)14-11-22-1-6-26(7-2-22)33-31(37)24-3-8-27(9-4-24)36-17-19-38-20-18-36/h3-5,8-10,21-23,26H,1-2,6-7,11-20H2,(H,33,37) CIQACWAFDSMBMG-UHFFFAOYSA-N 180725 US8829029, 25 D(3) dopamine receptor Homo sapiens 9.036 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180725 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180725&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206709 313362887 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327395 COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3ccc(F)cc23)CC1 |r,wU:7.6,wD:10.10,(5.82,1.49,;6.91,.4,;6.52,-1.09,;7.6,-2.18,;7.21,-3.67,;8.29,-4.75,;5.72,-4.06,;4.63,-2.98,;3.14,-3.37,;2.05,-2.29,;2.45,-.8,;1.36,.29,;-.13,-.11,;-1.21,.98,;-2.7,.58,;-3.79,1.67,;-3.39,3.16,;-1.9,3.56,;-.82,2.47,;-4.88,3.56,;-5.85,4.75,;-7.29,4.2,;-7.21,2.67,;-8.29,1.58,;-7.9,.09,;-6.41,-.31,;-6.01,-1.8,;-5.32,.78,;-5.72,2.27,;3.94,-.4,;5.03,-1.49,)| InChI=1S/C24H34FN3O3/c1-30-15-11-23(29)26-20-5-2-17(3-6-20)8-12-28-13-9-18(10-14-28)24-21-16-19(25)4-7-22(21)31-27-24/h4,7,16-18,20H,2-3,5-6,8-15H2,1H3,(H,26,29) HZDFSRLOPVRUAU-UHFFFAOYSA-N 180726 US8829029, 26 D(3) dopamine receptor Homo sapiens 3.099 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180726 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180726&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206710 313362888 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327396 Fc1ccc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)c4ccc(cc4)N4CCCCC4)CC3)c2c1 |r,wU:17.20,wD:14.13,(-2.72,-6.04,;-4.21,-5.64,;-5.3,-6.73,;-6.79,-6.33,;-7.18,-4.85,;-8.67,-4.45,;-7.98,-1.87,;-6.49,-2.27,;-5.41,-1.18,;-3.92,-1.58,;-2.83,-.49,;-3.23,1,;-2.14,2.09,;-.65,1.69,;.44,2.78,;1.93,2.38,;3.01,3.47,;2.62,4.95,;1.13,5.35,;.04,4.26,;3.7,6.04,;5.19,5.64,;6.28,6.73,;5.59,4.16,;4.5,3.07,;4.9,1.58,;6.39,1.18,;7.48,2.27,;7.08,3.76,;6.79,-.31,;5.7,-1.39,;6.1,-2.88,;7.58,-3.28,;8.67,-2.19,;8.27,-.7,;-4.72,1.39,;-5.8,.31,;-6.1,-3.76,;-4.61,-4.16,)| InChI=1S/C32H41FN4O2/c33-26-8-13-30-29(22-26)31(35-39-30)24-15-20-36(21-16-24)19-14-23-4-9-27(10-5-23)34-32(38)25-6-11-28(12-7-25)37-17-2-1-3-18-37/h6-8,11-13,22-24,27H,1-5,9-10,14-21H2,(H,34,38) IWQHFZLOBAGAOK-UHFFFAOYSA-N 180727 US8829029, 27 D(3) dopamine receptor Homo sapiens 7.7 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180727 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180727&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207028 313362889 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327397 CC1CN(CC(C)O1)c1ccc(cc1)C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3ccc(F)cc23)CC1 |r,wU:17.18,wD:20.22,(4.26,-3.97,;5.35,-2.88,;4.95,-1.39,;6.04,-.31,;7.53,-.7,;7.93,-2.19,;9.42,-2.59,;6.84,-3.28,;5.64,1.18,;4.16,1.58,;3.76,3.07,;4.85,4.16,;6.33,3.76,;6.73,2.27,;4.45,5.64,;5.54,6.73,;2.96,6.04,;1.87,4.95,;2.27,3.47,;1.18,2.38,;-.31,2.78,;-1.39,1.69,;-2.88,2.09,;-3.97,1,;-3.57,-.49,;-4.66,-1.58,;-6.15,-1.18,;-6.55,.31,;-5.46,1.39,;-7.24,-2.27,;-8.73,-1.87,;-9.42,-4.45,;-7.93,-4.85,;-7.53,-6.33,;-6.04,-6.73,;-4.95,-5.64,;-3.47,-6.04,;-5.35,-4.16,;-6.84,-3.76,;-.7,4.26,;.38,5.35,)| InChI=1S/C33H43FN4O3/c1-22-20-38(21-23(2)40-22)29-10-5-26(6-11-29)33(39)35-28-8-3-24(4-9-28)13-16-37-17-14-25(15-18-37)32-30-19-27(34)7-12-31(30)41-36-32/h5-7,10-12,19,22-25,28H,3-4,8-9,13-18,20-21H2,1-2H3,(H,35,39) RNAKUHHBSZEVQT-UHFFFAOYSA-N 180728 US8829029, 28 D(3) dopamine receptor Homo sapiens 85.773 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180728 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180728&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206870 313362890 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327398 Fc1ccc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)c4ccc(cc4)N4CCS(=O)(=O)CC4)CC3)c2c1 |r,wU:17.20,wD:14.13,(-2.72,-6.04,;-4.21,-5.64,;-5.3,-6.73,;-6.79,-6.33,;-7.18,-4.85,;-8.67,-4.45,;-7.98,-1.87,;-6.49,-2.27,;-5.41,-1.18,;-3.92,-1.58,;-2.83,-.49,;-3.23,1,;-2.14,2.09,;-.65,1.69,;.44,2.78,;1.93,2.38,;3.01,3.47,;2.62,4.95,;1.13,5.35,;.04,4.26,;3.7,6.04,;5.19,5.64,;6.28,6.73,;5.59,4.16,;4.5,3.07,;4.9,1.58,;6.39,1.18,;7.48,2.27,;7.08,3.76,;6.79,-.31,;5.7,-1.39,;6.1,-2.88,;7.58,-3.28,;7.18,-4.77,;8.67,-4.37,;8.67,-2.19,;8.27,-.7,;-4.72,1.39,;-5.8,.31,;-6.1,-3.76,;-4.61,-4.16,)| InChI=1S/C31H39FN4O4S/c32-25-5-10-29-28(21-25)30(34-40-29)23-12-15-35(16-13-23)14-11-22-1-6-26(7-2-22)33-31(37)24-3-8-27(9-4-24)36-17-19-41(38,39)20-18-36/h3-5,8-10,21-23,26H,1-2,6-7,11-20H2,(H,33,37) KHTOBAZDVUSQIH-UHFFFAOYSA-N 180729 US8829029, 29 D(3) dopamine receptor Homo sapiens 5.936 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180729 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180729&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205755 313362891 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327399 Fc1ccc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)c4ccc5OCOc5c4)CC3)c2c1 |r,wU:17.20,wD:14.13,(-2.81,-6.04,;-4.3,-5.64,;-5.39,-6.73,;-6.87,-6.33,;-7.27,-4.85,;-8.76,-4.45,;-8.07,-1.87,;-6.58,-2.27,;-5.49,-1.18,;-4.01,-1.58,;-2.92,-.49,;-3.32,1,;-2.23,2.09,;-.74,1.69,;.35,2.78,;1.84,2.38,;2.93,3.47,;2.53,4.95,;1.04,5.35,;-.05,4.26,;3.62,6.04,;5.1,5.64,;6.19,6.73,;5.5,4.16,;4.41,3.07,;4.81,1.58,;6.3,1.18,;7,-.19,;8.52,.05,;8.76,1.57,;7.39,2.27,;6.99,3.76,;-4.8,1.39,;-5.89,.31,;-6.18,-3.76,;-4.7,-4.16,)| InChI=1S/C28H32FN3O4/c29-21-4-8-24-23(16-21)27(31-36-24)19-10-13-32(14-11-19)12-9-18-1-5-22(6-2-18)30-28(33)20-3-7-25-26(15-20)35-17-34-25/h3-4,7-8,15-16,18-19,22H,1-2,5-6,9-14,17H2,(H,30,33) PGQVBLPLAKZWKQ-UHFFFAOYSA-N 180730 US8829029, 30 D(3) dopamine receptor Homo sapiens 3.861 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180730 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180730&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206871 313362892 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327400 COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:7.6,wD:10.10,(12.24,-1.15,;10.9,-1.92,;9.57,-1.15,;8.24,-1.92,;6.9,-1.15,;6.9,.39,;5.57,-1.92,;4.03,-1.92,;3.26,-3.26,;1.72,-3.26,;.95,-1.92,;-.59,-1.92,;-1.36,-.59,;-2.9,-.59,;-2.9,.95,;-4.23,1.72,;-5.57,.95,;-5.57,-.59,;-4.23,-1.36,;-6.9,1.72,;-6.9,3.26,;-9.57,3.26,;-9.57,1.72,;-10.9,.95,;-10.9,-.59,;-12.24,-1.36,;-9.57,-1.36,;-8.24,-.59,;-8.24,.95,;1.72,-.59,;3.26,-.59,)| InChI=1S/C24H34ClN3O3/c1-30-15-11-23(29)26-20-5-2-17(3-6-20)8-12-28-13-9-18(10-14-28)24-21-7-4-19(25)16-22(21)31-27-24/h4,7,16-18,20H,2-3,5-6,8-15H2,1H3,(H,26,29) IZWSUUXSTWDMST-UHFFFAOYSA-N 180731 US8829029, 32 D(3) dopamine receptor Homo sapiens 8.497 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180731 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180731&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206872 313362893 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327401 OC(C(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1)C(F)(F)F |r,wU:5.4,wD:8.8,(4.67,-3.46,;6,-4.23,;7.34,-3.46,;8.67,-4.23,;7.34,-1.92,;6,-1.15,;4.67,-1.92,;3.33,-1.15,;3.33,.39,;2,1.16,;2,2.7,;.67,3.46,;.67,5,;-.67,5.77,;-2,5,;-2,3.46,;-.67,2.69,;-3.33,5.77,;-3.33,7.31,;-6,7.31,;-6,5.77,;-7.34,5,;-7.34,3.46,;-8.67,2.69,;-6,2.69,;-4.67,3.46,;-4.67,5,;4.67,1.16,;6,.39,;6,-5.77,;6,-7.31,;7.54,-5.77,;4.46,-5.77,)| InChI=1S/C23H29ClF3N3O3/c24-16-3-6-18-19(13-16)33-29-20(18)15-8-11-30(12-9-15)10-7-14-1-4-17(5-2-14)28-22(32)21(31)23(25,26)27/h3,6,13-15,17,21,31H,1-2,4-5,7-12H2,(H,28,32) XXFBAYGHJVLPQT-UHFFFAOYSA-N 180732 US8829029, 33 D(3) dopamine receptor Homo sapiens 11.029 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180732 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180732&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206873 313362894 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327402 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCCCO2)CC1 |r,wU:19.24,wD:16.17,(-8.67,3.46,;-7.34,4.23,;-6,3.46,;-4.67,4.23,;-4.67,5.77,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.77,;-2,5.77,;-.67,6.54,;.67,5.77,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.16,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.16,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.46,;6,-3.46,;6,-5,;7.34,-5.77,;7.34,-7.31,;6,-8.08,;4.67,-7.31,;4.67,-5.77,;-.67,3.46,;-2,4.23,)| InChI=1S/C27H38ClN3O3/c28-21-6-9-24-25(17-21)34-30-27(24)20-11-14-31(15-12-20)13-10-19-4-7-22(8-5-19)29-26(32)18-23-3-1-2-16-33-23/h6,9,17,19-20,22-23H,1-5,7-8,10-16,18H2,(H,29,32) GAKGHYKFFZHEBW-UHFFFAOYSA-N 180733 US8829029, 34 D(3) dopamine receptor Homo sapiens 10.734 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180733 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180733&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25206874 313362895 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327403 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C[C@@H]2CCCCO2)CC1 |r,wU:19.24,wD:16.17,26.28,(-8.67,3.46,;-7.34,4.23,;-6,3.46,;-4.67,4.23,;-4.67,5.77,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.77,;-2,5.77,;-.67,6.54,;.67,5.77,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.16,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.16,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.46,;6,-3.46,;6,-5,;7.34,-5.77,;7.34,-7.31,;6,-8.08,;4.67,-7.31,;4.67,-5.77,;-.67,3.46,;-2,4.23,)| InChI=1S/C27H38ClN3O3/c28-21-6-9-24-25(17-21)34-30-27(24)20-11-14-31(15-12-20)13-10-19-4-7-22(8-5-19)29-26(32)18-23-3-1-2-16-33-23/h6,9,17,19-20,22-23H,1-5,7-8,10-16,18H2,(H,29,32) GAKGHYKFFZHEBW-UHFFFAOYSA-N 180734 US8829029, 34A D(3) dopamine receptor Homo sapiens 10.734 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180734 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180734&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207030 313362896 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327404 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C[C@H]2CCCCO2)CC1 |r,wU:19.24,26.28,wD:16.17,(-8.67,3.46,;-7.34,4.23,;-6,3.46,;-4.67,4.23,;-4.67,5.77,;-3.33,6.54,;-3.33,8.08,;-6,8.08,;-6,6.54,;-7.34,5.77,;-2,5.77,;-.67,6.54,;.67,5.77,;.67,4.23,;2,3.47,;2,1.93,;3.33,1.16,;3.33,-.38,;4.67,-1.15,;6,-.38,;6,1.16,;4.67,1.93,;7.34,-1.15,;7.34,-2.69,;8.67,-3.46,;6,-3.46,;6,-5,;7.34,-5.77,;7.34,-7.31,;6,-8.08,;4.67,-7.31,;4.67,-5.77,;-.67,3.46,;-2,4.23,)| InChI=1S/C27H38ClN3O3/c28-21-6-9-24-25(17-21)34-30-27(24)20-11-14-31(15-12-20)13-10-19-4-7-22(8-5-19)29-26(32)18-23-3-1-2-16-33-23/h6,9,17,19-20,22-23H,1-5,7-8,10-16,18H2,(H,29,32) GAKGHYKFFZHEBW-UHFFFAOYSA-N 180735 US8829029, 34B D(3) dopamine receptor Homo sapiens 3.708 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180735 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180735&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207029 313362897 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327405 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)OC1 |r,wU:10.9,2.1,wD:13.13,5.5,(7.34,-9.24,;6,-8.47,;6,-6.93,;7.34,-6.16,;7.34,-4.62,;6,-3.85,;6,-2.31,;7.34,-1.54,;8.67,-2.31,;7.34,,;6,.77,;4.67,,;3.33,.77,;3.33,2.31,;2,3.08,;2,4.62,;.67,5.39,;.67,6.93,;-.67,7.7,;-2,6.93,;-2,5.39,;-.67,4.62,;-3.33,7.7,;-3.33,9.24,;-6,9.24,;-6,7.7,;-7.34,6.93,;-7.34,5.39,;-8.67,4.62,;-6,4.62,;-4.67,5.39,;-4.67,6.93,;4.67,3.08,;6,2.31,;4.67,-4.62,;4.67,-6.16,)| InChI=1S/C28H40ClN3O4/c1-34-24-8-7-23(35-18-24)17-27(33)30-22-5-2-19(3-6-22)10-13-32-14-11-20(12-15-32)28-25-9-4-21(29)16-26(25)36-31-28/h4,9,16,19-20,22-24H,2-3,5-8,10-15,17-18H2,1H3,(H,30,33) RDWXEESICWYGFN-UHFFFAOYSA-N 180736 US8829029, 35 D(3) dopamine receptor Homo sapiens 11.578 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180736 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180736&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 89664252 313362898 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327406 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCC3(CC2)OCCO3)CC1 |r,wU:19.24,wD:16.17,(-13.67,-1.36,;-12.34,-.59,;-11.01,-1.36,;-9.67,-.59,;-9.67,.95,;-8.34,1.72,;-8.34,3.26,;-11.01,3.26,;-11.01,1.72,;-12.34,.95,;-7.01,.95,;-5.67,1.72,;-4.34,.95,;-4.34,-.59,;-2.8,-.59,;-2.03,-1.92,;-.49,-1.92,;.28,-3.26,;1.82,-3.26,;2.59,-1.92,;1.82,-.59,;.28,-.59,;4.13,-1.92,;5.47,-1.16,;5.47,.39,;6.8,-1.92,;8.13,-1.16,;9.47,-1.92,;10.8,-1.16,;10.8,.39,;9.47,1.16,;8.13,.39,;11.57,1.72,;12.9,2.49,;13.67,1.16,;12.34,.39,;-5.67,-1.36,;-7.01,-.59,)| InChI=1S/C30H42ClN3O4/c31-24-3-6-26-27(20-24)38-33-29(26)23-10-15-34(16-11-23)14-9-21-1-4-25(5-2-21)32-28(35)19-22-7-12-30(13-8-22)36-17-18-37-30/h3,6,20-23,25H,1-2,4-5,7-19H2,(H,32,35) YDGKDHWBZFSXFF-UHFFFAOYSA-N 180737 US8829029, 36 D(3) dopamine receptor Homo sapiens 12.221 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180737 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180737&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207032 313362899 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327407 COC(CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1)OC |r,wU:7.6,wD:10.10,(12.24,-1.15,;10.9,-1.92,;9.57,-1.15,;8.24,-1.92,;6.9,-1.15,;6.9,.39,;5.57,-1.92,;4.03,-1.92,;3.26,-3.26,;1.72,-3.26,;.95,-1.92,;-.59,-1.92,;-1.36,-.59,;-2.9,-.59,;-2.9,.95,;-4.23,1.72,;-5.57,.95,;-5.57,-.59,;-4.23,-1.36,;-6.9,1.72,;-6.9,3.26,;-9.57,3.26,;-9.57,1.72,;-10.9,.95,;-10.9,-.59,;-12.24,-1.36,;-9.57,-1.36,;-8.24,-.59,;-8.24,.95,;1.72,-.59,;3.26,-.59,;9.57,.39,;10.9,1.15,)| InChI=1S/C25H36ClN3O4/c1-31-24(32-2)16-23(30)27-20-6-3-17(4-7-20)9-12-29-13-10-18(11-14-29)25-21-8-5-19(26)15-22(21)33-28-25/h5,8,15,17-18,20,24H,3-4,6-7,9-14,16H2,1-2H3,(H,27,30) AOWKBRDSGSHTGO-UHFFFAOYSA-N 180738 US8829029, 37 D(3) dopamine receptor Homo sapiens 9.03 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180738 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180738&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207339 313362900 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327408 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCCO2)CC1 |r,wU:19.24,wD:16.17,(-11.91,-2.69,;-10.57,-1.92,;-9.24,-2.69,;-7.91,-1.92,;-7.91,-.39,;-6.76,.65,;-7.39,2.05,;-8.92,1.89,;-9.24,.39,;-10.57,-.39,;-5.27,.25,;-4.88,-1.24,;-3.39,-1.64,;-2.3,-.55,;-.81,-.95,;.28,.14,;1.76,-.26,;2.16,-1.75,;3.65,-2.14,;4.74,-1.06,;4.34,.43,;2.85,.83,;6.23,-1.45,;7.32,-.37,;6.92,1.12,;8.8,-.76,;9.89,.32,;11.43,.32,;11.91,1.79,;10.66,2.69,;9.42,1.79,;-2.7,.94,;-4.19,1.34,)| InChI=1S/C26H36ClN3O3/c27-20-5-8-23-24(16-20)33-29-26(23)19-10-13-30(14-11-19)12-9-18-3-6-21(7-4-18)28-25(31)17-22-2-1-15-32-22/h5,8,16,18-19,21-22H,1-4,6-7,9-15,17H2,(H,28,31) XLEPAPXUDZKLLX-UHFFFAOYSA-N 180739 US8829029, 38 D(3) dopamine receptor Homo sapiens 9 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180739 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180739&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207180 313362901 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327409 C[C@@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:7.6,1.1,wD:10.10,(11.57,-1.44,;10.24,-2.21,;10.24,-3.75,;8.9,-1.44,;7.57,-2.21,;7.57,-3.75,;6.24,-1.44,;4.7,-1.44,;3.93,-2.77,;2.39,-2.77,;1.62,-1.44,;.08,-1.44,;-.69,-.1,;-2.23,-.1,;-2.23,1.44,;-3.57,2.21,;-4.9,1.44,;-4.9,-.1,;-3.57,-.87,;-6.24,2.21,;-6.24,3.75,;-8.9,3.75,;-8.9,2.21,;-10.24,1.44,;-10.24,-.1,;-11.57,-.87,;-8.9,-.87,;-7.57,-.1,;-7.57,1.44,;2.39,-.1,;3.93,-.1,)| InChI=1S/C24H34ClN3O3/c1-16(29)14-23(30)26-20-5-2-17(3-6-20)8-11-28-12-9-18(10-13-28)24-21-7-4-19(25)15-22(21)31-27-24/h4,7,15-18,20,29H,2-3,5-6,8-14H2,1H3,(H,26,30) NSDNFDRCTHNFLQ-UHFFFAOYSA-N 180740 US8829029, 39 D(3) dopamine receptor Homo sapiens 17 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180740 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180740&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207181 313362902 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327410 CC1(C)OC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)O1 |r,wU:10.9,wD:13.13,5.5,(10.69,2.35,;11.09,.86,;12.18,1.95,;12,-.39,;11.09,-1.63,;9.63,-1.16,;8.29,-1.92,;6.96,-1.16,;6.96,.39,;5.63,-1.92,;4.09,-1.92,;3.32,-3.26,;1.78,-3.26,;1.01,-1.92,;-.53,-1.92,;-1.3,-.59,;-2.84,-.59,;-2.84,.95,;-4.18,1.72,;-5.51,.95,;-5.51,-.59,;-4.18,-1.36,;-6.85,1.72,;-6.85,3.26,;-9.51,3.26,;-9.51,1.72,;-10.85,.95,;-10.85,-.59,;-12.18,-1.36,;-9.51,-1.36,;-8.18,-.59,;-8.18,.95,;1.78,-.59,;3.32,-.59,;9.63,.39,)| InChI=1S/C27H38ClN3O4/c1-27(2)33-17-22(34-27)16-25(32)29-21-6-3-18(4-7-21)9-12-31-13-10-19(11-14-31)26-23-8-5-20(28)15-24(23)35-30-26/h5,8,15,18-19,21-22H,3-4,6-7,9-14,16-17H2,1-2H3,(H,29,32) KQMNZZIIXVDTBN-UHFFFAOYSA-N 180741 US8829029, 40 D(3) dopamine receptor Homo sapiens 6 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180741 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180741&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207182 313362903 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327411 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)C1 |r,wU:10.9,5.5,wD:13.13,2.1,(13.24,-1.72,;12.47,-.39,;10.93,-.39,;10.03,.86,;8.56,.39,;8.56,-1.16,;7.23,-1.92,;5.9,-1.16,;5.9,.39,;4.56,-1.92,;3.02,-1.92,;2.25,-3.26,;.71,-3.26,;-.06,-1.92,;-1.6,-1.92,;-2.37,-.59,;-3.91,-.59,;-3.91,.95,;-5.24,1.72,;-6.57,.95,;-6.57,-.59,;-5.24,-1.36,;-7.91,1.72,;-7.91,3.26,;-10.58,3.26,;-10.58,1.72,;-11.91,.95,;-11.91,-.59,;-13.24,-1.36,;-10.58,-1.36,;-9.24,-.59,;-9.24,.95,;.71,-.59,;2.25,-.59,;10.03,-1.63,)| InChI=1S/C28H40ClN3O3/c1-34-24-8-4-20(16-24)17-27(33)30-23-6-2-19(3-7-23)10-13-32-14-11-21(12-15-32)28-25-9-5-22(29)18-26(25)35-31-28/h5,9,18-21,23-24H,2-4,6-8,10-17H2,1H3,(H,30,33) FMGBBVCKDCTAKW-UHFFFAOYSA-N 180742 US8829029, 41 D(3) dopamine receptor Homo sapiens 10 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180742&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207183 313362904 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327412 COC1(C)CCC(CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)CC1 |r,wU:11.10,wD:14.14,(12.93,-.03,;12.53,1.46,;11.05,1.86,;10.65,3.34,;11.44,.37,;10.36,-.72,;8.87,-.32,;7.78,-1.41,;6.29,-1.01,;5.89,.47,;5.2,-2.1,;3.72,-1.7,;2.63,-2.79,;1.14,-2.39,;.74,-.91,;-.75,-.51,;-1.84,-1.6,;-3.32,-1.2,;-4.41,-2.29,;-5.9,-1.89,;-6.3,-.4,;-5.21,.69,;-3.72,.29,;-7.79,-0,;-8.41,1.4,;-9.94,1.24,;-10.26,-.26,;-11.6,-1.03,;-11.6,-2.57,;-12.93,-3.34,;-10.26,-3.34,;-8.93,-2.57,;-8.93,-1.03,;1.83,.18,;3.32,-.22,;8.47,1.16,;9.56,2.25,)| InChI=1S/C30H44ClN3O3/c1-30(36-2)14-9-22(10-15-30)19-28(35)32-25-6-3-21(4-7-25)11-16-34-17-12-23(13-18-34)29-26-8-5-24(31)20-27(26)37-33-29/h5,8,20-23,25H,3-4,6-7,9-19H2,1-2H3,(H,32,35) YUMQWMQAMSUQRF-UHFFFAOYSA-N 180743 US8829029, 42 D(3) dopamine receptor Homo sapiens 8 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180743&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207184 313362905 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327413 CO[C@@]1(C)CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)CC1 |r,wU:11.10,6.6,2.2,wD:14.14,2.1,(10.2,-8.06,;9.8,-6.57,;8.47,-5.8,;7.14,-6.57,;9.8,-5.03,;9.8,-3.49,;8.47,-2.72,;8.47,-1.18,;7.14,-.41,;7.14,1.13,;5.8,-1.18,;4.47,-.41,;3.13,-1.18,;1.8,-.41,;1.8,1.13,;.47,1.9,;.47,3.44,;-.87,4.21,;-.87,5.75,;-2.2,6.52,;-3.53,5.75,;-3.53,4.21,;-2.2,3.44,;-4.87,6.52,;-4.87,8.06,;-7.53,8.06,;-7.53,6.52,;-8.87,5.75,;-8.87,4.21,;-10.2,3.44,;-7.53,3.44,;-6.2,4.21,;-6.2,5.75,;3.13,1.9,;4.47,1.13,;7.14,-3.49,;7.14,-5.03,)| InChI=1S/C30H44ClN3O3/c1-30(36-2)14-9-22(10-15-30)19-28(35)32-25-6-3-21(4-7-25)11-16-34-17-12-23(13-18-34)29-26-8-5-24(31)20-27(26)37-33-29/h5,8,20-23,25H,3-4,6-7,9-19H2,1-2H3,(H,32,35) YUMQWMQAMSUQRF-UHFFFAOYSA-N 180744 US8829029, 42A D(3) dopamine receptor Homo sapiens 6 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180744&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207184 313362906 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327414 CO[C@]1(C)CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)CC1 |r,wU:11.10,6.6,2.1,wD:14.14,2.2,(10.2,-8.06,;9.8,-6.57,;8.47,-5.8,;7.14,-6.57,;9.8,-5.03,;9.8,-3.49,;8.47,-2.72,;8.47,-1.18,;7.14,-.41,;7.14,1.13,;5.8,-1.18,;4.47,-.41,;3.13,-1.18,;1.8,-.41,;1.8,1.13,;.47,1.9,;.47,3.44,;-.87,4.21,;-.87,5.75,;-2.2,6.52,;-3.53,5.75,;-3.53,4.21,;-2.2,3.44,;-4.87,6.52,;-4.87,8.06,;-7.53,8.06,;-7.53,6.52,;-8.87,5.75,;-8.87,4.21,;-10.2,3.44,;-7.53,3.44,;-6.2,4.21,;-6.2,5.75,;3.13,1.9,;4.47,1.13,;7.14,-3.49,;7.14,-5.03,)| InChI=1S/C30H44ClN3O3/c1-30(36-2)14-9-22(10-15-30)19-28(35)32-25-6-3-21(4-7-25)11-16-34-17-12-23(13-18-34)29-26-8-5-24(31)20-27(26)37-33-29/h5,8,20-23,25H,3-4,6-7,9-19H2,1-2H3,(H,32,35) YUMQWMQAMSUQRF-UHFFFAOYSA-N 180745 US8829029, 42B D(3) dopamine receptor Homo sapiens 4 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180745 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180745&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207184 313362907 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327415 COC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:8.7,wD:11.11,(11.57,1.16,;10.24,.39,;10.24,-1.15,;11.57,-1.92,;8.9,-1.92,;7.57,-1.15,;7.57,.39,;6.24,-1.92,;4.7,-1.92,;3.93,-3.26,;2.39,-3.26,;1.62,-1.92,;.08,-1.92,;-.69,-.59,;-2.23,-.59,;-2.23,.95,;-3.57,1.72,;-4.9,.95,;-4.9,-.59,;-3.57,-1.36,;-6.24,1.72,;-6.24,3.26,;-8.9,3.26,;-8.9,1.72,;-10.24,.95,;-10.24,-.59,;-11.57,-1.36,;-8.9,-1.36,;-7.57,-.59,;-7.57,.95,;2.39,-.59,;3.93,-.59,)| InChI=1S/C25H36ClN3O3/c1-17(31-2)15-24(30)27-21-6-3-18(4-7-21)9-12-29-13-10-19(11-14-29)25-22-8-5-20(26)16-23(22)32-28-25/h5,8,16-19,21H,3-4,6-7,9-15H2,1-2H3,(H,27,30) JIZQRMQHJXHWIA-UHFFFAOYSA-N 180746 US8829029, 43 D(3) dopamine receptor Homo sapiens 10 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180746&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207340 313362908 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327416 CO[C@H](C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:8.7,wD:11.11,2.2,(10.61,2.78,;9.52,1.69,;9.92,.2,;11.4,-.2,;8.83,-.89,;7.34,-.49,;6.94,1,;6.25,-1.58,;4.71,-1.58,;3.94,-2.91,;2.4,-2.91,;1.63,-1.58,;.09,-1.58,;-.31,-.09,;-1.8,.31,;-2.88,-.78,;-4.37,-.38,;-4.77,1.11,;-3.68,2.19,;-2.19,1.8,;-6.26,1.5,;-6.88,2.91,;-8.42,2.75,;-8.74,1.24,;-10.07,.47,;-10.07,-1.07,;-11.4,-1.84,;-8.74,-1.84,;-7.4,-1.07,;-7.4,.47,;2.4,-.24,;3.94,-.24,)| InChI=1S/C25H36ClN3O3/c1-17(31-2)15-24(30)27-21-6-3-18(4-7-21)9-12-29-13-10-19(11-14-29)25-22-8-5-20(26)16-23(22)32-28-25/h5,8,16-19,21H,3-4,6-7,9-15H2,1-2H3,(H,27,30) JIZQRMQHJXHWIA-UHFFFAOYSA-N 180747 US8829029, 43A D(3) dopamine receptor Homo sapiens 15 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180747&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207341 313362909 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327417 CO[C@@H](C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:8.7,2.2,wD:11.11,(11.57,1.16,;10.24,.39,;10.24,-1.15,;11.57,-1.92,;8.9,-1.92,;7.57,-1.15,;7.57,.39,;6.24,-1.92,;4.7,-1.92,;3.93,-3.26,;2.39,-3.26,;1.62,-1.92,;.08,-1.92,;-.69,-.59,;-2.23,-.59,;-2.23,.95,;-3.57,1.72,;-4.9,.95,;-4.9,-.59,;-3.57,-1.36,;-6.24,1.72,;-6.24,3.26,;-8.9,3.26,;-8.9,1.72,;-10.24,.95,;-10.24,-.59,;-11.57,-1.36,;-8.9,-1.36,;-7.57,-.59,;-7.57,.95,;2.39,-.59,;3.93,-.59,)| InChI=1S/C25H36ClN3O3/c1-17(31-2)15-24(30)27-21-6-3-18(4-7-21)9-12-29-13-10-19(11-14-29)25-22-8-5-20(26)16-23(22)32-28-25/h5,8,16-19,21H,3-4,6-7,9-15H2,1-2H3,(H,27,30) JIZQRMQHJXHWIA-UHFFFAOYSA-N 180748 US8829029, 43B D(3) dopamine receptor Homo sapiens 6 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180748&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207342 313362910 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327418 COC[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)CC1 |r,wU:11.10,6.6,wD:14.14,3.2,(7.34,-8.85,;7.34,-7.31,;8.67,-6.54,;8.67,-5,;10,-4.23,;10,-2.69,;8.67,-1.92,;8.67,-.38,;7.34,.39,;7.34,1.93,;6,-.38,;4.67,.39,;3.33,-.38,;2,.39,;2,1.93,;.67,2.7,;.67,4.24,;-.67,5,;-.67,6.54,;-2,7.31,;-3.33,6.54,;-3.33,5,;-2,4.23,;-4.67,7.31,;-4.67,8.85,;-7.34,8.85,;-7.34,7.31,;-8.67,6.54,;-8.67,5,;-10,4.23,;-7.34,4.23,;-6,5,;-6,6.54,;3.33,2.7,;4.67,1.93,;7.34,-2.69,;7.34,-4.23,)| InChI=1S/C30H44ClN3O3/c1-36-20-23-4-2-22(3-5-23)18-29(35)32-26-9-6-21(7-10-26)12-15-34-16-13-24(14-17-34)30-27-11-8-25(31)19-28(27)37-33-30/h8,11,19,21-24,26H,2-7,9-10,12-18,20H2,1H3,(H,32,35) JACOQOMTWSSQPK-UHFFFAOYSA-N 180749 US8829029, 44 D(3) dopamine receptor Homo sapiens 9 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180749&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205074 313362911 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327419 CC1(O)CCC(CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(Cl)ccc34)CC2)CC1 |r,wU:10.9,wD:13.13,(7.34,-7.31,;8.67,-6.54,;10,-7.31,;7.34,-5.77,;7.34,-4.23,;8.67,-3.46,;8.67,-1.92,;7.34,-1.15,;7.34,.39,;6,-1.92,;4.67,-1.15,;3.33,-1.92,;2,-1.15,;2,.39,;.67,1.16,;.67,2.7,;-.67,3.46,;-.67,5,;-2,5.77,;-3.33,5,;-3.33,3.46,;-2,2.69,;-4.67,5.77,;-4.67,7.31,;-7.34,7.31,;-7.34,5.77,;-8.67,5,;-8.67,3.46,;-10,2.69,;-7.34,2.69,;-6,3.46,;-6,5,;3.33,1.16,;4.67,.39,;10,-4.23,;10,-5.77,)| InChI=1S/C29H42ClN3O3/c1-29(35)13-8-21(9-14-29)18-27(34)31-24-5-2-20(3-6-24)10-15-33-16-11-22(12-17-33)28-25-7-4-23(30)19-26(25)36-32-28/h4,7,19-22,24,35H,2-3,5-6,8-18H2,1H3,(H,31,34) QSQXTUUDWHMEIT-UHFFFAOYSA-N 180750 US8829029, 45 D(3) dopamine receptor Homo sapiens 7 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180750&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207506 313362912 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327420 CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:4.3,wD:7.7,(10.36,-.44,;8.87,-.04,;8.47,1.44,;7.78,-1.13,;6.29,-.73,;5.2,-1.82,;3.72,-1.42,;3.32,.06,;1.83,.46,;.74,-.63,;-.75,-.23,;-1.84,-1.32,;-3.32,-.92,;-3.72,.57,;-2.63,1.66,;-1.15,1.26,;-5.21,.97,;-5.84,2.37,;-7.37,2.21,;-7.69,.71,;-9.02,-.06,;-9.02,-1.6,;-10.36,-2.37,;-7.69,-2.37,;-6.35,-1.6,;-6.35,-.06,;4.41,1.15,;5.89,.75,)| InChI=1S/C22H30ClN3O2/c1-15(27)24-19-5-2-16(3-6-19)8-11-26-12-9-17(10-13-26)22-20-7-4-18(23)14-21(20)28-25-22/h4,7,14,16-17,19H,2-3,5-6,8-13H2,1H3,(H,24,27) BKICZVHEIHZFNF-UHFFFAOYSA-N 180751 US8829029, 46 D(3) dopamine receptor Homo sapiens 8.189 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180751&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207507 313362913 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327421 CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:6.5,wD:9.9,(8.67,2.41,;8.67,3.95,;7.34,4.72,;8.11,6.06,;6.57,3.39,;6,5.49,;4.67,4.72,;4.67,3.18,;3.33,2.41,;2,3.18,;.67,2.41,;-.67,3.18,;-2,2.41,;-2,.87,;-3.33,.1,;-4.67,.87,;-4.67,2.41,;-3.33,3.18,;-6,.1,;-7.34,.87,;-8.67,-1.44,;-7.34,-2.21,;-7.34,-3.75,;-6,-4.52,;-6,-6.06,;-4.67,-3.75,;-4.67,-2.21,;-6,-1.44,;2,4.72,;3.33,5.49,)| InChI=1S/C22H32FN3O3S/c1-2-30(27,28)25-19-6-3-16(4-7-19)9-12-26-13-10-17(11-14-26)22-20-8-5-18(23)15-21(20)29-24-22/h5,8,15-17,19,25H,2-4,6-7,9-14H2,1H3 OZTXHPJAKOCEFC-UHFFFAOYSA-N 180752 US8829029, 47 D(3) dopamine receptor Homo sapiens 5.852 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180752&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207508 313362914 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327422 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NS(=O)(=O)c2ccc(Cl)cc2)CC1 |r,wU:19.24,wD:16.17,(-8,-6.06,;-8,-4.52,;-6.67,-3.75,;-6.67,-2.21,;-8,-1.44,;-8,.1,;-9.34,.87,;-10.67,-1.44,;-9.34,-2.21,;-9.34,-3.75,;-6.67,.87,;-5.33,.1,;-4,.87,;-4,2.41,;-2.67,3.18,;-1.33,2.41,;,3.18,;1.33,2.41,;2.67,3.18,;2.67,4.72,;1.33,5.49,;,4.72,;4,5.49,;5.33,4.72,;6.1,6.06,;4.56,3.39,;6.67,3.95,;6.67,2.41,;8,1.64,;9.34,2.41,;10.67,1.64,;9.34,3.95,;8,4.72,;-5.33,3.18,;-6.67,2.41,)| InChI=1S/C26H31ClFN3O3S/c27-20-3-8-23(9-4-20)35(32,33)30-22-6-1-18(2-7-22)11-14-31-15-12-19(13-16-31)26-24-10-5-21(28)17-25(24)34-29-26/h3-5,8-10,17-19,22,30H,1-2,6-7,11-16H2 AAUYCVIXPYMWAL-UHFFFAOYSA-N 180753 US8829029, 48 D(3) dopamine receptor Homo sapiens 5.867 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180753&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207509 313362915 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327423 COc1ccc(cc1)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)ccc23)CC1 |r,wU:12.12,wD:15.16,(10.67,.1,;10.67,1.64,;9.34,2.41,;8,1.64,;6.67,2.41,;6.67,3.95,;8,4.72,;9.34,3.95,;5.33,4.72,;6.1,6.06,;4.56,3.39,;4,5.49,;2.67,4.72,;2.67,3.18,;1.33,2.41,;,3.18,;-1.33,2.41,;-2.67,3.18,;-4,2.41,;-4,.87,;-5.33,.1,;-6.67,.87,;-6.67,2.41,;-5.33,3.18,;-8,.1,;-9.34,.87,;-10.67,-1.44,;-9.34,-2.21,;-9.34,-3.75,;-8,-4.52,;-8,-6.06,;-6.67,-3.75,;-6.67,-2.21,;-8,-1.44,;,4.72,;1.33,5.49,)| InChI=1S/C27H34FN3O4S/c1-34-23-7-9-24(10-8-23)36(32,33)30-22-5-2-19(3-6-22)12-15-31-16-13-20(14-17-31)27-25-11-4-21(28)18-26(25)35-29-27/h4,7-11,18-20,22,30H,2-3,5-6,12-17H2,1H3 LICMDQXLIJBJOR-UHFFFAOYSA-N 180754 US8829029, 49 D(3) dopamine receptor Homo sapiens 3.719 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180754&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25207510 313362916 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327424 Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NS(=O)(=O)c2cccnc2)CC1 |r,wU:19.24,wD:16.17,(-7.34,-6.06,;-7.34,-4.52,;-6,-3.75,;-6,-2.21,;-7.34,-1.44,;-7.34,.1,;-8.67,.87,;-10,-1.44,;-8.67,-2.21,;-8.67,-3.75,;-6,.87,;-4.67,.1,;-3.33,.87,;-3.33,2.41,;-2,3.18,;-.67,2.41,;.67,3.18,;2,2.41,;3.33,3.18,;3.33,4.72,;2,5.49,;.67,4.72,;4.67,5.49,;6,4.72,;6.77,6.06,;5.23,3.39,;7.34,3.95,;7.34,2.41,;8.67,1.64,;10,2.41,;10,3.95,;8.67,4.72,;-4.67,3.18,;-6,2.41,)| InChI=1S/C25H31FN4O3S/c26-20-5-8-23-24(16-20)33-28-25(23)19-10-14-30(15-11-19)13-9-18-3-6-21(7-4-18)29-34(31,32)22-2-1-12-27-17-22/h1-2,5,8,12,16-19,21,29H,3-4,6-7,9-11,13-15H2 OWNNKPRXFVCNAN-UHFFFAOYSA-N 180755 US8829029, 50 D(3) dopamine receptor Homo sapiens 1.95 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180755&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205075 313362917 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327425 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CCC#N)CC1 |r,wU:19.24,wD:16.17,(-11.91,-.96,;-10.57,-.19,;-9.24,-.96,;-7.91,-.19,;-7.91,1.35,;-6.76,2.38,;-7.39,3.78,;-8.92,3.62,;-9.24,2.12,;-10.57,1.35,;-5.43,1.61,;-5.43,.07,;-4.1,-.7,;-2.76,.07,;-1.43,-.7,;-.09,.07,;1.24,-.7,;1.24,-2.24,;2.57,-3.01,;3.91,-2.24,;3.91,-.7,;2.57,.07,;5.24,-3.01,;6.57,-2.24,;6.57,-.7,;7.91,-3.01,;9.24,-2.24,;10.57,-3.01,;11.91,-3.78,;-2.76,1.61,;-4.1,2.38,)| InChI=1S/C24H31ClN4O2/c25-19-5-8-21-22(16-19)31-28-24(21)18-10-14-29(15-11-18)13-9-17-3-6-20(7-4-17)27-23(30)2-1-12-26/h5,8,16-18,20H,1-4,6-7,9-11,13-15H2,(H,27,30) QSMRRBPLPRZVCE-UHFFFAOYSA-N 180756 US8829029, 51 D(3) dopamine receptor Homo sapiens 8.189 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180756&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205076 313362918 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327426 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC#N)CC1 |r,wU:19.24,wD:16.17,(-11.34,-1.15,;-10,-.38,;-8.67,-1.15,;-7.34,-.38,;-7.34,1.16,;-6,1.92,;-6,3.46,;-8.67,3.47,;-8.67,1.93,;-10,1.16,;-4.67,1.15,;-4.67,-.39,;-3.33,-1.16,;-2,-.39,;-.67,-1.16,;.67,-.39,;2,-1.16,;2,-2.7,;3.33,-3.47,;4.67,-2.7,;4.67,-1.16,;3.33,-.39,;6,-3.47,;7.34,-2.7,;7.34,-1.16,;8.67,-3.47,;10,-2.7,;11.34,-1.93,;-2,1.15,;-3.33,1.92,)| InChI=1S/C23H29ClN4O2/c24-18-3-6-20-21(15-18)30-27-23(20)17-9-13-28(14-10-17)12-8-16-1-4-19(5-2-16)26-22(29)7-11-25/h3,6,15-17,19H,1-2,4-5,7-10,12-14H2,(H,26,29) MDIVYFVFTFEFJF-UHFFFAOYSA-N 180757 US8829029, 52 D(3) dopamine receptor Homo sapiens 8.772 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180757&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205077 313362919 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327427 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)C[C@H]2CCCO2)CC1 |r,wU:19.24,wD:16.17,26.28,(-11.91,-2.69,;-10.57,-1.92,;-9.24,-2.69,;-7.91,-1.92,;-7.91,-.38,;-6.76,.65,;-7.39,2.05,;-8.92,1.89,;-9.24,.39,;-10.57,-.38,;-5.27,.25,;-4.88,-1.24,;-3.39,-1.64,;-2.3,-.55,;-.81,-.95,;.28,.14,;1.76,-.26,;2.16,-1.75,;3.65,-2.14,;4.74,-1.06,;4.34,.43,;2.85,.83,;6.23,-1.45,;7.32,-.37,;6.92,1.12,;8.8,-.76,;9.89,.33,;11.43,.33,;11.91,1.79,;10.66,2.69,;9.42,1.79,;-2.7,.94,;-4.19,1.34,)| InChI=1S/C26H36ClN3O3/c27-20-5-8-23-24(16-20)33-29-26(23)19-10-13-30(14-11-19)12-9-18-3-6-21(7-4-18)28-25(31)17-22-2-1-15-32-22/h5,8,16,18-19,21-22H,1-4,6-7,9-15,17H2,(H,28,31) XLEPAPXUDZKLLX-UHFFFAOYSA-N 180758 US8829029, 53 D(3) dopamine receptor Homo sapiens 14.446 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180758&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 66741766 313362920 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327428 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CC2)CC1 |r,wU:19.24,wD:16.17,(-10.11,1.15,;-8.77,1.93,;-7.44,1.15,;-6.1,1.93,;-6.1,3.47,;-4.77,4.23,;-4.77,5.78,;-7.44,5.78,;-7.44,4.23,;-8.77,3.47,;-3.44,3.47,;-3.44,1.93,;-2.1,1.15,;-.77,1.93,;.56,1.16,;.56,-.38,;1.9,-1.15,;1.9,-2.69,;3.23,-3.47,;4.56,-2.69,;4.56,-1.15,;3.23,-.38,;5.9,-3.46,;5.9,-5,;4.56,-5.78,;7.23,-5.78,;8.57,-5,;10.11,-5,;9.34,-3.67,;-.77,3.47,;-2.1,4.24,)| InChI=1S/C25H34ClN3O2/c26-20-5-8-22-23(16-20)31-28-25(22)19-10-13-29(14-11-19)12-9-17-3-6-21(7-4-17)27-24(30)15-18-1-2-18/h5,8,16-19,21H,1-4,6-7,9-15H2,(H,27,30) APRSYGAYLCLFDY-UHFFFAOYSA-N 180759 US8829029, 54 D(3) dopamine receptor Homo sapiens 3.206 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180759&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205244 313362921 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327429 OCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:5.4,wD:8.8,(10.92,-2.81,;9.59,-3.58,;8.25,-2.81,;8.25,-1.27,;6.92,-3.58,;5.58,-2.81,;4.25,-3.58,;2.92,-2.81,;2.92,-1.27,;1.58,-.5,;.25,-1.27,;-1.08,-.5,;-2.42,-1.27,;-3.75,-.5,;-3.75,1.04,;-2.42,1.81,;-1.08,1.04,;-5.08,1.81,;-5.33,3.33,;-6.85,3.58,;-7.55,2.2,;-9.03,1.81,;-9.43,.32,;-10.92,-.08,;-8.34,-.77,;-6.86,-.37,;-6.46,1.11,;4.25,-.5,;5.58,-1.27,)| InChI=1S/C22H30ClN3O3/c23-17-3-6-19-20(13-17)29-25-22(19)16-8-11-26(12-9-16)10-7-15-1-4-18(5-2-15)24-21(28)14-27/h3,6,13,15-16,18,27H,1-2,4-5,7-12,14H2,(H,24,28) RICCGUYAQMEDQJ-UHFFFAOYSA-N 180760 US8829029, 55 D(3) dopamine receptor Homo sapiens 16.81 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180760 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180760&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205245 313362922 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327430 CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)ccc23)CC1 |r,wU:8.7,wD:11.11,(11.59,-3.58,;10.25,-2.81,;9.48,-1.47,;11.02,-1.47,;8.92,-3.58,;7.59,-2.81,;7.59,-1.27,;6.25,-3.58,;4.92,-2.81,;3.58,-3.58,;2.25,-2.81,;2.25,-1.27,;.92,-.5,;-.42,-1.27,;-1.75,-.5,;-3.08,-1.27,;-4.42,-.5,;-4.42,1.04,;-3.08,1.81,;-1.75,1.04,;-5.75,1.81,;-5.99,3.33,;-7.51,3.58,;-8.21,2.2,;-9.7,1.81,;-10.1,.32,;-11.59,-.08,;-9.01,-.77,;-7.52,-.37,;-7.12,1.11,;3.58,-.5,;4.92,-1.27,)| InChI=1S/C23H32ClN3O4S/c1-32(29,30)15-22(28)25-19-5-2-16(3-6-19)8-11-27-12-9-17(10-13-27)23-20-7-4-18(24)14-21(20)31-26-23/h4,7,14,16-17,19H,2-3,5-6,8-13,15H2,1H3,(H,25,28) XASDIOYQYXRDEM-UHFFFAOYSA-N 180761 US8829029, 56 D(3) dopamine receptor Homo sapiens 14.784 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180761&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205246 313362923 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327431 Clc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2OCCCO2)CC1 |r,wU:19.24,wD:16.17,(-12.06,-1.36,;-10.72,-.59,;-9.39,-1.36,;-8.06,-.59,;-8.06,.95,;-6.91,1.98,;-7.54,3.39,;-9.07,3.23,;-9.39,1.72,;-10.72,.95,;-5.42,1.58,;-5.02,.09,;-3.54,-.3,;-2.45,.78,;-.96,.39,;-.56,-1.1,;.93,-1.5,;1.32,-2.99,;2.81,-3.39,;3.9,-2.3,;3.5,-.81,;2.01,-.41,;5.39,-2.7,;6.72,-1.93,;6.72,-.39,;8.06,-2.7,;9.39,-1.93,;10.72,-2.7,;12.06,-1.93,;12.06,-.39,;10.72,.38,;9.39,-.39,;-2.85,2.27,;-4.33,2.67,)| InChI=1S/C26H36ClN3O4/c27-20-4-7-22-23(16-20)34-29-26(22)19-9-12-30(13-10-19)11-8-18-2-5-21(6-3-18)28-24(31)17-25-32-14-1-15-33-25/h4,7,16,18-19,21,25H,1-3,5-6,8-15,17H2,(H,28,31) QXBMPTZQYXHXCG-UHFFFAOYSA-N 180762 US8829029, 57 D(3) dopamine receptor Homo sapiens 6.13 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180762 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180762&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205247 313362924 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327432 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4ccc(Cl)cc34)CC2)CC1 |r,wU:10.9,2.1,wD:13.13,5.5,(12.84,-1.27,;11.51,-.5,;10.18,-1.27,;10.18,-2.81,;8.84,-3.58,;7.51,-2.81,;6.17,-3.58,;4.84,-2.81,;4.84,-1.27,;3.51,-3.58,;2.17,-2.81,;.84,-3.58,;-.49,-2.81,;-.49,-1.27,;-1.83,-.5,;-3.16,-1.27,;-4.49,-.5,;-5.83,-1.27,;-7.16,-.5,;-7.16,1.04,;-5.83,1.81,;-4.49,1.04,;-8.5,1.81,;-8.74,3.33,;-10.26,3.58,;-10.96,2.2,;-12.44,1.81,;-12.84,.32,;-11.75,-.77,;-12.15,-2.26,;-10.27,-.37,;-9.87,1.11,;.84,-.5,;2.17,-1.27,;7.51,-1.27,;8.84,-.5,)| InChI=1S/C29H42ClN3O3/c1-35-25-9-4-21(5-10-25)18-28(34)31-24-7-2-20(3-8-24)12-15-33-16-13-22(14-17-33)29-26-19-23(30)6-11-27(26)36-32-29/h6,11,19-22,24-25H,2-5,7-10,12-18H2,1H3,(H,31,34) CMOUHGOJSYWQFR-UHFFFAOYSA-N 180763 US8829029, 58 D(3) dopamine receptor Homo sapiens 8.381 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180763 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180763&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205248 313362925 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327433 CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3ccc(F)cc23)CC1 |r,wU:5.4,wD:8.8,(9.91,.76,;8.43,.36,;8.43,1.9,;8.43,-1.18,;6.89,.36,;5.4,-.04,;5,-1.52,;3.51,-1.92,;2.42,-.83,;.94,-1.23,;-.15,-.14,;-1.64,-.54,;-2.04,-2.03,;-3.53,-2.43,;-4.61,-1.34,;-4.22,.15,;-2.73,.55,;-6.1,-1.74,;-6.73,-3.14,;-8.26,-2.98,;-8.58,-1.48,;-9.91,-.71,;-9.91,.83,;-8.58,1.6,;-8.58,3.14,;-7.25,.83,;-7.25,-.71,;2.82,.65,;4.31,1.05,)| InChI=1S/C21H30FN3O3S/c1-29(26,27)24-18-5-2-15(3-6-18)8-11-25-12-9-16(10-13-25)21-19-14-17(22)4-7-20(19)28-23-21/h4,7,14-16,18,24H,2-3,5-6,8-13H2,1H3 MPTVODVQFOZFHF-UHFFFAOYSA-N 180764 US8829029, 59 D(3) dopamine receptor Homo sapiens 7.98 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180764 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180764&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205249 313362926 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327434 COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(Cl)c(F)cc23)CC1 |r,wU:7.6,wD:10.10,(12.06,-1.93,;10.72,-2.7,;9.39,-1.93,;8.06,-2.7,;6.72,-1.93,;6.72,-.39,;5.39,-2.7,;3.9,-2.3,;2.81,-3.39,;1.32,-2.99,;.93,-1.5,;-.56,-1.1,;-.96,.39,;-2.45,.78,;-3.54,-.3,;-5.02,.09,;-5.42,1.58,;-4.33,2.67,;-2.85,2.27,;-6.91,1.98,;-7.54,3.39,;-9.07,3.23,;-9.39,1.72,;-10.72,.95,;-10.72,-.59,;-12.06,-1.36,;-9.39,-1.36,;-9.39,-2.9,;-8.06,-.59,;-8.06,.95,;2.01,-.41,;3.5,-.81,)| InChI=1S/C24H33ClFN3O3/c1-31-13-9-23(30)27-18-4-2-16(3-5-18)6-10-29-11-7-17(8-12-29)24-19-14-21(26)20(25)15-22(19)32-28-24/h14-18H,2-13H2,1H3,(H,27,30) HGFFXOQKGSYWIH-UHFFFAOYSA-N 180765 US8829029, 60 D(3) dopamine receptor Homo sapiens 13.54 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180765 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180765&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205417 313362927 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327435 Fc1cc2c(noc2cc1Cl)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)CC2CCCO2)CC1 |r,wU:20.25,wD:17.18,(-9.3,-2.9,;-9.3,-1.36,;-7.97,-.59,;-7.97,.95,;-6.82,1.98,;-7.45,3.39,;-8.98,3.23,;-9.3,1.72,;-10.63,.95,;-10.63,-.59,;-11.97,-1.36,;-5.34,1.58,;-4.94,.09,;-3.45,-.3,;-2.36,.78,;-.87,.39,;-.47,-1.1,;1.01,-1.5,;1.41,-2.99,;2.9,-3.39,;3.99,-2.3,;3.59,-.81,;2.1,-.41,;5.48,-2.7,;6.81,-1.93,;6.81,-.39,;8.14,-2.7,;9.48,-1.93,;10.72,-2.83,;11.97,-1.93,;11.49,-.46,;9.95,-.46,;-2.76,2.27,;-4.25,2.67,)| InChI=1S/C26H35ClFN3O3/c27-22-16-24-21(15-23(22)28)26(30-34-24)18-8-11-31(12-9-18)10-7-17-3-5-19(6-4-17)29-25(32)14-20-2-1-13-33-20/h15-20H,1-14H2,(H,29,32) QKGGUYOGIVKJFF-UHFFFAOYSA-N 180766 US8829029, 61 D(3) dopamine receptor Homo sapiens 17.732 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180766 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180766&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205418 313362928 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327436 COCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)c(F)cc23)CC1 |r,wU:6.5,wD:9.9,(11.39,-2.7,;10.06,-1.93,;8.72,-2.7,;7.39,-1.93,;7.39,-.39,;6.05,-2.7,;4.57,-2.3,;3.48,-3.39,;1.99,-2.99,;1.59,-1.5,;.1,-1.1,;-.29,.39,;-1.78,.78,;-2.87,-.3,;-4.36,.09,;-4.76,1.58,;-3.67,2.67,;-2.18,2.27,;-6.24,1.98,;-6.87,3.39,;-8.4,3.23,;-8.72,1.72,;-10.06,.95,;-10.06,-.59,;-11.39,-1.36,;-8.72,-1.36,;-8.72,-2.9,;-7.39,-.59,;-7.39,.95,;2.68,-.41,;4.17,-.81,)| InChI=1S/C23H31F2N3O3/c1-30-14-22(29)26-17-4-2-15(3-5-17)6-9-28-10-7-16(8-11-28)23-18-12-19(24)20(25)13-21(18)31-27-23/h12-13,15-17H,2-11,14H2,1H3,(H,26,29) OCLIEDSOSAGNEM-UHFFFAOYSA-N 180767 US8829029, 62 D(3) dopamine receptor Homo sapiens 32.674 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180767 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180767&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205419 313362929 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327437 CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)c(F)cc34)CC2)C1 |r,wU:10.9,2.1,wD:13.13,5.5,(13.26,-1.24,;12.17,-2.32,;10.68,-1.93,;10.2,-.46,;8.66,-.46,;8.19,-1.93,;6.85,-2.7,;5.52,-1.93,;5.52,-.39,;4.19,-2.7,;2.7,-2.3,;1.61,-3.39,;.12,-2.99,;-.27,-1.5,;-1.76,-1.1,;-2.16,.39,;-3.65,.78,;-4.74,-.3,;-6.22,.09,;-6.62,1.58,;-5.53,2.67,;-4.05,2.27,;-8.11,1.98,;-8.74,3.39,;-10.27,3.23,;-10.59,1.72,;-11.92,.95,;-11.92,-.59,;-13.26,-1.36,;-10.59,-1.36,;-10.59,-2.9,;-9.26,-.59,;-9.26,.95,;.81,-.41,;2.3,-.81,;9.43,-2.83,)| InChI=1S/C28H39F2N3O3/c1-35-22-7-4-19(14-22)15-27(34)31-21-5-2-18(3-6-21)8-11-33-12-9-20(10-13-33)28-23-16-24(29)25(30)17-26(23)36-32-28/h16-22H,2-15H2,1H3,(H,31,34) HJUAHZKICLIRDT-UHFFFAOYSA-N 180768 US8829029, 63 D(3) dopamine receptor Homo sapiens 19.994 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180768 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180768&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205420 313362930 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327438 CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)c(F)cc34)CC2)CC1 |r,wU:10.9,2.1,wD:13.13,5.5,(13.39,-.39,;12.06,.38,;10.72,-.39,;10.72,-1.93,;9.39,-2.7,;8.06,-1.93,;6.72,-2.7,;5.39,-1.93,;5.39,-.39,;4.05,-2.7,;2.57,-2.3,;1.48,-3.39,;-.01,-2.99,;-.41,-1.5,;-1.9,-1.1,;-2.29,.39,;-3.78,.78,;-4.87,-.3,;-6.36,.09,;-6.76,1.58,;-5.67,2.67,;-4.18,2.27,;-8.24,1.98,;-8.87,3.39,;-10.4,3.23,;-10.72,1.72,;-12.06,.95,;-12.06,-.59,;-13.39,-1.36,;-10.72,-1.36,;-10.72,-2.9,;-9.39,-.59,;-9.39,.95,;.68,-.41,;2.17,-.81,;8.06,-.39,;9.39,.38,)| InChI=1S/C29H41F2N3O3/c1-36-23-8-4-20(5-9-23)16-28(35)32-22-6-2-19(3-7-22)10-13-34-14-11-21(12-15-34)29-24-17-25(30)26(31)18-27(24)37-33-29/h17-23H,2-16H2,1H3,(H,32,35) ORNXSTGAFURZLS-UHFFFAOYSA-N 180769 US8829029, 64 D(3) dopamine receptor Homo sapiens 17.303 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180769&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205421 313362931 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327439 COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)c(F)cc23)CC1 |r,wU:7.6,wD:10.10,(12.06,-1.93,;10.72,-2.7,;9.39,-1.93,;8.06,-2.7,;6.72,-1.93,;6.72,-.39,;5.39,-2.7,;3.9,-2.3,;2.81,-3.39,;1.32,-2.99,;.93,-1.5,;-.56,-1.1,;-.96,.39,;-2.45,.78,;-3.54,-.3,;-5.02,.09,;-5.42,1.58,;-4.33,2.67,;-2.85,2.27,;-6.91,1.98,;-7.54,3.39,;-9.07,3.23,;-9.39,1.72,;-10.72,.95,;-10.72,-.59,;-12.06,-1.36,;-9.39,-1.36,;-9.39,-2.9,;-8.06,-.59,;-8.06,.95,;2.01,-.41,;3.5,-.81,)| InChI=1S/C24H33F2N3O3/c1-31-13-9-23(30)27-18-4-2-16(3-5-18)6-10-29-11-7-17(8-12-29)24-19-14-20(25)21(26)15-22(19)32-28-24/h14-18H,2-13H2,1H3,(H,27,30) OUHCXMUUIFHTFO-UHFFFAOYSA-N 180770 US8829029, 65 D(3) dopamine receptor Homo sapiens 11.356 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180770 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180770&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205584 313362932 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327440 CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)c(F)cc23)CC1 |r,wU:4.3,wD:7.7,(10.06,-2.7,;8.72,-1.93,;8.72,-.39,;7.39,-2.7,;5.9,-2.3,;4.81,-3.39,;3.32,-2.99,;2.93,-1.5,;1.44,-1.1,;1.04,.39,;-.45,.78,;-1.54,-.3,;-3.02,.09,;-3.42,1.58,;-2.33,2.67,;-.85,2.27,;-4.91,1.98,;-5.54,3.39,;-7.07,3.23,;-7.39,1.72,;-8.72,.95,;-8.72,-.59,;-10.06,-1.36,;-7.39,-1.36,;-7.39,-2.9,;-6.05,-.59,;-6.05,.95,;4.01,-.41,;5.5,-.81,)| InChI=1S/C22H29F2N3O2/c1-14(28)25-17-4-2-15(3-5-17)6-9-27-10-7-16(8-11-27)22-18-12-19(23)20(24)13-21(18)29-26-22/h12-13,15-17H,2-11H2,1H3,(H,25,28) WTUNYPKNGBFPKZ-UHFFFAOYSA-N 180771 US8829029, 66 D(3) dopamine receptor Homo sapiens 11.368 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180771 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180771&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205585 313362933 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327441 OCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)c(F)cc23)CC1 |r,wU:5.4,wD:8.8,(10.72,-1.93,;9.39,-2.7,;8.06,-1.93,;8.06,-.39,;6.72,-2.7,;5.23,-2.3,;4.15,-3.39,;2.66,-2.99,;2.26,-1.5,;.77,-1.1,;.37,.39,;-1.11,.78,;-2.2,-.3,;-3.69,.09,;-4.09,1.58,;-3,2.67,;-1.51,2.27,;-5.58,1.98,;-6.2,3.39,;-7.74,3.23,;-8.06,1.72,;-9.39,.95,;-9.39,-.59,;-10.72,-1.36,;-8.06,-1.36,;-8.06,-2.9,;-6.72,-.59,;-6.72,.95,;3.35,-.41,;4.84,-.81,)| InChI=1S/C22H29F2N3O3/c23-18-11-17-20(12-19(18)24)30-26-22(17)15-6-9-27(10-7-15)8-5-14-1-3-16(4-2-14)25-21(29)13-28/h11-12,14-16,28H,1-10,13H2,(H,25,29) MQHVJCAEBAKURM-UHFFFAOYSA-N 180772 US8829029, 67 D(3) dopamine receptor Homo sapiens 19.95 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180772 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180772&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205586 313362934 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327442 OCCC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(F)c(F)cc23)CC1 |r,wU:6.5,wD:9.9,(11.59,-3.58,;10.25,-2.81,;8.92,-3.58,;7.59,-2.81,;7.59,-1.27,;6.25,-3.58,;4.92,-2.81,;3.58,-3.58,;2.25,-2.81,;2.25,-1.27,;.92,-.5,;-.42,-1.27,;-1.75,-.5,;-3.08,-1.27,;-4.42,-.5,;-4.42,1.04,;-3.08,1.81,;-1.75,1.04,;-5.75,1.81,;-5.99,3.33,;-7.51,3.58,;-8.21,2.2,;-9.7,1.81,;-10.1,.32,;-11.59,-.08,;-9.01,-.77,;-9.41,-2.26,;-7.52,-.37,;-7.12,1.11,;3.58,-.5,;4.92,-1.27,)| InChI=1S/C23H31F2N3O3/c24-19-13-18-21(14-20(19)25)31-27-23(18)16-6-10-28(11-7-16)9-5-15-1-3-17(4-2-15)26-22(30)8-12-29/h13-17,29H,1-12H2,(H,26,30) ZCRJZGXULSARDJ-UHFFFAOYSA-N 180773 US8829029, 68 D(3) dopamine receptor Homo sapiens 11.72 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180773&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205587 313362935 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327443 O[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)c(F)cc34)CC2)CC1 |r,wU:9.8,1.0,wD:12.12,4.4,(12.92,-.5,;11.59,-1.27,;11.59,-2.81,;10.25,-3.58,;8.92,-2.81,;7.59,-3.58,;6.25,-2.81,;6.25,-1.27,;4.92,-3.58,;3.58,-2.81,;2.25,-3.58,;.92,-2.81,;.92,-1.27,;-.42,-.5,;-1.75,-1.27,;-3.08,-.5,;-4.42,-1.27,;-5.75,-.5,;-5.75,1.04,;-4.42,1.81,;-3.08,1.04,;-7.09,1.81,;-7.33,3.34,;-8.85,3.58,;-9.55,2.2,;-11.03,1.81,;-11.43,.32,;-12.92,-.08,;-10.34,-.77,;-10.74,-2.26,;-8.86,-.37,;-8.46,1.11,;2.25,-.5,;3.58,-1.27,;8.92,-1.27,;10.25,-.5,)| InChI=1S/C28H39F2N3O3/c29-24-16-23-26(17-25(24)30)36-32-28(23)20-10-13-33(14-11-20)12-9-18-1-5-21(6-2-18)31-27(35)15-19-3-7-22(34)8-4-19/h16-22,34H,1-15H2,(H,31,35) BIIZSYSIBVAOCG-UHFFFAOYSA-N 180774 US8829029, 69 D(3) dopamine receptor Homo sapiens 20.912 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180774 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180774&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205588 313362936 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327444 O[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(CC3)c3noc4cc(F)c(F)cc34)CC2)C1 |r,wU:9.8,1.0,wD:12.12,4.4,(12.68,-1.16,;11.14,-1.16,;10.23,.09,;8.77,-.39,;8.77,-1.93,;7.43,-2.7,;6.1,-1.93,;6.1,-.39,;4.77,-2.7,;3.28,-2.3,;2.19,-3.39,;.7,-2.99,;.3,-1.5,;-1.18,-1.1,;-1.58,.39,;-3.07,.78,;-4.16,-.3,;-5.65,.09,;-6.04,1.58,;-4.96,2.67,;-3.47,2.27,;-7.53,1.98,;-8.16,3.39,;-9.69,3.23,;-10.01,1.72,;-11.34,.95,;-11.34,-.59,;-12.68,-1.36,;-10.01,-1.36,;-10.01,-2.9,;-8.68,-.59,;-8.68,.95,;1.39,-.41,;2.88,-.81,;10.23,-2.4,)| InChI=1S/C27H37F2N3O3/c28-23-15-22-25(16-24(23)29)35-31-27(22)19-8-11-32(12-9-19)10-7-17-1-4-20(5-2-17)30-26(34)14-18-3-6-21(33)13-18/h15-21,33H,1-14H2,(H,30,34) RQSYJHOVRPMPEE-UHFFFAOYSA-N 180775 US8829029, 70 D(3) dopamine receptor Homo sapiens 19.756 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180775 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180775&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205589 313362937 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327445 Fc1cc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)C4CCOCC4)CC3)c2cc1F |r,wU:16.19,wD:13.12,(-11.59,1.07,;-10.1,1.47,;-9.7,2.96,;-8.21,3.36,;-7.51,4.73,;-5.99,4.49,;-5.75,2.97,;-4.42,2.2,;-4.42,.66,;-3.08,-.11,;-1.75,.66,;-.42,-.11,;.92,.66,;2.25,-.11,;2.25,-1.65,;3.58,-2.42,;4.92,-1.65,;4.92,-.11,;3.58,.66,;6.25,-2.42,;7.59,-1.65,;7.59,-.11,;8.92,-2.42,;8.92,-3.96,;10.25,-4.73,;11.59,-3.96,;11.59,-2.42,;10.25,-1.65,;-1.75,2.2,;-3.08,2.97,;-7.12,2.27,;-7.52,.78,;-9.01,.38,;-9.41,-1.1,)| InChI=1S/C26H35F2N3O3/c27-22-15-21-24(16-23(22)28)34-30-25(21)18-6-11-31(12-7-18)10-5-17-1-3-20(4-2-17)29-26(32)19-8-13-33-14-9-19/h15-20H,1-14H2,(H,29,32) XJIBUBWKKHZDSR-UHFFFAOYSA-N 180776 US8829029, 71 D(3) dopamine receptor Homo sapiens 18.169 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180776&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205751 313362938 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327446 Fc1cc2onc(C3CCN(CC[C@H]4CC[C@@H](CC4)NC(=O)CC4OCCCO4)CC3)c2cc1F |r,wU:16.19,wD:13.12,(-12.25,-.08,;-10.77,.32,;-10.37,1.81,;-8.88,2.2,;-8.18,3.58,;-6.66,3.33,;-6.42,1.81,;-5.08,1.04,;-5.08,-.5,;-3.75,-1.27,;-2.42,-.5,;-1.08,-1.27,;.25,-.5,;1.58,-1.27,;1.58,-2.81,;2.92,-3.58,;4.25,-2.81,;4.25,-1.27,;2.92,-.5,;5.58,-3.58,;6.92,-2.81,;6.92,-1.27,;8.25,-3.58,;9.59,-2.81,;10.92,-3.58,;12.25,-2.81,;12.25,-1.27,;10.92,-.5,;9.59,-1.27,;-2.42,1.04,;-3.75,1.81,;-7.79,1.11,;-8.19,-.37,;-9.68,-.77,;-10.08,-2.26,)| InChI=1S/C26H35F2N3O4/c27-21-14-20-23(15-22(21)28)35-30-26(20)18-7-10-31(11-8-18)9-6-17-2-4-19(5-3-17)29-24(32)16-25-33-12-1-13-34-25/h14-15,17-19,25H,1-13,16H2,(H,29,32) CWGVRZIECOGVLA-UHFFFAOYSA-N 180777 US8829029, 72 D(3) dopamine receptor Homo sapiens 13.512 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180777&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205752 313362939 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 327447 CC(=O)N[C@H]1CC[C@H](CCN2CCC(CC2)c2noc3cc(C)ccc23)CC1 |r,wU:4.3,wD:7.7,(10.25,-3.58,;8.92,-2.81,;8.92,-1.27,;7.59,-3.58,;6.25,-2.81,;4.92,-3.58,;3.58,-2.81,;3.58,-1.27,;2.25,-.5,;.92,-1.27,;-.42,-.5,;-1.75,-1.27,;-3.08,-.5,;-3.08,1.04,;-1.75,1.81,;-.42,1.04,;-4.42,1.81,;-4.66,3.33,;-6.18,3.58,;-6.88,2.2,;-8.37,1.81,;-8.77,.32,;-10.25,-.08,;-7.68,-.77,;-6.19,-.37,;-5.79,1.11,;4.92,-.5,;6.25,-1.27,)| InChI=1S/C23H33N3O2/c1-16-3-8-21-22(15-16)28-25-23(21)19-10-13-26(14-11-19)12-9-18-4-6-20(7-5-18)24-17(2)27/h3,8,15,18-20H,4-7,9-14H2,1-2H3,(H,24,27) FJCLYLWFKWDKEV-UHFFFAOYSA-N 180778 US8829029, 73 D(3) dopamine receptor Homo sapiens 9.275 US Patent 10.7270/Q22B8WSS aid1801625 US8829029 Gobbi, L; Jaeschke, G; Roche, O; Sarmiento, RM; Steward, L 9/9/2014 5/23/2016 Hoffmann-La Roche http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=180778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=180778&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 25205753 313362940 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 8IRT,7CMV,7CMU D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8